Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,A1BG,Alpha-1B-glycoprotein,14518,122,1.71 [0.60-4.86],0.3118942726883552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AAMDC,Mth938 domain-containing protein,14129,115,1.12 [0.80-1.58],0.5087933117652054
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AARSD1,Alanyl-tRNA editing protein Aarsd1,16535,147,1.26 [0.97-1.63],0.0810361849981942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABCA2,ATP-binding cassette sub-family A member 2,14028,116,0.92 [0.55-1.53],0.7401276136529016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABHD14B,Protein ABHD14B,16414,144,1.16 [0.89-1.50],0.2699512000930417
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABL1,Tyrosine-protein kinase ABL1,16535,147,1.07 [0.86-1.33],0.5618100025477293
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABO,Histo-blood group ABO system transferase,14510,123,1.01 [0.89-1.13],0.9328746215491628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABRAXAS2,BRISC complex subunit Abraxas 2,14028,116,1.03 [0.78-1.36],0.8309361101517847
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",16261,143,1.02 [0.84-1.23],0.8568824220480028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",14233,119,1.08 [0.87-1.35],0.4824809048456757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",14489,121,0.97 [0.79-1.18],0.7409545686612122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACAN,Aggrecan core protein,16418,141,1.48 [0.85-2.57],0.1626772944260036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACE,Angiotensin-converting enzyme,14510,123,1.28 [0.69-2.38],0.4381040295478402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACE2,Angiotensin-converting enzyme 2,16307,141,0.96 [0.71-1.29],0.7752138300740601
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACHE,Acetylcholinesterase,14204,118,1.23 [0.73-2.07],0.4283630504213335
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACOT13,Acyl-coenzyme A thioesterase 13,14431,123,0.98 [0.84-1.14],0.7927583870697186
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,16596,146,1.03 [0.77-1.38],0.8310644714161177
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACP1,Low molecular weight phosphotyrosine protein phosphatase,14069,119,1.24 [0.87-1.77],0.2265602038190359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACP5,Tartrate-resistant acid phosphatase type 5,16707,143,1.00 [0.63-1.60],0.9882237488928276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACP6,Lysophosphatidic acid phosphatase type 6,16731,145,1.01 [0.82-1.25],0.9171455634347114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACRBP,Acrosin-binding protein,14445,123,0.74 [0.46-1.19],0.2083635888918011
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACRV1,Acrosomal protein SP-10,14069,119,0.90 [0.73-1.11],0.3194954951854284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACSL1,Long-chain-fatty-acid--CoA ligase 1,14028,116,1.30 [0.88-1.91],0.1900305134623666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACTA2,"Actin, aortic smooth muscle",16307,141,1.23 [0.90-1.69],0.1984612554396605
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACTN2,Alpha-actinin-2,14028,116,1.20 [0.91-1.60],0.2023484254685696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACTN4,Alpha-actinin-4,16319,145,0.65 [0.37-1.13],0.125645335654279
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACVRL1,Serine/threonine-protein kinase receptor R3,16432,141,1.61 [0.90-2.90],0.1088846922677794
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACY1,Aminoacylase-1,16596,146,1.04 [0.81-1.33],0.7852730749583644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,14028,116,1.22 [0.89-1.67],0.2136318388381483
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACYP1,Acylphosphatase-1,14152,118,1.26 [0.96-1.64],0.0899905196604842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADA,Adenosine deaminase,16776,146,0.91 [0.60-1.38],0.6477881413983732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADA2,Adenosine deaminase 2,16544,143,1.23 [0.87-1.74],0.2322057376330904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,14069,119,1.40 [0.83-2.35],0.2038553147465869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,16307,141,1.32 [0.81-2.15],0.2595137261459607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,16463,144,1.24 [0.82-1.89],0.3090021516269078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,16776,146,0.95 [0.63-1.44],0.8241692559217717
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,16703,146,1.64 [0.98-2.76],0.0599778930042907
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,14431,123,1.21 [0.68-2.18],0.5173907469930812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,14069,119,1.57 [1.00-2.46],0.0500643011659141
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,16810,143,1.22 [0.64-2.31],0.549889797627646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,16535,147,0.85 [0.60-1.20],0.3517071173760688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,16307,141,1.27 [0.88-1.81],0.1982721758055542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,14069,119,0.74 [0.44-1.25],0.254600240783735
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,16671,146,1.11 [0.80-1.54],0.5481871223347168
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTSL2,ADAMTS-like protein 2,14504,123,1.39 [0.83-2.33],0.2070286236701517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTSL4,ADAMTS-like protein 4,14129,115,0.76 [0.35-1.65],0.4926351677938759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTSL5,ADAMTS-like protein 5,14489,121,0.74 [0.47-1.15],0.1808375911254384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,16261,143,1.06 [0.71-1.57],0.7888539034631353
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADD1,Alpha-adducin,14204,118,1.14 [0.88-1.46],0.3194004069174208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRB3,Adhesion G protein-coupled receptor B3,16432,141,1.50 [0.97-2.34],0.0702971461551089
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRD1,Adhesion G-protein coupled receptor D1,14204,118,0.99 [0.62-1.58],0.968313622901246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRE1,Adhesion G protein-coupled receptor E1,14431,123,1.10 [0.80-1.51],0.5468049723231732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRE2,Adhesion G protein-coupled receptor E2,16677,147,1.29 [0.77-2.15],0.3378305116800375
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRE5,Adhesion G protein-coupled receptor E5,16750,143,1.00 [0.62-1.64],0.9873629871215784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRF5,Adhesion G protein-coupled receptor F5,14489,121,1.02 [0.54-1.94],0.9482948985993004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRG1,Adhesion G-protein coupled receptor G1,16535,147,1.05 [0.88-1.25],0.6089293297553771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRG2,Adhesion G-protein coupled receptor G2,16596,146,0.82 [0.47-1.43],0.4926120018404732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRV1,Adhesion G-protein coupled receptor V1,14051,117,0.83 [0.62-1.11],0.2105111288111261
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADH1B,All-trans-retinol dehydrogenase,14204,118,1.14 [0.90-1.43],0.2806370877957441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,16307,141,1.10 [0.91-1.32],0.3367648574244323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADIPOQ,Adiponectin,14518,122,0.94 [0.73-1.21],0.6204631703842796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADM,Pro-adrenomedullin,16761,145,1.02 [0.57-1.83],0.9492330649790336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADRA2A,Alpha-2A adrenergic receptor,14028,116,1.18 [0.95-1.47],0.1360156063258232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AFAP1,Actin filament-associated protein 1,14204,118,1.02 [0.82-1.27],0.8427120788471857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AFM,Afamin,14518,122,1.04 [0.44-2.48],0.928226710798836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AFP,Alpha-fetoprotein,16408,141,1.09 [0.87-1.36],0.4735720188015985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGBL2,Cytosolic carboxypeptidase 2,14051,117,0.94 [0.78-1.14],0.5475900824979663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGER,Advanced glycosylation end product-specific receptor,16571,147,1.35 [0.94-1.93],0.1046978182277997
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGR2,Anterior gradient protein 2 homolog,16096,142,1.09 [0.94-1.26],0.2699346074085906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGR3,Anterior gradient protein 3,16225,142,0.83 [0.64-1.08],0.1754329250929028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGRN,Agrin,16677,147,1.47 [0.97-2.22],0.071128700258616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGRP,Agouti-related protein,16776,146,1.16 [0.86-1.55],0.3259102146804441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGT,Angiotensinogen,14510,123,1.68 [0.83-3.40],0.1514322943761387
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGXT,Serine--pyruvate aminotransferase,16596,146,0.93 [0.76-1.15],0.5019927650583931
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHCY,Adenosylhomocysteinase,16596,146,1.07 [0.86-1.33],0.5552787104471767
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHNAK,Neuroblast differentiation-associated protein AHNAK,14129,115,1.29 [0.73-2.26],0.3767614577843351
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHNAK2,Protein AHNAK2,14129,115,1.38 [0.81-2.37],0.2391646073926685
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,14445,123,1.11 [0.87-1.40],0.4083920787327422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHSG,Alpha-2-HS-glycoprotein,14510,123,1.57 [0.83-2.97],0.1609643269000452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHSP,Alpha-hemoglobin-stabilizing protein,16588,145,1.11 [0.93-1.33],0.2510819155405983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIDA,"Axin interactor, dorsalization-associated protein",14119,118,0.91 [0.72-1.14],0.3991945776468081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIF1,Allograft inflammatory factor 1,16261,143,0.90 [0.67-1.20],0.4655208827241253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIF1L,Allograft inflammatory factor 1-like,14129,115,0.91 [0.64-1.30],0.6172563971714713
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",16511,147,0.97 [0.85-1.12],0.7198216234664474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AK1,Adenylate kinase isoenzyme 1,16596,146,1.11 [0.89-1.39],0.3658781872410446
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AK2,"Adenylate kinase 2, mitochondrial",14478,121,1.03 [0.87-1.21],0.758243065504499
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKAP12,A-kinase anchor protein 12,14204,118,1.02 [0.44-2.38],0.9608464270724572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR1B1,Aldo-keto reductase family 1 member B1,16261,143,1.08 [0.89-1.32],0.4346673364255681
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR1B10,Aldo-keto reductase family 1 member B10,14119,118,0.82 [0.60-1.12],0.2037806427311564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR1C4,Aldo-keto reductase family 1 member C4,16307,141,1.15 [0.88-1.49],0.3033982034484504
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR7L,Aflatoxin B1 aldehyde reductase member 4,14069,119,1.04 [0.80-1.35],0.765318565194108
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKT1S1,Proline-rich AKT1 substrate 1,16227,143,1.10 [0.88-1.38],0.4079801953453007
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKT2,RAC-beta serine/threonine-protein kinase,14472,123,0.97 [0.85-1.12],0.6955230498286955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKT3,RAC-gamma serine/threonine-protein kinase,16194,143,0.91 [0.70-1.19],0.4859141092384539
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALCAM,CD166 antigen,16810,143,1.30 [0.60-2.83],0.5106300335375631
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH1A1,Retinal dehydrogenase 1,16623,145,1.38 [1.07-1.78],0.0128186316185859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH2,"Aldehyde dehydrogenase, mitochondrial",14445,123,1.00 [0.72-1.40],0.987366349911946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",16539,148,1.05 [0.85-1.29],0.6599834244181869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",14472,123,1.16 [0.81-1.65],0.4261580082124242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALMS1,Alstrom syndrome protein 1,14233,119,1.16 [0.81-1.67],0.4100997834701374
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALPI,Intestinal-type alkaline phosphatase,14069,119,1.03 [0.89-1.18],0.7287105217384386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALPP,"Alkaline phosphatase, placental type",16535,147,1.03 [0.89-1.18],0.7265992458559184
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMBN,Ameloblastin,16319,145,1.18 [0.72-1.95],0.5120599252182179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMBP,Protein AMBP,16733,145,1.44 [0.69-2.99],0.3334023152105542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,14504,123,1.00 [0.52-1.95],0.9945012742119016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMFR,E3 ubiquitin-protein ligase AMFR,16227,143,1.09 [0.87-1.36],0.4706054793296329
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMIGO1,Amphoterin-induced protein 1,14119,118,1.01 [0.70-1.44],0.9709897442314772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMIGO2,Amphoterin-induced protein 2,16535,147,0.97 [0.52-1.83],0.925004444700024
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMN,Protein amnionless,16319,145,1.23 [0.91-1.67],0.1802390352159266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMOT,Angiomotin,14204,118,1.60 [1.02-2.51],0.0415676940037869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMOTL2,Angiomotin-like protein 2,14388,123,1.16 [0.84-1.60],0.3668641967970697
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMPD3,AMP deaminase 3,14478,121,1.32 [1.04-1.67],0.0227277209403795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,13552,115,0.99 [0.68-1.42],0.939337526009393
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMY2A,Pancreatic alpha-amylase,15947,138,0.91 [0.67-1.25],0.5776176264507294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMY2B,Alpha-amylase 2B,15474,133,0.97 [0.71-1.34],0.8723515892801748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANG,Angiogenin,16602,145,1.19 [0.77-1.86],0.4328973256905383
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPT1,Angiopoietin-1,16535,146,0.88 [0.74-1.04],0.126719296847195
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPT2,Angiopoietin-2,16761,145,1.36 [0.93-2.00],0.1172408036851619
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL1,Angiopoietin-related protein 1,16371,143,1.56 [0.94-2.61],0.0870608394971651
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL2,Angiopoietin-related protein 2,16622,146,1.19 [0.82-1.72],0.3657680606208665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL3,Angiopoietin-related protein 3,16640,145,1.27 [0.83-1.94],0.2651898643801774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL4,Angiopoietin-related protein 4,16652,147,1.48 [1.06-2.06],0.0200455880837494
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL7,Angiopoietin-related protein 7,16761,145,1.07 [0.70-1.63],0.7512755609957125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANK2,Ankyrin-2,14028,116,0.76 [0.56-1.04],0.0829420372868629
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,14069,119,1.07 [0.86-1.33],0.551473539289921
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANKRA2,Ankyrin repeat family A protein 2,13997,119,0.79 [0.57-1.12],0.1850002403489417
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANKRD54,Ankyrin repeat domain-containing protein 54,16261,143,1.16 [0.92-1.46],0.2031037029072567
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,14129,115,0.86 [0.52-1.41],0.545321687569355
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANPEP,Aminopeptidase N,16678,144,1.14 [0.66-1.96],0.6312897442363706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA1,Annexin A1,14129,118,1.01 [0.67-1.53],0.9624528003101432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA10,Annexin A10,16227,143,0.93 [0.78-1.12],0.4519630285107158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA11,Annexin A11,16549,147,1.03 [0.83-1.28],0.7836736387606087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA2,Annexin A2,13911,115,1.28 [1.03-1.60],0.0251611951161116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA3,Annexin A3,16703,146,1.02 [0.83-1.26],0.8448574730635514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA4,Annexin A4,16525,146,0.97 [0.79-1.19],0.7857900428414537
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA5,Annexin A5,16177,143,0.94 [0.57-1.55],0.7944950669946015
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AOC1,Amiloride-sensitive amine oxidase [copper-containing],16319,145,1.10 [0.86-1.39],0.4553100973129322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AOC3,Membrane primary amine oxidase,16700,145,1.37 [0.83-2.27],0.2187256310210548
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP1G2,AP-1 complex subunit gamma-like 2,14445,123,1.11 [0.89-1.37],0.3529494400415003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP2B1,AP-2 complex subunit beta,14119,118,1.25 [0.88-1.77],0.2193679171500686
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP3B1,AP-3 complex subunit beta-1,14431,123,1.14 [0.91-1.42],0.2492463701201897
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP3S2,AP-3 complex subunit sigma-2,14478,121,1.33 [0.94-1.87],0.1102308540363393
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,16535,147,1.06 [0.77-1.46],0.7316941886817112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APCS,Serum amyloid P-component,14368,120,1.09 [0.64-1.85],0.7589613524615826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,16701,144,1.19 [0.94-1.50],0.1593186936822319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APLP1,Amyloid-like protein 1,16596,146,0.97 [0.73-1.30],0.8491635463022322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOA1,Apolipoprotein A-I,14518,122,1.01 [0.53-1.93],0.9721328291198508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOA2,Apolipoprotein A-II,14510,123,1.02 [0.72-1.44],0.9232970831742512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOA4,Apolipoprotein A-IV,14518,122,1.13 [0.69-1.83],0.6290355060815864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOB,Apolipoprotein B-100,14510,123,1.05 [0.49-2.23],0.9012882106526536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOBR,Apolipoprotein B receptor,14129,115,0.97 [0.64-1.47],0.8736764366269166
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOC1,Apolipoprotein C-I,14490,121,0.96 [0.59-1.54],0.8542242684189996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOD,Apolipoprotein D,13891,117,0.97 [0.63-1.51],0.9041668768282992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOE,Apolipoprotein E,14518,122,0.94 [0.72-1.24],0.6776100040598778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOF,Apolipoprotein F,14510,123,1.09 [0.49-2.42],0.8340152661698981
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOH,Beta-2-glycoprotein 1,16623,145,1.56 [1.08-2.23],0.0165828123563318
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOL1,Apolipoprotein L1,14510,123,1.12 [0.83-1.52],0.450315474209444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOM,Apolipoprotein M,16670,145,1.01 [0.60-1.70],0.9664378425056406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APP,Amyloid-beta precursor protein,16605,143,0.78 [0.63-0.98],0.0362004871748858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APPL2,DCC-interacting protein 13-beta,14204,118,1.04 [0.88-1.22],0.6575317181748566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APRT,Adenine phosphoribosyltransferase,16430,144,1.36 [0.98-1.88],0.0655084884294976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARAF,Serine/threonine-protein kinase A-Raf,14233,119,1.05 [0.82-1.34],0.7015895832910479
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AREG,Amphiregulin,16535,147,1.06 [0.73-1.53],0.7522419773283322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARF6,ADP-ribosylation factor 6,14431,123,1.07 [0.91-1.26],0.4107436634115197
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARFIP1,Arfaptin-1,14472,123,0.98 [0.76-1.27],0.900730497826113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARG1,Arginase-1,16521,140,1.14 [0.86-1.52],0.368446007901548
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARG2,"Arginase-2, mitochondrial",14445,123,0.88 [0.57-1.36],0.5771859567109525
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP1,Rho GTPase-activating protein 1,16261,143,1.03 [0.74-1.43],0.8631769181652167
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP25,Rho GTPase-activating protein 25,16261,143,1.04 [0.81-1.33],0.7645809497604898
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP30,Rho GTPase-activating protein 30,14233,119,1.17 [0.80-1.70],0.4136279207055279
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP45,Rho GTPase-activating protein 45,14204,118,1.04 [0.83-1.29],0.7348951134769526
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP5,Rho GTPase-activating protein 5,13997,119,0.92 [0.73-1.17],0.4978629467231128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF1,Rho guanine nucleotide exchange factor 1,14478,121,1.04 [0.86-1.27],0.6700736785569972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF10,Rho guanine nucleotide exchange factor 10,14472,123,1.12 [0.93-1.34],0.2263319028649381
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF12,Rho guanine nucleotide exchange factor 12,16574,148,1.04 [0.91-1.20],0.5530035312703052
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF5,Rho guanine nucleotide exchange factor 5,14051,117,1.01 [0.80-1.29],0.9125701071894664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARID3A,AT-rich interactive domain-containing protein 3A,14051,117,0.90 [0.57-1.42],0.6498143394446803
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARID4B,AT-rich interactive domain-containing protein 4B,16227,143,1.06 [0.75-1.49],0.7379306838638875
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARL13B,ADP-ribosylation factor-like protein 13B,14028,116,0.93 [0.71-1.21],0.5849441815276697
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,14028,116,1.12 [0.72-1.75],0.6089802170117561
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARMCX2,Armadillo repeat-containing X-linked protein 2,14051,117,1.04 [0.78-1.37],0.8040101412714515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARNT,Aryl hydrocarbon receptor nuclear translocator,16319,145,0.95 [0.62-1.45],0.8111193791370239
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,14028,116,1.15 [0.86-1.54],0.3525967227762098
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARSA,Arylsulfatase A,16623,145,1.44 [1.05-1.97],0.0237850752002044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARSB,Arylsulfatase B,16535,147,0.98 [0.75-1.28],0.8704338824825869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ART3,Ecto-ADP-ribosyltransferase 3,16700,145,1.34 [0.88-2.03],0.1733637712962479
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ART5,Ecto-ADP-ribosyltransferase 5,14051,117,1.11 [0.87-1.40],0.3945369812210137
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARTN,Artemin,16319,145,1.10 [0.81-1.50],0.5243656937321948
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASAH1,Acid ceramidase,14357,123,0.92 [0.62-1.37],0.686854574854395
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASAH2,Neutral ceramidase,16463,144,1.09 [0.82-1.46],0.5431406022616037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASGR1,Asialoglycoprotein receptor 1,16463,144,1.49 [0.92-2.44],0.106723301155205
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASGR2,Asialoglycoprotein receptor 2,14510,123,1.87 [1.00-3.50],0.0503151361142047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASPN,Asporin,14489,121,0.80 [0.42-1.53],0.5080631277285486
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASPSCR1,Tether containing UBX domain for GLUT4,14472,123,0.97 [0.75-1.26],0.8236984772740268
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASRGL1,Isoaspartyl peptidase/L-asparaginase,14129,115,1.09 [0.91-1.30],0.3628469948818186
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASS1,Argininosuccinate synthase,14028,116,1.04 [0.82-1.32],0.7471496558668398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATF2,Cyclic AMP-dependent transcription factor ATF-2,16227,143,0.89 [0.69-1.15],0.3751420618700705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATF4,Cyclic AMP-dependent transcription factor ATF-4,13997,119,0.94 [0.55-1.59],0.8127818885411505
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATG16L1,Autophagy-related protein 16-1,14431,123,1.09 [0.89-1.34],0.3897354057539611
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATG4A,Cysteine protease ATG4A,16261,143,1.26 [0.99-1.61],0.0570906646618339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATOX1,Copper transport protein ATOX1,16671,146,1.03 [0.84-1.28],0.748743800630354
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,14028,116,0.97 [0.66-1.43],0.8834189787268384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,14028,116,1.20 [0.72-2.00],0.4819125567789482
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,14028,116,1.09 [0.70-1.68],0.7064172776571893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B4,Protein ATP1B4,13997,119,0.76 [0.48-1.20],0.2322399433288795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP2B4,Plasma membrane calcium-transporting ATPase 4,14028,116,1.03 [0.78-1.36],0.8342194045055102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP5F1D,"ATP synthase subunit delta, mitochondrial",14028,116,1.16 [0.89-1.53],0.2713767467538498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP5IF1,"ATPase inhibitor, mitochondrial",16677,147,0.94 [0.82-1.07],0.36138127741449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP5PO,"ATP synthase subunit O, mitochondrial",16227,143,0.96 [0.67-1.39],0.8397971789487669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6AP2,Renin receptor,16261,143,1.18 [0.84-1.64],0.3444939559496627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1D,V-type proton ATPase subunit D,16535,147,1.01 [0.57-1.80],0.965590184201764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1F,V-type proton ATPase subunit F,16198,143,1.20 [0.96-1.49],0.1051566566570492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1G1,V-type proton ATPase subunit G 1,14129,115,1.17 [0.92-1.49],0.2010529461619764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1G2,V-type proton ATPase subunit G 2,14028,116,0.93 [0.77-1.13],0.4828138462380664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATRAID,All-trans retinoic acid-induced differentiation factor,14431,123,1.56 [1.00-2.43],0.0476391616691704
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATRN,"Attractin, Isoform 2",14518,122,2.94 [1.03-8.34],0.0433659698780336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN10,Ataxin-10,16227,143,1.00 [0.81-1.23],0.980089775416144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN2,Ataxin-2,14051,117,1.06 [0.91-1.23],0.4603446735894739
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN2L,Ataxin-2-like protein,14472,123,1.19 [0.85-1.65],0.3112142477670794
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN3,Ataxin-3,14478,121,1.23 [0.94-1.62],0.1340145067800565
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AXIN1,Axin-1,16574,148,1.03 [0.88-1.20],0.7499301714916133
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AXL,Tyrosine-protein kinase receptor UFO,16700,145,0.93 [0.54-1.61],0.8058881371587079
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AZI2,5-azacytidine-induced protein 2,14472,123,1.22 [0.91-1.65],0.1885758661783095
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AZU1,Azurocidin,16094,139,1.00 [0.82-1.22],0.9973159290267652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B2M,Beta-2-microglobulin,14518,122,1.26 [0.78-2.02],0.3389230031364983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,14028,116,1.17 [0.51-2.68],0.7108760690771805
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",14129,115,1.06 [0.65-1.74],0.8047092416253018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B4GALT1,"Beta-1,4-galactosyltransferase 1",16677,147,1.64 [0.97-2.79],0.0667392455916014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B4GAT1,"Beta-1,4-glucuronyltransferase 1",16623,145,1.67 [0.92-3.01],0.0900050842853664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BABAM1,BRISC and BRCA1-A complex member 1,14069,119,0.68 [0.35-1.34],0.267726535424622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BACH1,Transcription regulator protein BACH1,16574,148,1.03 [0.84-1.26],0.7777911078395017
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAG3,BAG family molecular chaperone regulator 3,16432,141,0.82 [0.57-1.16],0.2617366645120665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAG4,BAG family molecular chaperone regulator 4,14069,119,1.21 [0.86-1.69],0.2686016306706363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAG6,Large proline-rich protein BAG6,16307,141,1.28 [0.85-1.94],0.2378418195409384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,16261,143,1.22 [0.97-1.53],0.082238090108151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAMBI,BMP and activin membrane-bound inhibitor homolog,16261,143,1.19 [0.71-2.00],0.5039512588806867
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BANK1,B-cell scaffold protein with ankyrin repeats,16574,148,0.97 [0.85-1.12],0.6925214981927023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAP18,Chromatin complexes subunit BAP18,14478,121,1.12 [0.90-1.41],0.3165419558681335
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BATF,Basic leucine zipper transcriptional factor ATF-like,14119,118,0.93 [0.74-1.17],0.5507050365768432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAX,Apoptosis regulator BAX,16204,143,0.98 [0.83-1.16],0.8207331379459544
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAM,Basal cell adhesion molecule,16623,145,1.88 [1.05-3.34],0.0324591071631114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAN,Brevican core protein,16463,144,1.18 [0.76-1.81],0.4621256710928272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",14489,121,1.48 [0.87-2.49],0.1459351551891139
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",14051,117,1.02 [0.74-1.40],0.918655066139791
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCHE,Cholinesterase,14239,121,1.39 [0.71-2.70],0.3338784611527572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2,Apoptosis regulator Bcl-2,14431,123,1.10 [0.82-1.47],0.5223924393381436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2L1,Bcl-2-like protein 1,14478,121,1.00 [0.84-1.19],0.9925778492348036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",16574,148,0.62 [0.46-0.84],0.0019672395617212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2L15,Bcl-2-like protein 15,14069,119,1.08 [0.81-1.45],0.5820293361620485
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL7A,B-cell CLL/lymphoma 7 protein family member A,13997,119,1.02 [0.77-1.34],0.9011582177063152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL7B,B-cell CLL/lymphoma 7 protein family member B,14445,123,1.11 [0.79-1.55],0.5464026919138192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCR,Breakpoint cluster region protein,16574,148,1.00 [0.85-1.17],0.9836587532691798
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BDNF,Brain-derived neurotrophic factor,14504,123,0.86 [0.70-1.05],0.138302764899683
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BECN1,Beclin-1,14129,115,1.25 [0.93-1.67],0.1386906159644227
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BEX3,Protein BEX3,13997,119,0.98 [0.66-1.46],0.9236923971468528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BGLAP,Osteocalcin,14504,123,1.01 [0.82-1.23],0.9513417065654604
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BGN,Biglycan,16229,143,0.90 [0.80-1.03],0.1286949152820006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BHLHE40,Class E basic helix-loop-helix protein 40,14051,117,0.79 [0.59-1.04],0.0960892813202163
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,14028,116,1.01 [0.51-2.02],0.9777583970212412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BID,BH3-interacting domain death agonist,16574,148,1.14 [0.92-1.40],0.23244917941449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BIN2,Bridging integrator 2,16623,145,1.02 [0.87-1.20],0.8118853779287456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BIRC2,Baculoviral IAP repeat-containing protein 2,16261,143,1.05 [0.83-1.33],0.700110690950348
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLMH,Bleomycin hydrolase,16810,143,1.06 [0.65-1.71],0.8153358633463332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLNK,B-cell linker protein,14069,119,1.29 [0.85-1.94],0.2263978239356943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,14051,117,1.03 [0.81-1.30],0.8227069708129571
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,14478,121,1.09 [0.70-1.68],0.705344671032907
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLVRB,Flavin reductase,16623,145,1.18 [0.96-1.45],0.1245360350683271
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMP10,Bone morphogenetic protein 10,14204,118,0.98 [0.53-1.82],0.947414015957918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMP4,Bone morphogenetic protein 4,16432,141,1.37 [1.01-1.85],0.0439634443692399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMP6,Bone morphogenetic protein 6,16288,141,0.83 [0.57-1.20],0.3248814008652821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMPER,BMP-binding endothelial regulator protein,14204,118,1.60 [0.74-3.42],0.2295952630126496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,14489,121,0.84 [0.49-1.44],0.5290416264674684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,14069,119,1.30 [0.89-1.92],0.1779342657307007
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BOC,Brother of CDO,16307,141,0.87 [0.45-1.66],0.6651720711830824
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BOLA1,BolA-like protein 1,14051,117,1.29 [0.97-1.74],0.0850205252288446
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BOLA2_BOLA2B,BolA-like protein 2,14129,115,1.32 [0.94-1.85],0.1091591720873888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BPIFA2,BPI fold-containing family A member 2,13641,114,0.95 [0.80-1.13],0.5730053923418805
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BPIFB1,BPI fold-containing family B member 1,16568,143,1.13 [0.89-1.44],0.300609461900727
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BPIFB2,BPI fold-containing family B member 2,14459,120,0.97 [0.74-1.27],0.828845200770592
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRAP,BRCA1-associated protein,14296,122,1.04 [0.88-1.22],0.6545406101179692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRD1,Bromodomain-containing protein 1,14233,119,1.36 [0.82-2.26],0.2377297280142068
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRD2,Bromodomain-containing protein 2,14051,117,1.11 [0.70-1.77],0.657641525803244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRD3,Bromodomain-containing protein 3,14028,116,1.04 [0.74-1.47],0.8099332790634001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRDT,Bromodomain testis-specific protein,14028,116,0.90 [0.55-1.47],0.6652081524261259
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRK1,Protein BRICK1,16227,143,1.11 [0.80-1.55],0.5377954502309121
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRME1,Break repair meiotic recombinase recruitment factor 1,14051,117,1.04 [0.67-1.60],0.8751135622462459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRSK2,Serine/threonine-protein kinase BRSK2,14472,123,0.99 [0.62-1.59],0.9804951979775524
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BSG,Basigin,16750,145,1.38 [0.65-2.89],0.4009559229825719
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BSND,Barttin,13997,119,0.92 [0.53-1.59],0.764732243479159
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,16735,146,0.82 [0.63-1.05],0.1203965256391618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BST2,Bone marrow stromal antigen 2,16735,146,0.95 [0.69-1.30],0.7339475785836915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTC,Probetacellulin,16261,143,0.91 [0.74-1.12],0.3692347104682234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTD,Biotinidase,14518,122,1.14 [0.49-2.68],0.7628389395014112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTLA,B- and T-lymphocyte attenuator,13997,119,1.00 [0.82-1.22],0.9805588433059694
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTN1A1,Butyrophilin subfamily 1 member A1,14415,123,1.32 [1.00-1.75],0.0516260558593934
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTN2A1,Butyrophilin subfamily 2 member A1,16677,147,1.73 [1.02-2.95],0.043687384676997
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTN3A2,Butyrophilin subfamily 3 member A2,16574,148,1.14 [0.78-1.68],0.4960693367264422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTNL10,Butyrophilin-like protein 10,13997,119,0.85 [0.53-1.38],0.5188225945088837
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C19orf12,Protein C19orf12,16227,143,1.02 [0.81-1.30],0.8408797051932216
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1GALT1C1,C1GALT1-specific chaperone 1,14028,116,1.03 [0.59-1.79],0.918108866818221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QA,Complement C1q subcomponent subunit A,16696,144,1.11 [0.56-2.19],0.7607168459138094
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",14472,123,0.83 [0.61-1.13],0.2420358236193344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QL2,Complement C1q-like protein 2,14069,119,0.85 [0.56-1.31],0.466015322292683
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,16700,145,1.26 [0.90-1.78],0.1744357865752723
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,14204,118,0.93 [0.57-1.51],0.7615454074186179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,14472,123,1.30 [0.82-2.06],0.2633977155120506
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,14177,118,0.94 [0.65-1.34],0.7141665582295209
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1R,Complement C1r subcomponent,14518,122,0.69 [0.24-1.96],0.4852682992328703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1RL,Complement C1r subcomponent-like protein,14487,122,1.10 [0.45-2.67],0.8381126416835862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1S,Complement C1s subcomponent,14518,122,0.91 [0.39-2.09],0.8197794963879603
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C2,Complement C2,16670,145,1.18 [0.58-2.39],0.6411273160611594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C2CD2L,Phospholipid transfer protein C2CD2L,16198,143,1.24 [0.91-1.69],0.1788875759229692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C2orf69,UPF0565 protein C2orf69,14119,118,1.19 [0.94-1.51],0.1408778275295154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C3,Complement C3,13755,113,1.15 [0.79-1.68],0.4549692572709806
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C4BPB,C4b-binding protein beta chain,16671,146,1.13 [0.78-1.65],0.5175766377046647
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C5,Complement C5,14518,122,1.72 [0.56-5.32],0.3432136915714842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C7,Complement component C7,14145,117,2.00 [1.11-3.59],0.0203304197773789
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C7orf50,Uncharacterized protein C7orf50,14478,121,1.19 [0.62-2.29],0.6053107353671814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C8B,Complement component C8 beta chain,14518,122,0.79 [0.45-1.40],0.4166770852755802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C9,Complement component C9,14510,123,0.96 [0.70-1.32],0.8035584908372466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C9orf40,Uncharacterized protein C9orf40,14431,123,1.23 [1.01-1.51],0.0443048530639549
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA1,Carbonic anhydrase 1,16286,143,1.29 [1.01-1.65],0.0448346282553595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA11,Carbonic anhydrase-related protein 11,16261,143,0.72 [0.40-1.28],0.2621008303234086
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA12,Carbonic anhydrase 12,16535,147,0.86 [0.54-1.39],0.5460113276173391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA13,Carbonic anhydrase 13,16429,146,0.93 [0.81-1.07],0.3231444357087883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA14,Carbonic anhydrase 14,16761,145,1.16 [0.76-1.77],0.482718931195606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA2,Carbonic anhydrase 2,16560,145,1.19 [0.97-1.46],0.0948875930941714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA3,Carbonic anhydrase 3,16788,143,1.33 [1.06-1.68],0.0155521519625211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA4,Carbonic anhydrase 4,16810,143,1.02 [0.55-1.90],0.9454259752362744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA5A,"Carbonic anhydrase 5A, mitochondrial",16307,141,1.08 [0.92-1.28],0.3489170609471395
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA6,Carbonic anhydrase 6,16570,145,1.01 [0.80-1.29],0.9233882183162018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA7,Carbonic anhydrase 7,14233,119,0.80 [0.46-1.39],0.4236336238950169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA8,Carbonic anhydrase-related protein,14069,119,1.29 [0.76-2.19],0.3436960434663492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA9,Carbonic anhydrase 9,16761,145,1.16 [0.86-1.57],0.3277137165299756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CABP2,Calcium-binding protein 2,14119,118,1.00 [0.76-1.31],0.971768541354514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,14051,117,0.83 [0.47-1.49],0.5425928734438206
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,14028,116,0.97 [0.71-1.34],0.8736910195401775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,14051,117,1.22 [0.93-1.58],0.1466970816999315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,14472,123,0.98 [0.80-1.20],0.834696816661488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACYBP,Calcyclin-binding protein,14180,118,1.04 [0.87-1.24],0.6715160710380927
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CADPS,Calcium-dependent secretion activator 1,14119,118,1.13 [0.75-1.69],0.5558923251298802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALB1,Calbindin,16535,147,1.29 [0.92-1.81],0.1327801744160543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALB2,Calretinin,16227,143,1.34 [0.91-1.98],0.1387658854835038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCA,Calcitonin,16434,144,1.19 [0.95-1.48],0.1260246748187766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCB,Calcitonin gene-related peptide 2,14478,121,1.19 [0.81-1.73],0.3790803260439263
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,16704,145,1.07 [0.93-1.24],0.3541617997256566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,14129,115,1.15 [0.91-1.45],0.2546270882340894
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALY,Neuron-specific vesicular protein calcyon,14028,116,0.82 [0.49-1.39],0.4624532893199882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,16261,143,0.99 [0.70-1.40],0.9592162011075588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,14119,118,0.78 [0.54-1.13],0.1881631763979938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,14472,123,1.11 [0.94-1.30],0.2093699931224965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CANT1,Soluble calcium-activated nucleotidase 1,16536,146,1.57 [0.76-3.27],0.225754184822652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAPG,Macrophage-capping protein,16489,141,1.14 [0.88-1.46],0.3169859321944754
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAPN3,Calpain-3,14445,123,1.03 [0.66-1.63],0.8882515382257197
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAPS,Calcyphosin,14478,121,1.06 [0.91-1.23],0.4279227802701713
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CARHSP1,Calcium-regulated heat-stable protein 1,16227,143,1.08 [0.82-1.43],0.5744472751271618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASC3,Protein CASC3,14119,118,0.89 [0.57-1.38],0.5961685790028661
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP1,Caspase-1,16227,143,0.99 [0.80-1.23],0.9244499744470872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP10,Caspase-10,16227,143,1.00 [0.81-1.23],0.9643836596071136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP2,Caspase-2,16574,148,1.01 [0.81-1.25],0.9343469413008512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP3,Caspase-3,16810,143,0.97 [0.82-1.15],0.726186227073083
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP4,Caspase-4,14233,119,1.05 [0.95-1.16],0.3513375006050387
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP7,Caspase-7,14478,121,0.95 [0.77-1.17],0.6264912275208587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP8,Caspase-8,16703,145,1.19 [0.95-1.49],0.1249238870449136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP9,Caspase-9,14069,119,0.83 [0.62-1.13],0.2399774771336716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASQ2,Calsequestrin-2,14028,116,1.04 [0.74-1.48],0.8056388673233222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAT,Catalase,14296,118,1.41 [1.04-1.90],0.0252421185793996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBLIF,Cobalamin binding intrinsic factor,16570,146,0.91 [0.76-1.08],0.2797072923729192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBLN1,Cerebellin-1,14051,117,1.07 [0.90-1.27],0.4591562734551259
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBLN4,Cerebellin-4,16761,145,0.83 [0.52-1.31],0.419604047684761
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBS,Cystathionine beta-synthase,14129,115,0.94 [0.65-1.36],0.7361841041450079
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBX2,Chromobox protein homolog 2,14028,116,1.23 [0.85-1.77],0.2753424818412365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,16463,144,1.16 [0.96-1.42],0.1325494438554952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCAR2,Cell cycle and apoptosis regulator protein 2,14478,121,1.18 [0.91-1.53],0.2177942479703941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC134,Coiled-coil domain-containing protein 134,14445,123,0.95 [0.66-1.37],0.7929220903751638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC28A,Coiled-coil domain-containing protein 28A,14119,118,0.72 [0.40-1.32],0.2937490540553747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC50,Coiled-coil domain-containing protein 50,14472,123,0.90 [0.70-1.15],0.4013899603595655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC80,Coiled-coil domain-containing protein 80,16596,146,1.43 [0.97-2.11],0.067768805729381
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,14129,115,1.24 [0.94-1.64],0.1272724141123578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL11,Eotaxin,16776,146,0.98 [0.66-1.45],0.9022946603076863
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL13,C-C motif chemokine 13,16749,146,0.87 [0.70-1.08],0.221169602946844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL14,C-C motif chemokine 14,16602,145,1.45 [1.04-2.02],0.0288080606799298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL15,C-C motif chemokine 15,16810,143,0.96 [0.67-1.36],0.7993220079305214
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL16,C-C motif chemokine 16,16810,143,1.26 [0.93-1.72],0.1413587051760521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL17,C-C motif chemokine 17,16588,147,0.94 [0.80-1.10],0.4582049209429067
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL18,C-C motif chemokine 18,16402,145,1.06 [0.86-1.30],0.6135425613281305
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL19,C-C motif chemokine 19,16735,146,0.91 [0.80-1.04],0.1837096972691574
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL2,C-C motif chemokine 2,16432,141,1.01 [0.76-1.34],0.9299415248080812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL20,C-C motif chemokine 20,16776,146,1.02 [0.87-1.20],0.80323142769778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL21,C-C motif chemokine 21,16677,147,0.92 [0.63-1.35],0.6703570326981974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL22,C-C motif chemokine 22,16463,147,0.90 [0.68-1.20],0.4674975505356196
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL23,C-C motif chemokine 23,16677,147,1.35 [0.95-1.92],0.0963051879200984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL24,C-C motif chemokine 24,16652,147,1.03 [0.87-1.23],0.7316878692679549
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL25,C-C motif chemokine 25,16776,146,0.95 [0.70-1.29],0.744300360843783
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL26,C-C motif chemokine 26,16574,148,1.06 [0.91-1.23],0.4652434814259755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL27,C-C motif chemokine 27,16596,146,1.09 [0.84-1.40],0.517548918338532
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL28,C-C motif chemokine 28,16509,148,0.86 [0.66-1.12],0.2554095013054279
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL3,C-C motif chemokine 3,16574,148,1.03 [0.78-1.36],0.8122250293428008
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL4,C-C motif chemokine 4,16639,147,1.19 [1.00-1.41],0.0542703140818011
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL5,C-C motif chemokine 5,16700,145,0.86 [0.74-0.99],0.0375465177572602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL7,C-C motif chemokine 7,16574,148,0.94 [0.73-1.23],0.6589532192926792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL8,C-C motif chemokine 8,16733,145,0.87 [0.69-1.10],0.2474947539110916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN1,CCN family member 1,16503,147,1.00 [0.82-1.23],0.969384387980482
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN2,CCN family member 2,16592,146,0.87 [0.67-1.13],0.2933212924170785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN3,CCN family member 3,16781,143,1.60 [1.04-2.45],0.0312884534402692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN4,CCN family member 4,16761,145,1.16 [0.80-1.68],0.4450690668241102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN5,CCN family member 5,16623,145,1.29 [0.88-1.90],0.1951891188760195
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCND2,G1/S-specific cyclin-D2,14233,119,1.35 [0.82-2.22],0.2319920676834707
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCNE1,G1/S-specific cyclin-E1,14069,119,1.03 [0.85-1.24],0.7930944724860531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCS,Copper chaperone for superoxide dismutase,16463,144,1.15 [0.84-1.56],0.3874935551425236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCT5,T-complex protein 1 subunit epsilon,16261,143,1.07 [0.76-1.49],0.7097354243117318
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD101,Immunoglobulin superfamily member 2,14431,123,0.90 [0.61-1.33],0.6012362247192262
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD109,CD109 antigen,16623,145,1.45 [0.92-2.27],0.1096172970453332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD14,Monocyte differentiation antigen CD14,16321,144,1.25 [0.87-1.80],0.2292571517360081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD160,CD160 antigen,16776,146,1.01 [0.74-1.38],0.9574160832132332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD163,Scavenger receptor cysteine-rich type 1 protein M130,16700,145,0.80 [0.56-1.15],0.2297081600948703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD164,Sialomucin core protein 24,16623,145,1.31 [0.82-2.11],0.2586490625431682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD164L2,CD164 sialomucin-like 2 protein,14119,118,0.99 [0.61-1.60],0.9537326901684852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD177,CD177 antigen,16597,145,1.04 [0.93-1.17],0.4902958497633087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD1C,T-cell surface glycoprotein CD1c,16671,146,1.25 [0.67-2.32],0.4778151417143306
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD2,T-cell surface antigen CD2,14028,116,1.15 [0.76-1.74],0.5074342669051277
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD200,OX-2 membrane glycoprotein,16574,148,1.24 [0.71-2.17],0.4504603200900937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD200R1,Cell surface glycoprotein CD200 receptor 1,16521,148,1.18 [0.78-1.77],0.4346020331021443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD207,C-type lectin domain family 4 member K,16217,145,1.18 [0.81-1.74],0.3843632855307858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD209,CD209 antigen,16663,143,0.97 [0.66-1.42],0.8608869396053295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD22,B-cell receptor CD22,16776,146,0.83 [0.58-1.19],0.3074240952480288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD226,CD226 antigen,14069,119,0.76 [0.50-1.17],0.2171857898507747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD244,Natural killer cell receptor 2B4,16776,146,0.88 [0.51-1.51],0.6360999122741637
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD248,Endosialin,14504,123,1.59 [1.04-2.44],0.0342056472855994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD27,CD27 antigen,16671,146,1.53 [1.08-2.17],0.0166787480231085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD274,Programmed cell death 1 ligand 1,16463,144,1.18 [0.76-1.82],0.4648110492192397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD276,CD276 antigen,16598,147,1.36 [0.89-2.08],0.1489695898550404
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD28,T-cell-specific surface glycoprotein CD28,16261,143,1.07 [0.72-1.59],0.726938136213414
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD2AP,CD2-associated protein,16596,146,1.19 [0.95-1.50],0.1296609400634079
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300A,CMRF35-like molecule 8,14204,118,1.54 [0.86-2.75],0.1437780539188068
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300C,CMRF35-like molecule 6,16735,146,1.09 [0.71-1.66],0.6937105537149824
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300E,CMRF35-like molecule 2,16703,145,1.45 [1.02-2.05],0.0375845672612449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300LF,CMRF35-like molecule 1,16761,145,0.97 [0.76-1.24],0.813210466629867
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300LG,CMRF35-like molecule 9,16623,145,1.29 [0.87-1.90],0.2010277382568913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD302,CD302 antigen,16535,147,1.78 [1.12-2.81],0.0137833241101003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD33,Myeloid cell surface antigen CD33,16671,146,1.07 [0.89-1.29],0.4551181242671035
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD34,Hematopoietic progenitor cell antigen CD34,16688,146,1.19 [0.64-2.19],0.5865800903304382
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD36,Platelet glycoprotein 4,14069,119,0.91 [0.61-1.37],0.6515597322416495
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,16535,147,1.18 [0.74-1.86],0.4843156288269071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD3D,T-cell surface glycoprotein CD3 delta chain,14051,117,0.86 [0.48-1.52],0.5968537748078795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD3E,T-cell surface glycoprotein CD3 epsilon chain,14233,119,0.99 [0.61-1.60],0.972631366176526
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD3G,T-cell surface glycoprotein CD3 gamma chain,14069,119,0.69 [0.51-0.94],0.018358719918542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD4,T-cell surface glycoprotein CD4,16544,148,1.28 [0.85-1.93],0.2383195215977439
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD40,Tumor necrosis factor receptor superfamily member 5,16614,147,0.89 [0.65-1.21],0.4513848511412397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD40LG,CD40 ligand,16776,146,0.89 [0.74-1.07],0.2263622525987632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD46,Membrane cofactor protein,16551,144,1.22 [0.72-2.05],0.4633388393971809
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD48,CD48 antigen,16652,147,0.97 [0.59-1.60],0.9160006474396936
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD5,T-cell surface glycoprotein CD5,16733,145,1.40 [0.91-2.16],0.1296959974348559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD55,Complement decay-accelerating factor,16054,143,1.43 [0.83-2.47],0.1937857260735257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD58,Lymphocyte function-associated antigen 3,16581,147,1.01 [0.44-2.32],0.9742473343083584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD59,CD59 glycoprotein,16046,137,1.33 [0.70-2.54],0.3797721774322682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD5L,CD5 antigen-like,14442,121,1.19 [0.82-1.73],0.3486427296558216
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD6,T-cell differentiation antigen CD6,16750,145,0.95 [0.72-1.26],0.7155537186623323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD63,CD63 antigen,16432,141,0.84 [0.63-1.13],0.259951290420222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD69,Early activation antigen CD69,16540,146,0.94 [0.80-1.11],0.4707387431058479
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD7,T-cell antigen CD7,14037,119,0.98 [0.65-1.47],0.905756693538529
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD70,CD70 antigen,16574,148,1.58 [1.13-2.21],0.0080377683725553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD72,B-cell differentiation antigen CD72,14204,118,1.15 [0.75-1.77],0.5205147566742245
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD74,HLA class II histocompatibility antigen gamma chain,16735,146,1.30 [0.85-2.00],0.2281011407899573
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD79B,B-cell antigen receptor complex-associated protein beta chain,16776,146,1.44 [1.04-1.99],0.0269474130055093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD80,T-lymphocyte activation antigen CD80,14489,121,1.29 [0.76-2.19],0.3369724725089612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD82,CD82 antigen,14233,119,0.99 [0.64-1.53],0.9616352266186872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD83,CD83 antigen,16574,148,1.14 [0.73-1.76],0.5637589074759403
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD84,SLAM family member 5,16574,148,0.69 [0.43-1.09],0.1104042236689444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD86,T-lymphocyte activation antigen CD86,14431,123,1.33 [0.74-2.42],0.3413889011492386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD8A,T-cell surface glycoprotein CD8 alpha chain,16735,146,1.12 [0.85-1.49],0.4142447904063372
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD93,Complement component C1q receptor,16027,144,1.57 [0.98-2.50],0.061426949323672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD99,CD99 antigen,16623,145,1.39 [0.66-2.96],0.38889989241433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD99L2,CD99 antigen-like protein 2,16623,145,1.24 [0.67-2.29],0.4879946936358822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDA,Cytidine deaminase,14461,121,1.22 [0.86-1.72],0.2584340544824178
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDAN1,Codanin-1,14478,121,1.11 [0.53-2.33],0.7781989926363125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC123,Cell division cycle protein 123 homolog,13997,119,0.98 [0.74-1.31],0.908081540943306
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC25A,M-phase inducer phosphatase 1,13997,119,0.87 [0.54-1.41],0.5814504566165294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC26,Anaphase-promoting complex subunit CDC26,14401,123,1.14 [0.89-1.47],0.286174567270974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC27,Cell division cycle protein 27 homolog,16261,143,1.19 [0.93-1.51],0.1636939955145652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC37,Hsp90 co-chaperone Cdc37,16671,146,1.05 [0.88-1.26],0.5720207876804587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC42BPB,Serine/threonine-protein kinase MRCK beta,14431,123,1.10 [0.93-1.30],0.2568462293260302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDCP1,CUB domain-containing protein 1,16463,144,1.09 [0.83-1.42],0.5566168106057892
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH1,Cadherin-1,16084,142,1.43 [1.02-1.99],0.0378079424033321
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH15,Cadherin-15,16706,146,0.79 [0.62-1.01],0.0623093521499431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH17,Cadherin-17,16596,146,0.87 [0.70-1.09],0.2322768224261685
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH2,Cadherin-2,16596,146,1.14 [0.74-1.74],0.5503450151774635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH22,Cadherin-22,14233,119,0.63 [0.32-1.23],0.1759013708868048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH23,Cadherin-23,14478,121,1.31 [0.70-2.43],0.3952113504301221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH3,Cadherin-3,16735,146,1.34 [0.90-2.00],0.1511436888811517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH4,Cadherin-4,14051,117,0.93 [0.63-1.37],0.7078253426198916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH5,Cadherin-5,16810,143,1.12 [0.69-1.83],0.6469277220510206
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH6,Cadherin-6,16596,146,1.13 [0.76-1.66],0.543418762205111
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR1,Cadherin-related family member 1,16227,143,1.35 [0.99-1.83],0.0594023099560519
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR2,Cadherin-related family member 2,16535,147,1.21 [0.97-1.50],0.0974495403097092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR5,Cadherin-related family member 5,16596,146,0.90 [0.62-1.30],0.5600453621923123
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDK1,Cyclin-dependent kinase 1,13997,119,1.28 [0.79-2.07],0.3230714575829276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,14472,123,0.83 [0.61-1.15],0.2700456000492679
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDKL5,Cyclin-dependent kinase-like 5,14051,117,1.15 [0.85-1.55],0.3701987857436306
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDKN1A,Cyclin-dependent kinase inhibitor 1,16535,147,1.01 [0.88-1.17],0.8385174718117004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,16535,147,1.00 [0.86-1.17],0.9867069394118626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDNF,Cerebral dopamine neurotrophic factor,16535,147,1.30 [0.86-1.96],0.2135291782912209
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,16626,147,0.68 [0.39-1.17],0.1651693755897915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDSN,Corneodesmosin,16726,146,1.34 [0.96-1.88],0.0883708647494341
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,16644,146,1.66 [0.79-3.52],0.1831128768948859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,14431,123,0.97 [0.78-1.21],0.785604015428817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,14233,119,0.77 [0.55-1.07],0.1169674846000627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,14431,123,1.13 [0.74-1.74],0.5629310820500273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,14233,119,0.93 [0.61-1.42],0.7309553560747124
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,16574,148,1.06 [0.90-1.25],0.5110155094070918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,16261,143,1.07 [0.79-1.45],0.6747514702528186
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,16071,141,1.17 [0.93-1.48],0.1800030203477839
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,14504,123,0.84 [0.53-1.33],0.4537629906810884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,16307,141,1.23 [0.92-1.65],0.163823484636353
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEBPA,CCAAT/enhancer-binding protein alpha,14069,119,1.10 [0.69-1.75],0.6888576762476668
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEBPB,CCAAT/enhancer-binding protein beta,16307,141,1.36 [0.94-1.95],0.0988920193448693
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CELA2A,Chymotrypsin-like elastase family member 2A,14504,123,1.02 [0.78-1.35],0.8667272860302059
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CELA3A,Chymotrypsin-like elastase family member 3A,16786,143,0.99 [0.77-1.27],0.9239713862148776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,14204,118,0.82 [0.44-1.53],0.5419816846742612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEMIP2,Cell surface hyaluronidase,14069,119,1.31 [0.82-2.10],0.2524418948221643
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEND1,Cell cycle exit and neuronal differentiation protein 1,14051,117,0.72 [0.48-1.07],0.1034064121854244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CENPF,Centromere protein F,14233,119,1.33 [0.99-1.78],0.0553471585036737
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CENPJ,Centromere protein J,14233,119,0.98 [0.76-1.26],0.8588536645498848
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP112,Centrosomal protein of 112 kDa,14028,116,0.95 [0.63-1.44],0.8204278223641444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP152,Centrosomal protein of 152 kDa,13997,119,1.29 [0.90-1.85],0.1729137787197524
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP164,Centrosomal protein of 164 kDa,16319,145,1.20 [1.00-1.44],0.0535536686036291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP170,Centrosomal protein of 170 kDa,14129,115,1.22 [0.98-1.52],0.0723399535010405
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP20,Centrosomal protein 20,16261,143,1.03 [0.84-1.25],0.7930181653887334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP290,Centrosomal protein of 290 kDa,14233,119,0.91 [0.65-1.29],0.6067095838329707
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP350,Centrosome-associated protein 350,13997,119,1.18 [0.76-1.84],0.4557392060982644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP43,Centrosomal protein 43,16184,141,1.04 [0.84-1.30],0.7052656622437196
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP85,Centrosomal protein of 85 kDa,16261,143,1.23 [0.98-1.54],0.0776350357350171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CERT,Ceramide transfer protein,16227,143,0.91 [0.71-1.16],0.4267683819709754
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CES1,Liver carboxylesterase 1,16660,143,1.02 [0.84-1.23],0.8616190472564961
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CES2,Cocaine esterase,16535,147,1.09 [0.84-1.41],0.5366733136148855
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CES3,Carboxylesterase 3,16535,147,1.13 [0.92-1.38],0.2432917049707955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CETN2,Centrin-2,16227,143,1.03 [0.82-1.28],0.8016016726267228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CETN3,Centrin-3,14431,123,1.07 [0.85-1.34],0.5613436592751697
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFB,Complement factor B,14260,119,1.00 [0.58-1.74],0.9908818063381076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFC1,Cryptic protein,16261,143,0.97 [0.70-1.36],0.8822468259600046
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFD,Complement factor D,14518,122,1.64 [0.78-3.42],0.1899069801822862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFH,Complement factor H,13665,112,1.60 [0.73-3.52],0.2404740758732726
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFHR2,Complement factor H-related protein 2,14414,122,1.06 [0.78-1.45],0.7120419187234592
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFHR4,Complement factor H-related protein 4,14492,122,1.02 [0.80-1.29],0.8897329255440461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFHR5,Complement factor H-related protein 5,14312,121,1.07 [0.69-1.65],0.7723820889999287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFI,Complement factor I,14518,122,0.97 [0.39-2.37],0.9408419266338376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFP,Properdin,14518,122,1.26 [0.65-2.46],0.489924309908467
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGA,Glycoprotein hormones alpha chain,16623,145,1.11 [0.88-1.41],0.3772273165769986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,14510,123,0.93 [0.59-1.47],0.7539008719891148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGN,Cingulin,14119,118,1.17 [0.78-1.75],0.4436686121759963
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGREF1,Cell growth regulator with EF hand domain protein 1,16596,146,1.06 [0.75-1.49],0.7592375999130235
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,16261,143,1.19 [0.94-1.51],0.1480048006115051
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHAD,Chondroadherin,14204,118,1.14 [0.79-1.64],0.4871288152831338
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",14478,121,1.31 [0.87-1.98],0.1993264212144652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHCHD6,MICOS complex subunit MIC25,14445,123,1.58 [0.95-2.63],0.0802517151704188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHEK2,Serine/threonine-protein kinase Chk2,16307,141,1.15 [0.73-1.81],0.5536631599445457
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHGA,Chromogranin-A,14504,123,0.92 [0.75-1.12],0.3902670824584365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHGB,Secretogranin-1,16681,145,0.81 [0.56-1.17],0.2657912439920726
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHI3L1,Chitinase-3-like protein 1,16301,144,1.06 [0.89-1.27],0.5138904797782302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHIT1,Chitotriosidase-1,16696,143,1.09 [0.98-1.23],0.1251432827468232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHL1,Neural cell adhesion molecule L1-like protein,16679,145,1.13 [0.70-1.83],0.6240747216808167
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHM,Rab proteins geranylgeranyltransferase component A 1,14119,118,0.90 [0.67-1.22],0.5171411677626956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHMP1A,Charged multivesicular body protein 1a,16463,144,0.94 [0.78-1.13],0.4855648295893401
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHMP6,Charged multivesicular body protein 6,14489,121,1.01 [0.74-1.38],0.937049045969391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHP1,Calcineurin B homologous protein 1,14051,117,0.95 [0.74-1.22],0.6828067993585044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHRDL1,Chordin-like protein 1,16652,147,1.22 [0.76-1.96],0.4025141386643721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHRDL2,Chordin-like protein 2,16596,146,0.99 [0.72-1.36],0.958044141219032
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHRM1,Muscarinic acetylcholine receptor M1,14119,118,1.23 [0.80-1.89],0.3517414899490645
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CIAPIN1,Anamorsin,16671,146,1.13 [0.89-1.43],0.3205089186253151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CILP,Cartilage intermediate layer protein 1,14504,123,1.37 [0.98-1.91],0.069196662283857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CINP,Cyclin-dependent kinase 2-interacting protein,14233,119,0.89 [0.58-1.37],0.6045016221211733
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CIRBP,Cold-inducible RNA-binding protein,14431,123,1.03 [0.86-1.23],0.7652987839456131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CIT,Citron Rho-interacting kinase,14119,118,1.56 [1.16-2.09],0.0030378253399186
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CKAP4,Cytoskeleton-associated protein 4,16712,145,1.60 [1.02-2.51],0.0391780653901971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CKB,Creatine kinase B-type,14504,123,1.12 [0.83-1.51],0.4650558801526768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",16569,147,0.88 [0.72-1.06],0.1836768542233016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLASP1,CLIP-associating protein 1,13997,119,0.92 [0.71-1.18],0.5164688146584162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLC,Galectin-10,16567,146,1.06 [0.85-1.32],0.6035669792645966
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC10A,C-type lectin domain family 10 member A,16463,144,0.96 [0.63-1.45],0.8437043345377198
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC11A,C-type lectin domain family 11 member A,16594,145,1.05 [0.77-1.42],0.7712588283926267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC12A,C-type lectin domain family 12 member A,14069,119,1.64 [0.75-3.57],0.2118788250950308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC14A,C-type lectin domain family 14 member A,16623,145,1.47 [0.94-2.28],0.0900211301594294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC1A,C-type lectin domain family 1 member A,16307,141,1.61 [1.05-2.49],0.0307783941031315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC1B,C-type lectin domain family 1 member B,16735,146,0.92 [0.79-1.07],0.2859979165247924
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC2L,C-type lectin domain family 2 member L,14119,118,1.14 [0.84-1.55],0.4095807437264395
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC3B,Tetranectin,14167,118,0.98 [0.42-2.25],0.9545214851928556
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4A,C-type lectin domain family 4 member A,16574,148,0.77 [0.51-1.17],0.2218735301461911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4C,C-type lectin domain family 4 member C,16574,148,1.07 [0.79-1.45],0.6733864365119817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4D,C-type lectin domain family 4 member D,16574,148,0.91 [0.71-1.16],0.4461128799563636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4G,C-type lectin domain family 4 member G,16574,148,1.01 [0.65-1.57],0.9683308659412448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4M,C-type lectin domain family 4 member M,14478,123,0.88 [0.62-1.25],0.4697504517233275
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC5A,C-type lectin domain family 5 member A,16559,146,1.19 [0.73-1.95],0.4883390557261229
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC6A,C-type lectin domain family 6 member A,16261,143,1.23 [0.90-1.68],0.1978960464143173
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC7A,C-type lectin domain family 7 member A,16776,146,0.93 [0.75-1.17],0.5473332889950435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLGN,Calmegin,14119,118,1.10 [0.76-1.60],0.6046898115295583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLIC5,Chloride intracellular channel protein 5,14119,118,1.52 [0.98-2.37],0.0636691962934497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLINT1,Clathrin interactor 1,13997,119,0.77 [0.50-1.19],0.2348721196898941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLIP2,CAP-Gly domain-containing linker protein 2,16574,148,1.04 [0.91-1.18],0.5614038913178163
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLMP,CXADR-like membrane protein,16761,145,0.98 [0.48-1.99],0.961544634185268
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLNS1A,Methylosome subunit pICln,14119,118,1.30 [0.79-2.12],0.3004686990178538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",16434,144,0.88 [0.75-1.03],0.1085674470941295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLPS,Colipase,16588,145,1.17 [0.95-1.44],0.1330728210675255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSPN,Claspin,16198,143,1.12 [0.78-1.63],0.5358255053744703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSTN1,Calsyntenin-1,16227,143,1.08 [0.82-1.41],0.5855314603918618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSTN2,Calsyntenin-2,16776,146,1.29 [0.90-1.84],0.1672054491713523
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSTN3,Calsyntenin-3,14478,121,1.18 [0.67-2.07],0.5777514472473126
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLTA,Clathrin light chain A,16307,141,1.25 [0.93-1.68],0.1397306832267245
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLU,Clusterin,14518,122,0.90 [0.46-1.76],0.7660873268334857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLUL1,Clusterin-like protein 1,16569,145,1.19 [0.85-1.66],0.3030516643293811
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CMC1,COX assembly mitochondrial protein homolog,14489,121,1.01 [0.83-1.22],0.949670545283086
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CMIP,C-Maf-inducing protein,14445,123,1.01 [0.82-1.24],0.957643565695194
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNDP1,Beta-Ala-His dipeptidase,16700,145,1.10 [0.78-1.53],0.5954172941406946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNGB3,Cyclic nucleotide-gated cation channel beta-3,14051,117,1.19 [0.91-1.57],0.20878336129521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",14102,115,1.14 [0.91-1.43],0.2587114238223137
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNPY2,Protein canopy homolog 2,16307,141,0.95 [0.74-1.23],0.7200198904821007
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNPY4,Protein canopy homolog 4,16535,147,0.93 [0.76-1.13],0.4449167257784746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNST,Consortin,16596,146,0.98 [0.85-1.12],0.7186147392227539
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTF,Ciliary neurotrophic factor,14051,117,0.90 [0.53-1.50],0.6769297493240721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN1,Contactin-1,16810,143,1.02 [0.59-1.75],0.9466635544775168
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN2,Contactin-2,16761,145,0.91 [0.65-1.28],0.5958121309760613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN3,Contactin-3,16623,145,1.01 [0.61-1.66],0.9768002975343066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN4,Contactin-4,16623,145,1.34 [0.72-2.48],0.3585269198899834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN5,Contactin-5,16638,146,1.33 [0.90-1.96],0.1484790940949421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTNAP2,Contactin-associated protein-like 2,16574,148,1.23 [0.87-1.75],0.2359624419684271
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTNAP4,Contactin-associated protein-like 4,14119,118,1.07 [0.92-1.25],0.3879511540067335
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COCH,Cochlin,14489,121,1.43 [0.99-2.06],0.0540300074494161
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL15A1,Collagen alpha-1(XV) chain,14504,123,1.57 [0.82-3.00],0.1700392815984455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL18A1,Collagen alpha-1(XVIII) chain,16700,143,1.17 [0.62-2.22],0.6275897511646132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL1A1,Collagen alpha-1(I) chain,16810,143,1.25 [0.69-2.27],0.4597980549255435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL24A1,Collagen alpha-1(XXIV) chain,14431,123,0.99 [0.72-1.35],0.942276645636132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL28A1,Collagen alpha-1(XXVIII) chain,14119,118,1.05 [0.83-1.32],0.6804435998617379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL2A1,Collagen alpha-1(II) chain,14129,115,0.93 [0.74-1.17],0.5536072033879684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL3A1,Collagen alpha-1(III) chain,14504,123,1.13 [0.54-2.36],0.7498991982263902
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL4A1,Collagen alpha-1(IV) chain,16596,146,0.96 [0.65-1.42],0.8394860392961547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL4A4,Collagen alpha-4(IV) chain,14208,119,0.99 [0.71-1.37],0.9447927719022304
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL5A1,Collagen alpha-1(V) chain,14204,118,1.08 [0.69-1.69],0.7452379658671675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL6A3,Collagen alpha-3(VI) chain,16810,143,1.44 [0.96-2.17],0.0807620053086368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL9A1,Collagen alpha-1(IX) chain,16574,148,1.04 [0.77-1.42],0.7828394200828652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL9A2,Collagen alpha-2(IX) chain,14233,119,1.02 [0.69-1.49],0.9320437051645366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COLEC12,Collectin-12,16598,147,1.61 [0.93-2.77],0.0887434656409165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMMD1,COMM domain-containing protein 1,14129,115,1.18 [0.88-1.58],0.2685391036248329
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMMD9,COMM domain-containing protein 9,14445,123,1.00 [0.65-1.54],0.9882501686407974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMP,Cartilage oligomeric matrix protein,16451,144,1.85 [1.18-2.90],0.007462730418821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMT,Catechol O-methyltransferase,16147,139,1.11 [0.92-1.33],0.2701324928549027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COPB2,Coatomer subunit beta',14028,116,0.90 [0.59-1.36],0.6096948446473172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COPE,Coatomer subunit epsilon,16227,143,0.61 [0.41-0.91],0.0161426482981091
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",14129,115,1.27 [0.89-1.83],0.1925957285218273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CORO1A,Coronin-1A,16263,139,1.00 [0.85-1.19],0.9545155345040138
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CORO6,Coronin-6,14051,117,0.93 [0.56-1.53],0.770531835250374
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",16535,147,0.90 [0.72-1.12],0.3402168315744347
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COX6B1,Cytochrome c oxidase subunit 6B1,14489,121,0.87 [0.50-1.51],0.6220487946016766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPA1,Carboxypeptidase A1,16810,143,1.05 [0.83-1.34],0.6658831421549292
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPA2,Carboxypeptidase A2,16685,146,1.14 [0.91-1.41],0.250691540027973
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPA4,Carboxypeptidase A4,13927,118,1.13 [0.74-1.72],0.5760278658723742
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPB1,Carboxypeptidase B,16810,143,1.09 [0.86-1.40],0.4730234899226346
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPB2,Carboxypeptidase B2,14490,121,0.85 [0.39-1.85],0.6740146699045503
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPE,Carboxypeptidase E,16617,145,0.94 [0.65-1.37],0.763232425053767
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPLX2,Complexin-2,13997,119,0.65 [0.35-1.20],0.1709575715394692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPM,Carboxypeptidase M,16645,145,0.95 [0.61-1.49],0.8353562880923237
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",14069,119,1.38 [0.76-2.52],0.2951499879580645
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPPED1,Serine/threonine-protein phosphatase CPPED1,16735,146,1.04 [0.84-1.30],0.7029312704874741
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPQ,Carboxypeptidase Q,14471,123,1.18 [0.71-1.94],0.5258851138664441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPTP,Ceramide-1-phosphate transfer protein,14028,116,0.72 [0.43-1.20],0.2094500601744633
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPVL,Probable serine carboxypeptidase CPVL,16740,145,0.78 [0.56-1.10],0.1555892103346272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPXM1,Probable carboxypeptidase X1,16671,146,0.88 [0.71-1.09],0.2459873878432464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPXM2,Inactive carboxypeptidase-like protein X2,14489,121,1.60 [0.91-2.83],0.1045665790181313
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CR1,Complement receptor type 1,14458,123,1.08 [0.66-1.77],0.7638886113417053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CR2,Complement receptor type 2,16700,145,0.84 [0.61-1.15],0.2818481955623265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,16261,143,1.13 [0.96-1.34],0.1504568833675199
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRADD,Death domain-containing protein CRADD,16434,144,1.04 [0.85-1.26],0.7246928856818826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CREB3,Cyclic AMP-responsive element-binding protein 3,13997,119,0.84 [0.59-1.19],0.3247165090266978
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CREBZF,CREB/ATF bZIP transcription factor,13997,119,1.17 [0.61-2.27],0.632404656789028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CREG1,Protein CREG1,16419,144,1.13 [0.78-1.64],0.5112003260350552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRELD1,Protein disulfide isomerase CRELD1,14204,118,0.85 [0.52-1.39],0.5263665633045941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRELD2,Protein disulfide isomerase CRELD2,16652,147,0.97 [0.73-1.30],0.8618216032340773
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRH,Corticoliberin,16235,143,1.02 [0.86-1.22],0.817403738596971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRHBP,Corticotropin-releasing factor-binding protein,16598,147,1.52 [0.89-2.62],0.1286530329723648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRHR1,Corticotropin-releasing factor receptor 1,16307,141,0.97 [0.76-1.25],0.8431103436169459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRIM1,Cysteine-rich motor neuron 1 protein,16677,147,1.68 [0.81-3.47],0.1642188708168318
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRIP2,Cysteine-rich protein 2,16463,144,1.36 [0.98-1.88],0.0627029915281264
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRISP2,Cysteine-rich secretory protein 2,16761,145,0.80 [0.62-1.01],0.065705717299979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRISP3,Cysteine-rich secretory protein 3,14381,122,0.94 [0.49-1.79],0.8448114795595384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRKL,Crk-like protein,16635,147,1.02 [0.89-1.18],0.75124700276927
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRLF1,Cytokine receptor-like factor 1,16677,147,1.80 [0.99-3.27],0.0538297585723932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRNN,Cornulin,16175,136,0.99 [0.79-1.24],0.9164595611206996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRTAC1,Cartilage acidic protein 1,16810,143,1.12 [0.69-1.83],0.6436132765110651
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRTAM,Cytotoxic and regulatory T-cell molecule,16463,144,1.16 [0.87-1.56],0.3100495371177642
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRTAP,Cartilage-associated protein,14119,118,1.02 [0.71-1.46],0.9079314617010452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRX,Cone-rod homeobox protein,16307,141,1.10 [0.97-1.24],0.1330585122855339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYBB1,Beta-crystallin B1,14489,121,1.04 [0.79-1.37],0.759998144181629
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYBB2,Beta-crystallin B2,14478,121,0.92 [0.71-1.18],0.4955917287418969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYGD,Gamma-crystallin D,14478,121,1.08 [0.90-1.30],0.3932456546367922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYM,Ketimine reductase mu-crystallin,14051,117,1.09 [0.87-1.37],0.434931498709913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYZL1,Quinone oxidoreductase-like protein 1,14129,115,1.08 [0.88-1.32],0.4603486387508287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSDE1,Cold shock domain-containing protein E1,14028,116,1.07 [0.93-1.23],0.3747011160678668
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF1,Macrophage colony-stimulating factor 1,16677,147,1.79 [1.05-3.05],0.031679380924847
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF1R,Macrophage colony-stimulating factor 1 receptor,14510,123,1.06 [0.68-1.65],0.7933864893836738
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF2,Granulocyte-macrophage colony-stimulating factor,14028,116,0.99 [0.60-1.63],0.9803400976250826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,16463,144,0.82 [0.64-1.05],0.1231766532400624
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF2RB,Cytokine receptor common subunit beta,14069,119,1.15 [0.75-1.75],0.5187431192314037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF3,Granulocyte colony-stimulating factor,16319,145,0.73 [0.54-1.01],0.0545369539521282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF3R,Granulocyte colony-stimulating factor receptor,14069,119,0.99 [0.53-1.85],0.9744479070965896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSH1,Chorionic somatomammotropin hormone 1,14510,123,1.30 [0.72-2.34],0.3842885217603139
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSNK1D,Casein kinase I isoform delta,14069,119,0.97 [0.73-1.29],0.8210953156855525
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSNK2A1,Casein kinase II subunit alpha,14472,123,1.08 [0.73-1.58],0.6990243146473343
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSPG4,Chondroitin sulfate proteoglycan 4,14504,123,1.86 [1.10-3.13],0.020630180290752
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSPG5,Chondroitin sulfate proteoglycan 5,14051,117,0.93 [0.64-1.35],0.6900049820630408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSRP3,Cysteine and glycine-rich protein 3,14028,116,1.09 [0.92-1.30],0.3362209816591469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST1,Cystatin-SN,12620,107,0.96 [0.80-1.15],0.6510255981130255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST3,Cystatin-C,16673,145,1.76 [1.07-2.88],0.0247361633438896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST5,Cystatin-D,16285,141,1.02 [0.78-1.34],0.8708975894642089
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST6,Cystatin-M,16172,139,1.23 [0.90-1.68],0.1898256635116146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST7,Cystatin-F,16639,147,1.11 [0.97-1.27],0.1212575754268351
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSTB,Cystatin-B,16384,139,1.36 [0.96-1.92],0.0803793198870251
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTAG1A_CTAG1B,Cancer/testis antigen 1,14209,119,1.13 [0.80-1.59],0.4850292110826287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTBS,Di-N-acetylchitobiase,14288,122,1.48 [0.75-2.91],0.2597468248710327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTF1,Cardiotrophin-1,16307,141,0.97 [0.81-1.16],0.733206897752188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTHRC1,Collagen triple helix repeat-containing protein 1,14504,123,1.57 [0.87-2.81],0.1334574175551433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTLA4,Cytotoxic T-lymphocyte protein 4,14504,123,0.68 [0.38-1.21],0.1910390748351505
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTNNA1,Catenin alpha-1,14051,117,1.22 [0.79-1.89],0.3679069368006357
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTRB1,Chymotrypsinogen B,16623,145,0.91 [0.70-1.18],0.4744135396335243
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTRC,Chymotrypsin-C,16605,146,0.92 [0.73-1.15],0.44623350793314
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTRL,Chymotrypsin-like protease CTRL-1,14478,121,1.02 [0.79-1.31],0.8702030034554107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSB,Cathepsin B,16645,143,1.21 [0.92-1.57],0.1696633634693508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSC,Dipeptidyl peptidase 1,16579,146,1.09 [0.79-1.52],0.5916783556714392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSD,Cathepsin D,15568,140,1.10 [0.77-1.58],0.6080400686937844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSE,Cathepsin E,14204,118,0.92 [0.65-1.29],0.6168719042860265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSF,Cathepsin F,16671,146,1.15 [0.80-1.67],0.4496060613599307
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSH,Pro-cathepsin H,16250,141,0.94 [0.77-1.15],0.5437803550594928
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSL,Cathepsin L1,16596,146,1.91 [1.07-3.43],0.0289437848406657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSO,Cathepsin O,16776,146,1.33 [0.82-2.14],0.2439349022421195
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSS,Cathepsin S,12998,115,2.15 [1.03-4.47],0.0414095778161912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSV,Cathepsin L2,16707,145,1.26 [0.90-1.78],0.1772939959737905
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSZ,Cathepsin Z,16654,144,1.50 [0.94-2.39],0.0910264561896745
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CUZD1,CUB and zona pellucida-like domain-containing protein 1,14119,118,0.77 [0.45-1.32],0.3434978494091207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CWC15,Spliceosome-associated protein CWC15 homolog,14339,123,1.16 [0.91-1.47],0.2370013964510797
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CX3CL1,Fractalkine,16463,144,1.13 [0.72-1.76],0.5991839776590095
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXADR,Coxsackievirus and adenovirus receptor,16574,148,1.22 [0.92-1.61],0.169423095357
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL1,Growth-regulated alpha protein,16594,147,1.06 [0.91-1.23],0.4342995490823261
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL10,C-X-C motif chemokine 10,16677,147,1.15 [0.93-1.42],0.1982308149515149
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL11,C-X-C motif chemokine 11,16735,146,1.06 [0.88-1.26],0.5588720363615558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL12,Stromal cell-derived factor 1,16319,145,0.90 [0.61-1.31],0.5819737074534324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL13,C-X-C motif chemokine 13,16735,146,1.22 [1.00-1.49],0.0461924799946814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL14,C-X-C motif chemokine 14,16319,145,1.18 [0.95-1.48],0.1336799614670132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL16,C-X-C motif chemokine 16,16790,143,1.69 [0.90-3.19],0.1037188805063544
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL17,C-X-C motif chemokine 17,16776,146,0.72 [0.50-1.04],0.0800356349424044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL3,C-X-C motif chemokine 3,16614,147,0.93 [0.80-1.09],0.3803673683460914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL5,C-X-C motif chemokine 5,16546,146,0.87 [0.77-1.00],0.0421417937226229
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL6,C-X-C motif chemokine 6,16776,146,0.82 [0.67-0.99],0.0428525052328277
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL8,Interleukin-8,16514,142,1.03 [0.83-1.27],0.7851070776014185
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL9,C-X-C motif chemokine 9,16677,147,1.18 [0.96-1.46],0.1150979094799258
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYB5A,Cytochrome b5,13997,119,1.03 [0.81-1.30],0.8312688315670209
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYB5R2,NADH-cytochrome b5 reductase 2,14278,122,1.32 [0.97-1.78],0.0773073879181527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",14028,116,1.05 [0.87-1.28],0.6142486121893789
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYTH3,Cytohesin-3,13997,119,1.01 [0.79-1.28],0.9546991665900372
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYTL1,Cytokine-like protein 1,14504,123,1.53 [0.76-3.06],0.2304107173752996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAAM1,Disheveled-associated activator of morphogenesis 1,14204,118,1.06 [0.85-1.31],0.601103032726201
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAB2,Disabled homolog 2,16761,145,1.00 [0.88-1.14],0.9714605512410428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAG1,Dystroglycan,16677,147,0.87 [0.63-1.19],0.3795126928487702
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAND5,DAN domain family member 5,14069,119,1.11 [0.82-1.50],0.5002966141342224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAPK2,Death-associated protein kinase 2,14069,119,1.22 [0.93-1.61],0.1460551819072545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,16574,148,0.98 [0.87-1.10],0.7505808450030939
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DARS1,"Aspartate--tRNA ligase, cytoplasmic",16434,144,1.09 [0.89-1.34],0.3905013979076867
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBH,Dopamine beta-hydroxylase,14482,123,0.98 [0.84-1.14],0.7622157755707124
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBI,Acyl-CoA-binding protein,16551,143,1.04 [0.85-1.26],0.7202892097845046
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBN1,Drebrin,14069,119,1.24 [0.88-1.75],0.2245177959759359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBNL,Drebrin-like protein,16677,147,1.01 [0.86-1.18],0.912657978584631
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",16671,146,1.22 [0.80-1.86],0.3608781135627833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCC,Netrin receptor DCC,14119,118,0.69 [0.28-1.67],0.4092754702954834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCDC2C,Doublecortin domain-containing protein 2C,13997,119,1.01 [0.76-1.33],0.9649574951608836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCLRE1C,Protein artemis,13997,119,1.57 [0.96-2.58],0.0738517629160636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCN,Decorin,16307,141,1.75 [0.94-3.25],0.0758733395742021
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTD,Deoxycytidylate deaminase,14204,118,1.01 [0.84-1.22],0.9128386739022007
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTN1,Dynactin subunit 1,16761,145,1.14 [0.90-1.43],0.2722104415188173
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTN2,Dynactin subunit 2,16535,147,1.04 [0.89-1.21],0.6575657946982411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTN6,Dynactin subunit 6,16227,143,0.96 [0.77-1.18],0.6860100460174572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTPP1,dCTP pyrophosphatase 1,16596,146,1.05 [0.65-1.70],0.8275933078207603
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCUN1D1,DCN1-like protein 1,14051,117,1.06 [0.85-1.33],0.5770908121270382
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCUN1D2,DCN1-like protein 2,13997,119,1.08 [0.88-1.33],0.4779972684152351
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCXR,L-xylulose reductase,16671,146,1.12 [0.85-1.48],0.4101654326420512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDA1,DET1- and DDB1-associated protein 1,14028,116,1.17 [0.77-1.77],0.4599142476610031
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",16535,147,1.14 [0.82-1.58],0.4515564966643894
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDC,Aromatic-L-amino-acid decarboxylase,16570,146,1.09 [0.80-1.50],0.5722290953668095
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDHD2,Phospholipase DDHD2,14472,123,1.09 [0.84-1.42],0.5134757193018284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDI2,Protein DDI1 homolog 2,14204,118,1.11 [0.88-1.38],0.3743170473019167
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDR1,Epithelial discoidin domain-containing receptor 1,16735,146,1.65 [0.87-3.10],0.1231228545632229
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDT,D-dopachrome decarboxylase,14504,123,1.42 [0.97-2.06],0.0707695679821614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX1,ATP-dependent RNA helicase DDX1,14431,123,1.09 [0.78-1.52],0.612190800567902
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX25,ATP-dependent RNA helicase DDX25,14119,118,1.05 [0.65-1.69],0.8436637366385182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX39A,ATP-dependent RNA helicase DDX39A,14069,119,1.19 [0.61-2.31],0.6137057382381198
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX4,Probable ATP-dependent RNA helicase DDX4,14069,119,1.01 [0.72-1.41],0.9557117680135448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX53,Probable ATP-dependent RNA helicase DDX53,14119,118,0.96 [0.59-1.57],0.877304507205653
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX58,Antiviral innate immune response receptor RIG-I,16261,143,1.00 [0.77-1.30],0.9933786235720896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",16574,148,0.97 [0.83-1.12],0.654917609282381
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFA1_DEFA1B,Neutrophil defensin 1,16307,144,1.02 [0.77-1.34],0.9041933383327104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB103A_DEFB103B,Beta-defensin 103,13954,118,1.33 [0.98-1.81],0.0682132523445837
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB104A_DEFB104B,Beta-defensin 104,14051,117,1.03 [0.75-1.42],0.86398113518246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB116,Beta-defensin 116,14051,117,1.01 [0.79-1.28],0.953926757211576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB118,Beta-defensin 118,14051,117,1.17 [0.91-1.51],0.2131766107240129
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB4A_DEFB4B,Beta-defensin 4A,16393,147,1.13 [1.03-1.25],0.0111553344669542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DENND2B,DENN domain-containing protein 2B,14028,116,0.78 [0.50-1.20],0.2583079746801254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DENR,Density-regulated protein,14069,119,1.02 [0.75-1.40],0.8769119340510877
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DFFA,DNA fragmentation factor subunit alpha,16776,146,1.04 [0.84-1.30],0.7061099327597771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DGCR6,Protein DGCR6,14051,117,1.25 [0.90-1.74],0.1770463473957724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DGKA,Diacylglycerol kinase alpha,14069,119,1.11 [0.80-1.53],0.524741679680876
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DGKZ,Diacylglycerol kinase zeta,16319,145,0.76 [0.49-1.16],0.2000687735278604
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DHODH,Dihydroorotate dehydrogenase,14028,116,1.01 [0.69-1.46],0.9712593324058304
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DHPS,Deoxyhypusine synthase,14445,123,1.28 [0.90-1.84],0.1733302989649631
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,14478,121,0.85 [0.57-1.28],0.4392858660992323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DIABLO,"Diablo homolog, mitochondrial",16559,146,0.95 [0.83-1.08],0.4151913133072449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DIPK1C,Divergent protein kinase domain 1C,14119,118,1.00 [0.65-1.52],0.9903125226968992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DIPK2B,Divergent protein kinase domain 2B,14204,118,2.10 [1.22-3.61],0.0070430225872343
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKK1,Dickkopf-related protein 1,16735,146,0.85 [0.66-1.09],0.2043371393688461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKK3,Dickkopf-related protein 3,16810,143,1.19 [0.72-1.96],0.4987851641026408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKK4,Dickkopf-related protein 4,16440,142,1.25 [0.91-1.70],0.1665087631939072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKKL1,Dickkopf-like protein 1,16535,147,1.03 [0.87-1.21],0.7737909280806721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLG4,Disks large homolog 4,14478,121,1.12 [0.88-1.42],0.3462840665946162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLGAP5,Disks large-associated protein 5,14472,123,0.89 [0.61-1.31],0.564809566971834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLK1,Protein delta homolog 1,16810,143,1.23 [0.94-1.61],0.1304977716444772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLL1,Delta-like protein 1,16671,146,1.50 [0.92-2.44],0.0999458778320106
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLL4,Delta-like protein 4,14129,115,1.05 [0.89-1.24],0.5400170397955818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DMD,Dystrophin,14129,115,1.31 [0.96-1.78],0.0921774613644431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DMP1,Dentin matrix acidic phosphoprotein 1,14129,115,0.90 [0.66-1.21],0.4727919619547233
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJA1,DnaJ homolog subfamily A member 1,13997,119,1.14 [0.79-1.64],0.4875356243179282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJA2,DnaJ homolog subfamily A member 2,16738,146,1.03 [0.86-1.23],0.7306284115070036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJA4,DnaJ homolog subfamily A member 4,14478,121,1.19 [0.94-1.51],0.1456548754360621
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB1,DnaJ homolog subfamily B member 1,16535,147,1.07 [0.91-1.27],0.4054806750537334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB14,DnaJ homolog subfamily B member 14,14431,123,1.16 [0.89-1.51],0.2775542569578433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB2,DnaJ homolog subfamily B member 2,14204,118,1.39 [1.01-1.90],0.0403534540184456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB6,DnaJ homolog subfamily B member 6,14069,118,1.08 [0.87-1.34],0.4682532404284203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB8,DnaJ homolog subfamily B member 8,16307,141,1.02 [0.79-1.32],0.8825249137968464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJC21,DnaJ homolog subfamily C member 21,14478,121,1.18 [0.77-1.81],0.4581050498919331
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJC6,Putative tyrosine-protein phosphatase auxilin,14129,115,1.10 [0.88-1.36],0.4097426662364217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJC9,DnaJ homolog subfamily C member 9,14431,123,1.25 [1.00-1.56],0.0507936967517004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNER,Delta and Notch-like epidermal growth factor-related receptor,16572,146,1.06 [0.59-1.91],0.8396023407669648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNLZ,DNL-type zinc finger protein,14051,117,1.10 [0.92-1.31],0.3078394199868774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNM1,Dynamin-1,14431,123,0.89 [0.76-1.03],0.1138527935430093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNM3,Dynamin-3,14472,123,1.02 [0.74-1.41],0.8996044785849211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNMBP,Dynamin-binding protein,16463,144,1.08 [0.84-1.38],0.5496697121296031
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNPEP,Aspartyl aminopeptidase,14478,121,1.43 [1.04-1.96],0.0257847320866231
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,16660,147,1.14 [0.86-1.51],0.3484611250955139
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOC2B,Double C2-like domain-containing protein beta,14119,118,0.75 [0.42-1.35],0.3361900931173898
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOCK9,Dedicator of cytokinesis protein 9,14051,117,0.97 [0.83-1.14],0.732859600105553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOK1,Docking protein 1,14478,121,1.00 [0.88-1.14],0.9911734386937048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOK2,Docking protein 2,16596,146,0.99 [0.87-1.11],0.8371430705800789
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPEP1,Dipeptidase 1,16434,144,1.02 [0.75-1.39],0.8795751190342684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPEP2,Dipeptidase 2,16535,147,1.17 [0.71-1.93],0.5263671923978784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP10,Inactive dipeptidyl peptidase 10,16574,148,1.26 [0.85-1.88],0.2469220405081486
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP4,Dipeptidyl peptidase 4,16352,144,1.03 [0.59-1.81],0.910338797280157
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP6,Dipeptidyl aminopeptidase-like protein 6,16535,147,1.13 [0.73-1.74],0.5840504829175419
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP7,Dipeptidyl peptidase 2,16473,146,1.10 [0.86-1.40],0.4452615997995022
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPT,Dermatopontin,16810,143,1.73 [0.93-3.23],0.0833489300069406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPY30,Protein dpy-30 homolog,16701,144,1.07 [0.84-1.36],0.591954985678371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DRAXIN,Draxin,16463,144,1.00 [0.70-1.41],0.9792489521542882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DRG2,Developmentally-regulated GTP-binding protein 2,16535,147,1.05 [0.81-1.36],0.7261535156944474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSC2,Desmocollin-2,16443,142,1.37 [0.90-2.10],0.1448244505410658
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSCAM,Down syndrome cell adhesion molecule,14472,123,1.33 [0.82-2.17],0.2440293564748732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSG2,Desmoglein-2,16623,145,1.10 [0.64-1.91],0.723821302131208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSG3,Desmoglein-3,16704,144,1.47 [0.96-2.26],0.0786984642278574
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSG4,Desmoglein-4,16479,146,1.00 [0.74-1.35],0.9898059366358528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTD1,D-aminoacyl-tRNA deacylase 1,14204,118,0.99 [0.81-1.22],0.9503790380224671
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTNB,Dystrobrevin beta,14415,123,1.81 [1.25-2.62],0.0015622518174651
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTX2,Probable E3 ubiquitin-protein ligase DTX2,14119,118,0.87 [0.64-1.20],0.4116358385827572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTX3,Probable E3 ubiquitin-protein ligase DTX3,16535,147,1.56 [0.86-2.84],0.1471601964374769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTYMK,Thymidylate kinase,14489,121,1.24 [0.96-1.61],0.0948640915371158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUOX2,Dual oxidase 2,16307,141,1.03 [0.84-1.26],0.8050073578962071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUSP13,Dual specificity protein phosphatase 13 isoform A,14445,123,0.98 [0.64-1.49],0.9212994307103012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUSP29,Dual specificity phosphatase 29,14119,118,1.18 [0.94-1.49],0.1571184040402818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUSP3,Dual specificity protein phosphatase 3,16227,143,0.98 [0.83-1.17],0.8593122324904522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",14431,123,0.96 [0.81-1.14],0.6298902097300922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DXO,Decapping and exoribonuclease protein,14478,121,1.26 [0.86-1.83],0.2348888381976688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,14445,123,1.08 [0.76-1.53],0.669596241036027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DYNLT1,Dynein light chain Tctex-type 1,14119,118,1.09 [0.88-1.35],0.4395768041935978
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DYNLT3,Dynein light chain Tctex-type 3,14445,123,1.09 [0.73-1.61],0.6733765621524159
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,16463,144,1.03 [0.88-1.20],0.7381323822724419
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EBI3_IL27,Interleukin-27,16731,145,0.93 [0.57-1.53],0.7721407437343462
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECE1,Endothelin-converting enzyme 1,16227,143,0.94 [0.62-1.43],0.7792403587670581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",14489,121,0.88 [0.68-1.14],0.3450604631128842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECHS1,"Enoyl-CoA hydratase, mitochondrial",14129,115,0.88 [0.72-1.07],0.1907576311856678
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECI2,Enoyl-CoA delta isomerase 2,14028,116,0.98 [0.73-1.32],0.9022161318176848
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECM1,Extracellular matrix protein 1,14129,117,1.06 [0.65-1.72],0.8200340131040377
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECSCR,Endothelial cell-specific chemotaxis regulator,14051,117,0.78 [0.51-1.18],0.2390089916794773
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDA2R,Tumor necrosis factor receptor superfamily member 27,16761,145,1.41 [0.95-2.07],0.08509585661259
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDAR,Tumor necrosis factor receptor superfamily member EDAR,16574,148,0.97 [0.83-1.14],0.7188426972415287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDDM3B,Epididymal secretory protein E3-beta,14445,123,0.91 [0.65-1.26],0.560319429681384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,14028,116,1.15 [0.74-1.78],0.5274603973133423
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDF1,Endothelial differentiation-related factor 1,14472,123,1.02 [0.80-1.31],0.8504567575344861
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,16307,141,1.16 [0.75-1.81],0.5046048418782973
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDN1,Endothelin-1,14129,115,0.95 [0.51-1.78],0.8788170935310887
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDNRB,Endothelin receptor type B,14069,119,1.32 [0.98-1.78],0.063004739126022
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EEF1D,Elongation factor 1-delta,14489,121,1.17 [0.97-1.41],0.0958459106408841
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFCAB14,EF-hand calcium-binding domain-containing protein 14,14431,123,1.33 [0.80-2.22],0.272037243518479
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFCAB2,Dynein regulatory complex protein 8,14233,119,1.01 [0.60-1.68],0.9748048174648134
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,16680,145,1.58 [0.99-2.53],0.0559676767137446
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFHD1,EF-hand domain-containing protein D1,14472,123,0.94 [0.56-1.56],0.806059189358072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFNA1,Ephrin-A1,16600,143,1.38 [0.83-2.31],0.2146458408485914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFNA4,Ephrin-A4,16432,141,1.39 [0.85-2.26],0.1899282644626288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFNB2,Ephrin-B2,14119,118,1.00 [0.73-1.39],0.9795096118835808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGF,Pro-epidermal growth factor,16588,146,0.93 [0.81-1.07],0.2866079601931415
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGFL7,Epidermal growth factor-like protein 7,16261,143,0.93 [0.63-1.36],0.7018438010534298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGFLAM,Pikachurin,14431,123,1.27 [0.74-2.19],0.3864898198404239
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGFR,Epidermal growth factor receptor,16810,143,1.16 [0.46-2.94],0.7500019172954331
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGLN1,Egl nine homolog 1,16574,148,1.03 [0.79-1.33],0.8354572900765103
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EHBP1,EH domain-binding protein 1,14489,121,1.08 [0.85-1.36],0.5313865859323961
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EHD3,EH domain-containing protein 3,14129,115,0.96 [0.83-1.13],0.6475467439814429
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",14478,121,1.05 [0.77-1.41],0.7728028721070398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",14369,123,1.04 [0.89-1.22],0.5934714639636218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,14028,116,1.11 [0.85-1.45],0.4389936560673945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,14129,115,1.11 [0.73-1.67],0.6245556886898814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4B,Eukaryotic translation initiation factor 4B,16463,144,1.15 [0.88-1.49],0.3087933157533897
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4E,Eukaryotic translation initiation factor 4E,14069,119,1.03 [0.85-1.26],0.7390516333783559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,16596,146,1.17 [0.94-1.46],0.1659700278803922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,16776,146,1.10 [0.95-1.28],0.2122062935049531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,14472,123,1.18 [0.92-1.52],0.1895389842317941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF5,Eukaryotic translation initiation factor 5,14028,116,0.90 [0.59-1.39],0.6487804509011295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF5A,Eukaryotic translation initiation factor 5A-1,16319,145,1.36 [0.92-2.01],0.1284929608998634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELAC1,Zinc phosphodiesterase ELAC protein 1,14472,123,0.98 [0.80-1.20],0.8408975938109602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELAVL4,ELAV-like protein 4,14051,117,0.93 [0.74-1.16],0.5163503630658746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELN,Elastin,14489,121,1.69 [1.03-2.79],0.03801030840862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELOA,Elongin-A,16535,147,1.18 [0.94-1.49],0.1612394857885981
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELOB,Elongin-B,14028,116,0.92 [0.56-1.50],0.7377821332712715
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENAH,Protein enabled homolog,16319,145,1.34 [1.00-1.79],0.0486225575440583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENDOU,Poly(U)-specific endoribonuclease,13362,119,1.32 [0.96-1.81],0.0881214544049623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENG,Endoglin,16810,143,1.22 [0.52-2.87],0.6548932823654254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENO1,Alpha-enolase,16578,146,0.97 [0.81-1.17],0.7496109832130939
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENO2,Gamma-enolase,16735,146,0.96 [0.76-1.20],0.714677438557072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENO3,Beta-enolase,14129,115,1.02 [0.75-1.39],0.9003284468698969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENOPH1,Enolase-phosphatase E1,14445,123,1.00 [0.73-1.39],0.9768342737205612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,14028,116,1.35 [0.74-2.44],0.3281184750130811
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPEP,Glutamyl aminopeptidase,14028,116,1.17 [0.83-1.66],0.3654499637348111
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,16810,143,1.01 [0.57-1.80],0.9615717769155304
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,16677,147,1.25 [0.86-1.82],0.2437655656937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,14129,115,0.83 [0.50-1.36],0.4595780639578458
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,16047,142,1.06 [0.88-1.27],0.5442707211420345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENSA,Alpha-endosulfine,14445,123,1.46 [1.13-1.88],0.0036043476338526
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,16261,143,1.11 [0.79-1.58],0.5411620561222337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,16307,141,1.20 [0.60-2.41],0.6125478844229748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,16307,141,0.77 [0.47-1.26],0.2942331218470825
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTR1,Endosome-associated-trafficking regulator 1,14129,115,1.30 [0.99-1.72],0.0634192625082613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EP300,Histone acetyltransferase p300,14069,119,1.21 [0.71-2.03],0.484432380288929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPB41L5,Band 4.1-like protein 5,14119,118,1.07 [0.81-1.40],0.6505707417868951
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPCAM,Epithelial cell adhesion molecule,16593,147,1.09 [0.94-1.27],0.2372808847285641
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPGN,Epigen,14445,123,0.84 [0.53-1.33],0.4566352900486844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA1,Ephrin type-A receptor 1,16660,147,1.36 [0.85-2.17],0.1943082101824469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA10,Ephrin type-A receptor 10,16227,143,1.08 [0.88-1.33],0.4788013624667634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA2,Ephrin type-A receptor 2,16033,143,1.19 [0.74-1.94],0.4729228912396327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA4,Ephrin type-A receptor 4,14204,118,1.55 [0.83-2.87],0.1678757337279796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHB4,Ephrin type-B receptor 4,16810,143,1.65 [0.92-2.94],0.0923859458422668
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHB6,Ephrin type-B receptor 6,16434,144,1.51 [0.95-2.40],0.0794626693160885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHX2,Bifunctional epoxide hydrolase 2,16307,141,1.02 [0.81-1.30],0.8462519234455469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPN1,Epsin-1,14233,119,1.06 [0.72-1.55],0.7686577546511087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPO,Erythropoietin,16574,148,1.08 [0.89-1.32],0.4428936776590843
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPPK1,Epiplakin,14129,115,1.00 [0.77-1.29],0.9783499449156088
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,16731,144,1.27 [0.78-2.07],0.3381023647188976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBB2,Receptor tyrosine-protein kinase erbB-2,16671,146,1.23 [0.65-2.32],0.519757355482018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBB3,Receptor tyrosine-protein kinase erbB-3,16571,147,1.24 [0.59-2.60],0.5679777623177508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBB4,Receptor tyrosine-protein kinase erbB-4,16671,146,1.15 [0.61-2.15],0.6676198996545333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBIN,Erbin,16535,147,0.98 [0.85-1.13],0.7866338907593731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERC2,ERC protein 2,14119,118,1.03 [0.82-1.29],0.8135261787810015
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERCC1,DNA excision repair protein ERCC-1,13997,119,0.83 [0.47-1.45],0.5061435153274347
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EREG,Proepiregulin,16434,144,0.85 [0.70-1.04],0.1128542815486747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERI1,3'-5' exoribonuclease 1,14233,119,1.28 [0.78-2.09],0.3330205512107765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERMAP,Erythroid membrane-associated protein,14069,119,0.99 [0.66-1.49],0.9698999014612352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,14445,123,1.33 [0.86-2.04],0.2008747237226043
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERP29,Endoplasmic reticulum resident protein 29,14204,118,1.00 [0.86-1.16],0.995862949439762
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERP44,Endoplasmic reticulum resident protein 44,16503,147,1.03 [0.58-1.83],0.9172626243947826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,14028,116,0.92 [0.59-1.41],0.6880652724286909
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESAM,Endothelial cell-selective adhesion molecule,16810,143,1.01 [0.63-1.61],0.9728084508339776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESM1,Endothelial cell-specific molecule 1,16598,147,1.05 [0.68-1.62],0.8270369239570226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESPL1,Separin,13997,119,1.16 [0.89-1.50],0.2758558714052991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESR1,Estrogen receptor,14069,119,0.93 [0.66-1.31],0.676521499409386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESYT2,Extended synaptotagmin-2,14478,121,1.04 [0.84-1.29],0.7230510915938836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EVI2B,Protein EVI2B,13997,119,0.87 [0.54-1.41],0.5809262525817747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EVI5,Ecotropic viral integration site 5 protein homolog,14069,119,1.04 [0.85-1.26],0.7291258708403523
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EVPL,Envoplakin,14233,119,1.15 [0.69-1.90],0.5907734025436444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EXOSC10,Exosome component 10,14028,116,1.02 [0.74-1.40],0.9153719572220246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EXTL1,Exostosin-like 1,14028,116,0.91 [0.61-1.36],0.6502586466638585
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EZR,Ezrin,16735,146,1.44 [0.79-2.62],0.2387065125000134
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F10,Coagulation factor X,14510,123,1.43 [0.83-2.46],0.1940899954165394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F11,Coagulation factor XI,14312,120,1.38 [0.88-2.16],0.166984343615284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F11R,Junctional adhesion molecule A,16623,145,1.04 [0.80-1.36],0.7732241322397146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F12,Coagulation factor XII,14518,122,0.92 [0.61-1.39],0.6814247846585859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F13B,Coagulation factor XIII B chain,14442,121,0.71 [0.36-1.42],0.3374488563112077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F2,Prothrombin,14518,122,2.28 [0.72-7.22],0.1621435284570717
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F2R,Proteinase-activated receptor 1,16652,147,0.93 [0.72-1.21],0.5996609395878207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F3,Tissue factor,16661,144,1.31 [0.75-2.29],0.3434009575901241
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F7,Coagulation factor VII,16682,145,1.22 [0.74-1.99],0.4354450560508405
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F9,Coagulation factor IX,16670,145,1.38 [0.61-3.13],0.4362395023107875
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP1,"Fatty acid-binding protein, liver",16598,147,1.09 [0.93-1.27],0.2790476423764286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP2,"Fatty acid-binding protein, intestinal",16596,146,1.03 [0.86-1.24],0.7257886320451953
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP3,"Fatty acid-binding protein, heart",14489,121,1.29 [0.93-1.79],0.1239174308527295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP4,"Fatty acid-binding protein, adipocyte",16810,143,1.03 [0.76-1.41],0.835988850818311
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP5,Fatty acid-binding protein 5,16675,146,1.02 [0.82-1.27],0.8413429525612496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP6,Gastrotropin,16277,141,1.29 [1.02-1.63],0.0340893746399853
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP9,Fatty acid-binding protein 9,16574,148,0.95 [0.73-1.23],0.7021999481309602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FADD,FAS-associated death domain protein,16596,146,0.98 [0.80-1.19],0.8164117789784466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM13A,Protein FAM13A,14431,123,1.27 [0.99-1.63],0.0588580564024254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM171A2,Protein FAM171A2,14472,123,1.04 [0.94-1.16],0.4597623961236983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM171B,Protein FAM171B,14445,123,1.68 [1.10-2.57],0.0163513527780007
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM172A,Cotranscriptional regulator FAM172A,14129,115,1.09 [0.81-1.47],0.5562228336952135
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM20A,Pseudokinase FAM20A,14489,121,1.19 [0.64-2.21],0.5824184180743683
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM3B,Protein FAM3B,16535,147,1.05 [0.68-1.62],0.8255149815150009
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM3C,Protein FAM3C,16570,146,1.27 [0.77-2.08],0.3465328178130108
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM3D,Protein FAM3D,14431,123,1.01 [0.83-1.24],0.901828354269162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAP,Prolyl endopeptidase FAP,16810,143,1.30 [0.74-2.27],0.3601506685322037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FARSA,Phenylalanine--tRNA ligase alpha subunit,14119,118,0.96 [0.74-1.25],0.7618162234183827
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAS,Tumor necrosis factor receptor superfamily member 6,16772,143,1.00 [0.64-1.57],0.9996401064921964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FASLG,Tumor necrosis factor ligand superfamily member 6,16776,146,0.95 [0.63-1.41],0.7835416058730906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FBLN2,Fibulin-2,14504,123,1.81 [1.04-3.14],0.0350895726764706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FBN2,Fibrillin-2,14119,118,1.04 [0.77-1.41],0.8012013325280054
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FBP1,"Fructose-1,6-bisphosphatase 1",16596,146,1.07 [0.87-1.30],0.5361001327879643
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,14489,121,1.23 [0.96-1.56],0.0960913499609788
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCAR,Immunoglobulin alpha Fc receptor,16574,148,1.06 [0.78-1.43],0.7304466848990385
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,14472,123,1.88 [0.96-3.70],0.0671823109972302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCER2,Low affinity immunoglobulin epsilon Fc receptor,16623,145,1.20 [0.90-1.61],0.2215278900481571
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,16573,145,1.22 [0.92-1.61],0.1730760583718871
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,16261,143,0.93 [0.71-1.21],0.5816384509460683
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,16656,145,0.94 [0.70-1.26],0.66709902082538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCN1,Ficolin-1,14482,123,1.36 [0.96-1.92],0.0810027082884743
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCN2,Ficolin-2,16560,144,1.14 [0.78-1.66],0.5116256827797008
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL1,Fc receptor-like protein 1,16596,146,1.00 [0.71-1.40],0.9930400115780778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL2,Fc receptor-like protein 2,16690,144,1.33 [1.00-1.77],0.0473785809077236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL3,Fc receptor-like protein 3,16319,145,1.18 [0.90-1.54],0.230610027046676
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL5,Fc receptor-like protein 5,16623,145,1.26 [0.97-1.63],0.081396097579187
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL6,Fc receptor-like protein 6,16574,148,1.29 [1.04-1.60],0.0205084954631216
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRLB,Fc receptor-like B,16261,143,0.94 [0.73-1.21],0.6198140520584019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FDX1,"Adrenodoxin, mitochondrial",14028,116,0.99 [0.74-1.33],0.9579371396044928
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FDX2,"Ferredoxin-2, mitochondrial",14028,116,0.76 [0.53-1.08],0.1224195163686676
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FEN1,Flap endonuclease 1,16261,143,1.13 [0.94-1.37],0.2018075262483565
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FES,Tyrosine-protein kinase Fes/Fps,16261,143,1.35 [1.06-1.71],0.0133541618691672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FETUB,Fetuin-B,16670,145,1.37 [0.85-2.22],0.1926559803744521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGA,Fibrinogen alpha chain,14175,116,0.96 [0.53-1.74],0.8965169664503531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",14472,123,1.03 [0.83-1.28],0.7643269537785435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF12,Fibroblast growth factor 12,14069,119,0.97 [0.65-1.43],0.8601815765835831
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF16,Fibroblast growth factor 16,14069,119,1.19 [0.84-1.66],0.3244936712521481
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF19,Fibroblast growth factor 19,16677,147,1.10 [0.91-1.33],0.3289840160051402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF2,Fibroblast growth factor 2,16574,148,0.95 [0.76-1.18],0.6399279058998114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF20,Fibroblast growth factor 20,14069,119,1.04 [0.72-1.52],0.8225677476975202
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF21,Fibroblast growth factor 21,16731,145,0.96 [0.84-1.09],0.5389605028938693
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF23,Fibroblast growth factor 23,16737,145,1.20 [0.93-1.56],0.1658847687360777
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF3,Fibroblast growth factor 3,14069,119,0.57 [0.28-1.17],0.1238991513837447
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF5,Fibroblast growth factor 5,16319,145,1.04 [0.66-1.64],0.8625214351659223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF6,Fibroblast growth factor 6,14069,119,1.22 [0.83-1.80],0.3124833488808923
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF7,Fibroblast growth factor 7,13997,119,0.87 [0.67-1.13],0.3012662273778081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF9,Fibroblast growth factor 9,13975,119,1.07 [0.69-1.65],0.7590376534387563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFBP1,Fibroblast growth factor-binding protein 1,16671,146,0.82 [0.52-1.29],0.383465808655728
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFBP2,Fibroblast growth factor-binding protein 2,14504,123,1.23 [0.88-1.71],0.2291977991250363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFBP3,Fibroblast growth factor-binding protein 3,14478,121,1.00 [0.62-1.61],0.9854692189936638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFR2,Fibroblast growth factor receptor 2,16671,146,2.13 [1.10-4.12],0.0244457800463152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFR4,Fibroblast growth factor receptor 4,14204,118,1.00 [0.71-1.40],0.9776119569204228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGL1,Fibrinogen-like protein 1,14510,123,0.94 [0.72-1.23],0.6459580200171978
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGR,Tyrosine-protein kinase Fgr,16227,143,1.17 [0.95-1.44],0.1396500924970402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FH,"Fumarate hydratase, mitochondrial",14051,117,1.01 [0.82-1.25],0.9162221076684032
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FHIP2A,FHF complex subunit HOOK interacting protein 2A,14028,116,1.24 [0.92-1.68],0.1578275239837933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FHIT,Bis(5'-adenosyl)-triphosphatase,16227,143,1.09 [0.89-1.34],0.4011491722360727
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FIS1,Mitochondrial fission 1 protein,16622,147,1.02 [0.84-1.24],0.8414509759835901
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,14472,123,1.03 [0.86-1.22],0.7508872482824358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,16640,145,0.97 [0.85-1.11],0.6794710996332598
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,16463,144,1.17 [0.83-1.66],0.3624360809253765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,16463,144,1.00 [0.86-1.18],0.9550176442109076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,16198,143,0.85 [0.60-1.20],0.3512717667915983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBPL,FK506-binding protein-like,14431,123,1.27 [0.95-1.69],0.1015785746935721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLI1,Friend leukemia integration 1 transcription factor,16261,143,0.98 [0.85-1.12],0.7795126159690466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,16463,144,1.21 [0.71-2.04],0.4842088327351822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT1,Vascular endothelial growth factor receptor 1,16499,147,1.87 [0.98-3.60],0.0588309610685146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT3,Receptor-type tyrosine-protein kinase FLT3,16261,143,0.93 [0.56-1.52],0.7631560449580616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT3LG,Fms-related tyrosine kinase 3 ligand,16776,146,1.21 [0.79-1.87],0.3822429138245775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT4,Vascular endothelial growth factor receptor 3,16671,146,1.14 [0.73-1.77],0.576127225577317
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FMNL1,Formin-like protein 1,16227,143,1.15 [0.95-1.39],0.1572524074846912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FMR1,Synaptic functional regulator FMR1,16261,143,0.94 [0.61-1.45],0.7964879936826457
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FN1,Fibronectin,14518,122,0.95 [0.50-1.83],0.8833349160107005
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FNDC1,Fibronectin type III domain-containing protein 1,14478,121,0.99 [0.68-1.44],0.9498024383555328
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,14445,123,1.03 [0.62-1.70],0.9089592439280392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLH1,Glutamate carboxypeptidase 2,14069,119,1.01 [0.86-1.20],0.8818006350792379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLR1,Folate receptor alpha,16600,145,1.41 [0.85-2.33],0.1857403376589766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLR2,Folate receptor beta,16735,146,1.52 [0.92-2.51],0.1006052921108521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLR3,Folate receptor gamma,16619,146,1.10 [1.03-1.17],0.0039378161312987
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOS,Proto-oncogene c-Fos,13975,119,1.34 [0.83-2.17],0.2308403615736428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOSB,Protein fosB,16227,143,1.31 [0.98-1.74],0.0641610362276575
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOXJ3,Forkhead box protein J3,14069,119,1.25 [0.87-1.79],0.2228605679417379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOXO1,Forkhead box protein O1,16574,148,0.96 [0.81-1.14],0.6520510618634643
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOXO3,Forkhead box protein O3,16261,143,1.04 [0.89-1.22],0.6147076584774562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FRMD4B,FERM domain-containing protein 4B,14028,116,1.22 [0.95-1.56],0.1214851829412582
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FRMD7,FERM domain-containing protein 7,14119,118,0.79 [0.47-1.33],0.3675930552098677
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FRZB,Secreted frizzled-related protein 3,16404,140,1.21 [0.64-2.27],0.5559501209463864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FSHB,Follitropin subunit beta,14129,115,1.27 [0.90-1.77],0.1705072405256403
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FST,Follistatin,16652,147,1.12 [0.83-1.51],0.4539998850428804
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FSTL1,Follistatin-related protein 1,14129,115,1.45 [0.65-3.26],0.3637085636048931
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FSTL3,Follistatin-related protein 3,16570,147,1.48 [0.94-2.35],0.0937462328951432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FTCD,Formimidoyltransferase-cyclodeaminase,14448,121,1.03 [0.84-1.27],0.7536039127225932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUCA1,Tissue alpha-L-fucosidase,16722,142,1.02 [0.85-1.22],0.8470297826048527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUOM,Fucose mutarotase,14204,118,1.11 [0.83-1.49],0.4612236628154267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FURIN,Furin,16671,146,1.16 [0.73-1.83],0.5258958474140067
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUS,RNA-binding protein FUS,16238,143,1.23 [0.85-1.76],0.2738058436021476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",14198,119,1.02 [0.77-1.35],0.8948626050661073
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,16735,146,0.99 [0.72-1.36],0.962426691703536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUT8,"Alpha-(1,6)-fucosyltransferase",16463,144,0.83 [0.64-1.08],0.1650283824457513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FXN,"Frataxin, mitochondrial",16761,145,1.04 [0.85-1.27],0.704454922027771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FXYD5,FXYD domain-containing ion transport regulator 5,16319,145,1.01 [0.80-1.27],0.964024942824124
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FYB1,FYN-binding protein 1,16588,145,1.00 [0.85-1.17],0.9922116385485517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FZD10,Frizzled-10,14119,118,0.98 [0.72-1.33],0.9128790949354652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FZD8,Frizzled-8,14051,117,1.01 [0.68-1.52],0.9490656593688456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GABARAP,Gamma-aminobutyric acid receptor-associated protein,14445,123,0.90 [0.62-1.32],0.5999515777545005
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,14233,119,1.13 [0.90-1.43],0.2975429928383947
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,14051,117,1.19 [0.93-1.52],0.1753971960815772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAD1,Glutamate decarboxylase 1,13997,119,1.23 [0.62-2.43],0.5536158099378307
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAD2,Glutamate decarboxylase 2,14069,119,1.01 [0.69-1.47],0.9600815441354856
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,14233,119,1.19 [0.90-1.59],0.2185275981624345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,14129,115,0.88 [0.61-1.25],0.4663158324844817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAGE2A,G antigen 2A,13997,119,1.12 [0.89-1.41],0.3290151216655892
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAL,Galanin peptides,16677,147,1.17 [0.93-1.46],0.17421994198113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,16535,147,1.34 [0.78-2.28],0.2857393928557688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,16761,145,1.47 [0.85-2.56],0.1723623828170001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,16319,145,1.15 [0.81-1.62],0.4319389228242559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,14489,121,1.54 [0.88-2.73],0.1332507385702776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT7,N-acetylgalactosaminyltransferase 7,16535,147,1.30 [0.64-2.64],0.4674320279141313
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAMT,Guanidinoacetate N-methyltransferase,14028,116,1.00 [0.60-1.65],0.9968445340533556
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,13883,117,0.74 [0.44-1.24],0.2512807267331228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GART,Trifunctional purine biosynthetic protein adenosine-3,14472,123,1.08 [0.57-2.04],0.8095109227140627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAS2,Growth arrest-specific protein 2,14233,119,1.16 [0.86-1.56],0.3443698831345886
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAS6,Growth arrest-specific protein 6,16721,143,1.05 [0.58-1.92],0.8700718724595101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GASK1A,Golgi-associated kinase 1A,14028,116,1.06 [0.70-1.62],0.7859969996783214
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAST,Gastrin,14478,121,0.97 [0.85-1.10],0.6374561646370672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,13997,119,0.68 [0.35-1.33],0.2633501966105695
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",14129,115,0.89 [0.70-1.14],0.3648581423385961
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBA,Lysosomal acid glucosylceramidase,14119,118,1.05 [0.76-1.45],0.7695734153297891
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP1,Guanylate-binding protein 1,14452,121,1.16 [0.89-1.52],0.2568216244599198
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP2,Guanylate-binding protein 2,16319,145,0.98 [0.76-1.26],0.8806926026837131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP4,Guanylate-binding protein 4,16227,143,0.98 [0.72-1.33],0.8730981361617915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP6,Guanylate-binding protein 6,14028,116,0.84 [0.54-1.31],0.4441845188374448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GC,Vitamin D-binding protein,14518,122,0.93 [0.48-1.81],0.8224685788266688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCC1,GRIP and coiled-coil domain-containing protein 1,14478,121,1.03 [0.87-1.21],0.762400966666053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCG,Pro-glucagon,16261,143,0.96 [0.85-1.08],0.4671665267547781
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,13871,116,1.33 [0.99-1.80],0.0624042940651474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCLM,Glutamate--cysteine ligase regulatory subunit,14028,116,1.32 [0.96-1.80],0.0832815269975802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",16535,147,0.94 [0.61-1.44],0.7748717506543432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GDF15,Growth/differentiation factor 15,16810,143,1.41 [1.02-1.94],0.0350242774284489
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GDF2,Growth/differentiation factor 2,16596,146,0.69 [0.46-1.06],0.0879258506810431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GDNF,Glial cell line-derived neurotrophic factor,16227,143,1.45 [1.02-2.08],0.0407545941333534
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GET3,ATPase GET3,14489,121,0.96 [0.69-1.34],0.8021981300273578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFAP,Glial fibrillary acidic protein,16228,142,0.96 [0.70-1.32],0.8110604764105905
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFER,FAD-linked sulfhydryl oxidase ALR,16261,143,1.07 [0.84-1.36],0.5828015620460663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,16261,143,1.08 [0.97-1.20],0.1802528770564893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRA1,GDNF family receptor alpha-1,16731,145,1.41 [0.84-2.38],0.1936265591789646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRA2,GDNF family receptor alpha-2,16535,147,0.86 [0.43-1.72],0.6737727121376602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRA3,GDNF family receptor alpha-3,16422,144,1.20 [0.71-2.02],0.5031988127468956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRAL,GDNF family receptor alpha-like,14032,118,1.06 [0.79-1.41],0.7002976817979921
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGA1,ADP-ribosylation factor-binding protein GGA1,16227,143,0.96 [0.76-1.22],0.745526149156541
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGACT,Gamma-glutamylaminecyclotransferase,14489,121,1.02 [0.80-1.31],0.8626306888482882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGCT,Gamma-glutamylcyclotransferase,14456,121,1.28 [0.90-1.81],0.1643158482281113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGH,Gamma-glutamyl hydrolase,16373,144,1.23 [0.80-1.88],0.3453498162693885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGT1,Glutathione hydrolase 1 proenzyme,16600,143,0.93 [0.67-1.27],0.6303297849870955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGT5,Glutathione hydrolase 5 proenzyme,16463,144,1.85 [1.01-3.38],0.0458950556995973
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GH1,Somatotropin,16570,146,1.02 [0.94-1.11],0.686435584127152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GH2,Growth hormone variant,16261,143,0.97 [0.88-1.07],0.5619914547904725
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GHR,Growth hormone receptor,14204,118,0.92 [0.49-1.75],0.8034255256487942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GHRHR,Growth hormone-releasing hormone receptor,16227,143,0.92 [0.68-1.24],0.5795361922616771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GHRL,Appetite-regulating hormone,16596,146,1.02 [0.85-1.21],0.8623763641670558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GID8,Glucose-induced degradation protein 8 homolog,14472,123,0.74 [0.40-1.35],0.3251503167152996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIGYF2,GRB10-interacting GYF protein 2,14472,123,1.17 [0.93-1.46],0.1818025190496966
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIMAP7,GTPase IMAP family member 7,14204,118,1.03 [0.59-1.79],0.9158142823100326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIMAP8,GTPase IMAP family member 8,13997,119,1.22 [0.91-1.65],0.1833401186219745
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIP,Gastric inhibitory polypeptide,14129,115,1.04 [0.77-1.41],0.7766030549218382
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIPC2,PDZ domain-containing protein GIPC2,14478,121,1.93 [1.17-3.20],0.0105025942156628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIPC3,PDZ domain-containing protein GIPC3,14431,123,0.99 [0.83-1.19],0.9371355555240964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIPR,Gastric inhibitory polypeptide receptor,14069,119,0.83 [0.54-1.27],0.3837376101965576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIT1,ARF GTPase-activating protein GIT1,14069,119,1.05 [0.87-1.26],0.6041110459710162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GJA8,Gap junction alpha-8 protein,13997,119,1.05 [0.81-1.36],0.7260606040452309
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GKN1,Gastrokine-1,15923,141,1.00 [0.58-1.73],0.9899549609739464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLA,Alpha-galactosidase A,14180,118,0.93 [0.57-1.51],0.7577900395620009
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLB1,Beta-galactosidase,16463,144,1.15 [0.80-1.63],0.4487589931719337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLI2,Zinc finger protein GLI2,14069,119,1.08 [0.63-1.86],0.7842122349060836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLO1,Lactoylglutathione lyase,16307,141,1.06 [0.82-1.37],0.6685419608787844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLOD4,Glyoxalase domain-containing protein 4,16597,147,1.31 [0.86-2.00],0.2040820956051939
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLP1R,Glucagon-like peptide 1 receptor,14051,117,1.23 [0.81-1.87],0.3240332594430912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLRX,Glutaredoxin-1,16477,145,1.16 [0.90-1.49],0.2587185583787168
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",14204,118,0.95 [0.77-1.16],0.6128031028368555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,16227,143,0.98 [0.70-1.38],0.9278144753544856
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLYR1,Putative oxidoreductase GLYR1,14445,123,1.01 [0.75-1.37],0.9501539127664336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GM2A,Ganglioside GM2 activator,14143,120,1.12 [0.72-1.76],0.6133537882645048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GMFG,Glia maturation factor gamma,14489,121,1.00 [0.78-1.27],0.9826770675231696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GMPR,GMP reductase 1,16776,146,1.30 [0.96-1.77],0.0912451104302491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GMPR2,GMP reductase 2,14204,118,1.15 [0.88-1.50],0.3156172342584123
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNAS,Neuroendocrine secretory protein 55,14472,123,1.10 [0.91-1.34],0.3237141901670858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,16261,143,0.95 [0.75-1.20],0.6644382866049607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,14119,118,1.10 [0.79-1.53],0.5601858804928568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNLY,Granulysin,16623,145,1.21 [0.92-1.58],0.1645955145549785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNPDA1,Glucosamine-6-phosphate isomerase 1,14129,115,1.13 [0.70-1.83],0.624014003387596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNPDA2,Glucosamine-6-phosphate isomerase 2,14204,118,0.95 [0.58-1.56],0.8445589806187923
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOLGA3,Golgin subfamily A member 3,14472,123,1.06 [0.85-1.32],0.604490353798669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOLM2,Protein GOLM2,16735,146,1.55 [0.83-2.89],0.1661146942013877
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,16574,148,0.99 [0.86-1.14],0.9055613082183636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GORASP2,Golgi reassembly-stacking protein 2,14431,123,1.16 [0.81-1.66],0.4276997844431319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOT1,"Aspartate aminotransferase, cytoplasmic",14504,123,1.37 [0.93-2.01],0.1140193030905678
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP1BA,Platelet glycoprotein Ib alpha chain,16560,144,1.01 [0.65-1.60],0.9507093334928224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP1BB,Platelet glycoprotein Ib beta chain,14028,116,0.98 [0.75-1.28],0.8767003045496814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,16112,137,1.10 [0.92-1.31],0.3031029661428673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP5,Platelet glycoprotein V,14204,118,0.78 [0.48-1.26],0.3126385846588695
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP6,Platelet glycoprotein VI,16588,145,0.93 [0.79-1.11],0.4313678720021683
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPA33,Cell surface A33 antigen,16535,147,1.06 [0.96-1.18],0.2707454677193036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPC1,Glypican-1,16761,145,1.16 [0.70-1.92],0.5615044473971806
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPC5,Glypican-5,16463,144,0.88 [0.68-1.15],0.358554476041126
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPD1,Glycerol-3-phosphate dehydrogenase,14445,123,0.99 [0.70-1.40],0.9481697915460724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPHA2,Glycoprotein hormone alpha-2,14431,123,1.24 [0.89-1.73],0.2054584196707679
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPI,Glucose-6-phosphate isomerase,14510,123,1.06 [0.73-1.52],0.7721873621487108
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,14431,123,1.19 [0.92-1.55],0.1823165654887079
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPKOW,G-patch domain and KOW motifs-containing protein,16227,143,1.20 [0.78-1.85],0.4029308381949241
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPNMB,Transmembrane glycoprotein NMB,16149,143,0.92 [0.54-1.55],0.7532413327329438
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR101,Probable G-protein coupled receptor 101,14051,117,1.09 [0.82-1.45],0.5610698524274991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR158,Probable G-protein coupled receptor 158,14472,123,1.32 [0.85-2.04],0.2184820713867094
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR15L,Protein GPR15L,14431,123,1.14 [0.85-1.51],0.3799547844906219
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR37,Prosaposin receptor GPR37,16307,141,0.95 [0.76-1.20],0.6933731780688979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPRC5C,G-protein coupled receptor family C group 5 member C,14445,123,1.23 [0.93-1.63],0.1468319408876611
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRAP2,GRB2-related adapter protein 2,16596,146,0.99 [0.88-1.11],0.8644385344440648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,14489,121,1.16 [0.88-1.53],0.2955668651666109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRIK2,"Glutamate receptor ionotropic, kainate 2",14472,123,1.10 [0.77-1.57],0.6086267968488531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",14051,117,1.11 [0.84-1.47],0.4495215629659074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRK5,G protein-coupled receptor kinase 5,16307,141,1.08 [0.81-1.44],0.587528715257293
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRN,Progranulin,16544,143,1.27 [0.68-2.37],0.4610555386593666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRP,Gastrin-releasing peptide,14129,115,1.01 [0.73-1.41],0.9473362634335748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRPEL1,"GrpE protein homolog 1, mitochondrial",16535,147,0.91 [0.70-1.19],0.4907055188916112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRSF1,G-rich sequence factor 1,13920,118,0.99 [0.79-1.23],0.9064382791554048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSAP,Gamma-secretase-activating protein,16261,143,1.04 [0.88-1.22],0.6734855975591434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSN,Gelsolin,14458,122,2.25 [0.95-5.32],0.0657317173751535
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSR,"Glutathione reductase, mitochondrial",14428,123,1.48 [0.67-3.28],0.3356209458703673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTA1,Glutathione S-transferase A1,16567,146,1.07 [0.89-1.27],0.4867630714591464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTA3,Glutathione S-transferase A3,16261,143,1.05 [0.86-1.28],0.6433883299201109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTM4,Glutathione S-transferase Mu 4,14028,116,1.16 [0.94-1.43],0.1572482768456553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTP1,Glutathione S-transferase P,16129,141,0.93 [0.74-1.17],0.5482552021331265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTT2B,Glutathione S-transferase theta-2B,14478,121,1.06 [0.98-1.14],0.1363960127025748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,14233,119,0.89 [0.66-1.19],0.418880920882844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GTPBP2,GTP-binding protein 2,14119,118,0.97 [0.78-1.22],0.8139604548451688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUCA2A,Guanylin,16529,142,1.26 [0.82-1.95],0.2948751389222807
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUCY2C,Heat-stable enterotoxin receptor,14233,119,0.96 [0.76-1.21],0.707561637696742
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUK1,Guanylate kinase,14028,116,1.39 [0.99-1.94],0.0581608221113647
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUSB,Beta-glucuronidase,16707,143,1.17 [0.92-1.48],0.2050139646442084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GYS1,"Glycogen [starch] synthase, muscle",16307,141,1.00 [0.85-1.18],0.9819169364935249
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GZMA,Granzyme A,16776,146,1.43 [0.95-2.14],0.0870968401832883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GZMB,Granzyme B,16574,148,0.99 [0.79-1.24],0.9442531873474636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GZMH,Granzyme H,16307,141,1.20 [1.02-1.40],0.0295525439767092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,H2AP,Huntingtin-interacting protein M,13997,119,0.91 [0.62-1.35],0.6432088320245379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",14028,116,0.94 [0.70-1.25],0.6550178036800036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",16703,145,1.25 [1.02-1.52],0.0296775044377201
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAO1,Hydroxyacid oxidase 1,16761,145,0.94 [0.83-1.06],0.314378760745592
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HARS1,"Histidine--tRNA ligase, cytoplasmic",16623,145,1.01 [0.83-1.22],0.952306688012506
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAVCR1,Hepatitis A virus cellular receptor 1,16733,145,1.21 [0.96-1.53],0.1048937364680758
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAVCR2,Hepatitis A virus cellular receptor 2,16623,145,1.49 [0.99-2.24],0.0551171828971431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HBEGF,Proheparin-binding EGF-like growth factor,16703,145,0.75 [0.62-0.92],0.0066699502160141
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HBQ1,Hemoglobin subunit theta-1,16761,145,1.20 [0.95-1.50],0.121988176754616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HBZ,Hemoglobin subunit zeta,14489,121,1.13 [0.96-1.32],0.142354881095056
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HCG22,Protein PBMUCL2,14028,116,0.99 [0.71-1.38],0.9583456649996832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HCLS1,Hematopoietic lineage cell-specific protein,16776,146,1.10 [0.84-1.44],0.4691742269756888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDAC8,Histone deacetylase 8,14069,119,1.02 [0.76-1.37],0.8968438179419204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDAC9,Histone deacetylase 9,14051,117,0.85 [0.62-1.16],0.3024620967538234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDDC2,5'-deoxynucleotidase HDDC2,14431,123,1.39 [0.95-2.02],0.0878254445880334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDGF,Hepatoma-derived growth factor,16727,145,1.02 [0.87-1.19],0.8438355901869994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDGFL2,Hepatoma-derived growth factor-related protein 2,14478,121,1.18 [0.91-1.53],0.2089491604885358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEBP1,Heme-binding protein 1,16307,141,1.23 [0.98-1.56],0.0764759541959769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEG1,Protein HEG homolog 1,14204,118,1.18 [0.60-2.33],0.6235168784544071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEPACAM2,HEPACAM family member 2,14478,121,1.00 [0.66-1.52],0.9846242744472884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEPH,Hephaestin,14489,121,1.38 [0.70-2.74],0.3523367220175428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEXIM1,Protein HEXIM1,16574,148,1.02 [0.85-1.22],0.8362141721582027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HGF,Hepatocyte growth factor,16776,146,1.41 [0.92-2.16],0.1126809398798917
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HGFAC,Hepatocyte growth factor activator,14372,121,0.80 [0.44-1.44],0.4570669032212618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,16261,143,1.09 [0.90-1.32],0.3564061274025077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HHEX,Hematopoietically-expressed homeobox protein HHEX,14478,121,1.05 [0.84-1.33],0.6571387805181428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HIF1A,Hypoxia-inducible factor 1-alpha,14069,119,1.19 [0.95-1.51],0.1331370453810265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HIP1,Huntingtin-interacting protein 1,14028,116,1.27 [0.80-2.01],0.3183946625119986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HIP1R,Huntingtin-interacting protein 1-related protein,14442,121,1.34 [0.99-1.82],0.0586583225774028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HJV,Hemojuvelin,14472,123,1.00 [0.67-1.49],0.9921822973822724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HK2,Hexokinase-2,16307,141,1.09 [0.64-1.87],0.7467843201214075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",14472,123,0.97 [0.58-1.64],0.9204907123545883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",16528,147,1.38 [0.94-2.04],0.1006568072864648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",16574,148,1.22 [0.74-2.00],0.4348370881380009
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMBS,Porphobilinogen deaminase,16761,145,1.30 [0.92-1.83],0.1436636175984209
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMCN2,Hemicentin-2,14180,118,0.94 [0.69-1.28],0.687473628764754
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",14129,115,1.10 [0.76-1.59],0.6009553720814531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",14028,116,1.18 [0.82-1.72],0.3760168578849167
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMMR,Hyaluronan mediated motility receptor,13967,119,1.24 [0.92-1.66],0.1615757390645542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMOX1,Heme oxygenase 1,16424,145,1.17 [0.87-1.58],0.3019777257184799
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMOX2,Heme oxygenase 2,16227,143,0.95 [0.67-1.33],0.7494579982552678
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNF1A,Hepatocyte nuclear factor 1-alpha,14119,118,0.86 [0.63-1.16],0.3230471185477891
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNMT,Histamine N-methyltransferase,16380,141,1.11 [0.80-1.53],0.5350847187934038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,16262,140,1.08 [0.89-1.31],0.454361068609961
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,14472,123,1.18 [0.86-1.62],0.3130475920712423
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HPCAL1,Hippocalcin-like protein 1,16776,146,0.96 [0.79-1.16],0.654560941195283
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HPGDS,Hematopoietic prostaglandin D synthase,16261,143,0.76 [0.51-1.15],0.1923068415106325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HPSE,Heparanase,14312,123,0.94 [0.78-1.13],0.5185479122795744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HRAS,GTPase Hras,14197,119,1.05 [0.89-1.24],0.5507837801998058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,14129,115,1.39 [0.87-2.23],0.173411747171007
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HRG,Histidine-rich glycoprotein,14442,121,1.10 [0.64-1.90],0.7200742975388168
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS1BP3,HCLS1-binding protein 3,14129,115,1.05 [0.85-1.29],0.6565367712571935
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,16535,147,0.76 [0.51-1.13],0.1735879498762801
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,16761,145,1.71 [1.33-2.20],2.921416916821616e-05
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,14069,119,1.21 [0.74-1.99],0.4475409639084167
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSBP1,Heat shock factor-binding protein 1,14129,115,1.16 [0.96-1.40],0.1241655525094957
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,16574,148,0.95 [0.65-1.37],0.7789244198066377
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,14478,121,1.30 [0.98-1.71],0.0660620273893749
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSD17B3,Testosterone 17-beta-dehydrogenase 3,14028,116,0.88 [0.60-1.29],0.506526769364598
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,14129,115,1.16 [0.80-1.68],0.4250485391446942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSP90B1,Endoplasmin,16145,142,0.94 [0.74-1.21],0.6318292606150775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPA1A,Heat shock 70 kDa protein 1A,16660,147,1.06 [0.86-1.30],0.6032688595303277
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPA2,Heat shock-related 70 kDa protein 2,14445,123,1.39 [0.87-2.20],0.1640721432872977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPB1,Heat shock protein beta-1,16357,145,1.10 [0.88-1.37],0.3854073626018613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPB6,Heat shock protein beta-6,16761,145,1.28 [0.88-1.86],0.1953378987521983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,16517,144,1.98 [1.17-3.35],0.0111244672358075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HTR1A,5-hydroxytryptamine receptor 1A,14051,117,1.02 [0.81-1.29],0.8680236193574261
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HTR1B,5-hydroxytryptamine receptor 1B,14051,117,0.92 [0.61-1.40],0.703764841251509
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HTRA2,"Serine protease HTRA2, mitochondrial",16671,146,1.06 [0.83-1.35],0.6313932556012911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HYAL1,Hyaluronidase-1,16548,145,0.78 [0.40-1.51],0.4621651836421188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HYOU1,Hypoxia up-regulated protein 1,16810,143,2.32 [1.22-4.40],0.0103234547617072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICA1,Islet cell autoantigen 1,16319,145,1.08 [0.89-1.30],0.4244073450815128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM1,Intercellular adhesion molecule 1,16566,144,1.47 [0.87-2.49],0.1484494813530414
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM2,Intercellular adhesion molecule 2,16810,143,1.14 [0.72-1.80],0.5821888893684946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM3,Intercellular adhesion molecule 3,16810,143,1.26 [0.71-2.24],0.4279197718628429
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM4,Intercellular adhesion molecule 4,16574,148,1.23 [0.92-1.62],0.1568128784213266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM5,Intercellular adhesion molecule 5,16596,146,0.86 [0.63-1.19],0.3759841489849375
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICOSLG,ICOS ligand,16535,147,2.26 [1.06-4.85],0.0357428926911146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ID4,DNA-binding protein inhibitor ID-4,14233,119,1.27 [0.92-1.75],0.1407372918790086
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDI2,Isopentenyl-diphosphate delta-isomerase 2,16227,143,1.36 [1.04-1.77],0.022554505250249
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDO1,"Indoleamine 2,3-dioxygenase 1",14129,115,1.24 [0.95-1.62],0.1153340495882433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDS,Iduronate 2-sulfatase,16776,146,1.41 [0.26-7.74],0.6938389843307566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDUA,Alpha-L-iduronidase,16761,145,0.92 [0.67-1.27],0.6240250057881511
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,14062,119,1.71 [1.12-2.60],0.0121548202477612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,14233,119,1.18 [0.87-1.62],0.2882271947145479
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,14233,119,1.30 [0.85-1.99],0.2222971539278621
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNAR1,Interferon alpha/beta receptor 1,14431,123,1.66 [0.93-2.96],0.0891016231829468
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNG,Interferon gamma,16319,145,0.96 [0.85-1.10],0.588538076653704
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNGR1,Interferon gamma receptor 1,16677,147,2.13 [1.17-3.88],0.0137968866979691
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNGR2,Interferon gamma receptor 2,16463,144,0.84 [0.63-1.14],0.2664574895938053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNL1,Interferon lambda-1,16227,143,0.98 [0.70-1.37],0.901694673945665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNL2,Interferon lambda-2,14051,117,1.19 [0.94-1.51],0.1472244682077826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNLR1,Interferon lambda receptor 1,16574,148,1.28 [0.88-1.86],0.1946374535115873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNW1,Interferon omega-1,14028,116,0.90 [0.53-1.53],0.7059090310880722
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFT20,Intraflagellar transport protein 20 homolog,14119,118,1.21 [0.82-1.77],0.3400956427095497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGBP1,Immunoglobulin-binding protein 1,14472,123,1.29 [0.98-1.70],0.074824169173693
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,14051,117,1.12 [0.80-1.55],0.5080493060329674
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,14504,123,1.07 [0.56-2.04],0.8490161996397572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGF1R,Insulin-like growth factor 1 receptor,16535,147,1.29 [0.65-2.56],0.4700756957000528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,14028,116,1.19 [0.84-1.68],0.328502257738242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGF2R,Cation-independent mannose-6-phosphate receptor,16623,145,1.62 [0.86-3.06],0.1328077082035223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP1,Insulin-like growth factor-binding protein 1,16788,143,1.05 [0.93-1.19],0.4479520147480932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP2,Insulin-like growth factor-binding protein 2,16788,143,1.10 [0.86-1.42],0.44751155581303
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP3,Insulin-like growth factor-binding protein 3,16700,145,1.29 [0.79-2.11],0.3032425098844592
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP4,Insulin-like growth factor-binding protein 4,16423,143,1.43 [1.04-1.97],0.027045716099757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP6,Insulin-like growth factor-binding protein 6,16559,145,1.68 [1.07-2.64],0.0234966373986553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP7,Insulin-like growth factor-binding protein 7,16810,143,1.50 [0.97-2.34],0.0710834816180909
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBPL1,Insulin-like growth factor-binding protein-like 1,16596,146,1.57 [1.03-2.41],0.0373782863807941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFL4,Insulin growth factor-like family member 4,14069,119,0.97 [0.76-1.25],0.8377483412362793
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGHMBP2,DNA-binding protein SMUBP-2,14028,116,1.05 [0.76-1.44],0.7672103825542412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGLC2,Immunoglobulin lambda constant 2,14488,122,1.42 [0.88-2.30],0.1517003364976597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGLON5,IgLON family member 5,13997,119,1.11 [0.95-1.31],0.185853612871266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF21,Immunoglobulin superfamily member 21,14129,115,1.03 [0.65-1.62],0.9084437016613712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF3,Immunoglobulin superfamily member 3,16535,147,2.12 [1.43-3.13],0.0001636503966448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF8,Immunoglobulin superfamily member 8,16596,146,1.07 [0.66-1.75],0.7725800794333637
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF9,Protein turtle homolog A,14489,121,1.04 [0.84-1.29],0.7337931075481539
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IKBKG,NF-kappa-B essential modulator,16574,148,1.04 [0.89-1.23],0.6162214446212679
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IKZF2,Zinc finger protein Helios,16261,143,0.90 [0.74-1.09],0.2991756912505365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL10,Interleukin-10,16319,145,0.98 [0.81-1.18],0.8254349295577353
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL10RA,Interleukin-10 receptor subunit alpha,16319,145,0.98 [0.75-1.27],0.865063012139607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL10RB,Interleukin-10 receptor subunit beta,16677,147,1.63 [1.02-2.60],0.0412222659523722
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL11,Interleukin-11,16319,145,1.04 [0.82-1.31],0.7552215921565995
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12A_IL12B,Interleukin-12,16535,147,1.08 [0.89-1.30],0.4298158380529621
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12B,Interleukin-12 subunit beta,16776,146,1.09 [0.83-1.43],0.5274151490143122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12RB1,Interleukin-12 receptor subunit beta-1,16319,145,0.97 [0.65-1.44],0.8781979330182053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12RB2,Interleukin-12 receptor subunit beta-2,14069,119,1.30 [0.87-1.95],0.2039609440114223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL13,Interleukin-13,16319,145,0.90 [0.64-1.27],0.5476914737856712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL13RA1,Interleukin-13 receptor subunit alpha-1,16420,144,1.56 [0.81-3.01],0.1785490161279709
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL13RA2,Interleukin-13 receptor subunit alpha-2,14051,117,0.91 [0.49-1.68],0.7627805877660754
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL15,Interleukin-15,16574,148,1.52 [1.00-2.33],0.0520579276176621
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL15RA,Interleukin-15 receptor subunit alpha,16319,145,0.92 [0.60-1.41],0.6969932913717757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL16,Pro-interleukin-16,16776,146,1.09 [0.78-1.53],0.6057392491183237
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17A,Interleukin-17A,16298,145,1.19 [0.87-1.62],0.2666256624084352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17C,Interleukin-17C,16319,145,1.14 [0.94-1.38],0.1744096332925798
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17D,Interleukin-17D,16319,145,1.24 [0.90-1.70],0.198295411320121
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17F,Interleukin-17F,16319,145,0.96 [0.78-1.18],0.6838429377553581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17RA,Interleukin-17 receptor A,16623,145,1.19 [0.85-1.66],0.3147381169232431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17RB,Interleukin-17 receptor B,16371,145,1.02 [0.77-1.36],0.8658339017420166
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18,Interleukin-18,16551,147,1.00 [0.72-1.38],0.9925464044363552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18BP,Interleukin-18-binding protein,16700,145,1.46 [0.91-2.32],0.115118072283042
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18R1,Interleukin-18 receptor 1,16776,146,1.39 [0.89-2.18],0.1491372252812723
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18RAP,Interleukin-18 receptor accessory protein,16356,141,1.00 [0.91-1.09],0.9240458032367832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL19,Interleukin-19,16174,143,1.14 [0.93-1.39],0.2192278583941764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1A,Interleukin-1 alpha,16319,145,0.92 [0.71-1.19],0.5197951537897927
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1B,Interleukin-1 beta,16249,144,0.92 [0.70-1.22],0.5760380424264253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1R1,Interleukin-1 receptor type 1,16600,143,1.49 [0.78-2.83],0.2299929194336211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1R2,Interleukin-1 receptor type 2,16580,147,0.92 [0.44-1.94],0.8326804105306819
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RAP,Interleukin-1 receptor accessory protein,16623,145,1.10 [0.80-1.51],0.5494155273636656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RL1,Interleukin-1 receptor-like 1,16772,143,1.12 [0.81-1.56],0.4878107346992035
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RL2,Interleukin-1 receptor-like 2,16319,145,1.31 [0.88-1.95],0.1863921060431807
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RN,Interleukin-1 receptor antagonist protein,16589,147,1.11 [0.85-1.46],0.4337320463853854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2,Interleukin-2,16319,145,0.95 [0.59-1.52],0.8369641779488175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL20,Interleukin-20,16319,145,0.79 [0.56-1.12],0.1800545554629937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL20RA,Interleukin-20 receptor subunit alpha,16319,145,1.00 [0.71-1.39],0.9899017302984102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL20RB,Interleukin-20 receptor subunit beta,14069,119,0.97 [0.63-1.50],0.8908669331330992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL21R,Interleukin-21 receptor,14069,119,1.12 [0.85-1.46],0.4278314013528261
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL22,Interleukin-22,14445,123,1.01 [0.78-1.30],0.9551282716148688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL22RA1,Interleukin-22 receptor subunit alpha-1,16319,145,1.17 [0.89-1.54],0.2625668711951341
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL24,Interleukin-24,16319,145,0.88 [0.64-1.21],0.4370640488504893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL25,Interleukin-25,13945,119,1.41 [0.84-2.36],0.1942290645032828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2RA,Interleukin-2 receptor subunit alpha,16482,139,0.97 [0.66-1.43],0.896295960546939
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2RB,Interleukin-2 receptor subunit beta,16319,145,0.79 [0.52-1.21],0.2764876980939931
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2RG,Cytokine receptor common subunit gamma,14445,123,1.22 [0.81-1.85],0.3347563037731729
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL3,Interleukin-3,13997,119,0.92 [0.71-1.20],0.5465670292777667
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL31,Interleukin-31,14069,119,1.24 [0.97-1.60],0.0919490306906885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL31RA,Interleukin-31 receptor subunit alpha,14008,119,1.09 [0.68-1.75],0.7059464107252025
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL32,Interleukin-32,16574,148,0.93 [0.65-1.33],0.7042276708261741
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL33,Interleukin-33,16319,145,1.02 [0.70-1.49],0.9131698060909796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL34,Interleukin-34,16204,143,1.27 [0.83-1.93],0.2746326365655785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL36A,Interleukin-36 alpha,14069,119,0.91 [0.65-1.27],0.5774720696356581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL36G,Interleukin-36 gamma,14007,119,1.13 [0.89-1.43],0.3058703218753458
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL3RA,Interleukin-3 receptor subunit alpha,16319,145,1.33 [0.84-2.08],0.2209522560095805
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL4,Interleukin-4,16319,145,1.09 [0.91-1.30],0.3327035249542023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL4R,Interleukin-4 receptor subunit alpha,16574,148,1.20 [0.80-1.81],0.3767953888370772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL5,Interleukin-5,16319,145,1.06 [0.96-1.17],0.2615724906065583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL5RA,Interleukin-5 receptor subunit alpha,16574,148,0.94 [0.72-1.22],0.6379412650283696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL6,Interleukin-6,16535,147,0.99 [0.81-1.21],0.9217162109441848
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL6R,Interleukin-6 receptor subunit alpha,16544,144,1.46 [0.94-2.25],0.0887113713201762
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL6ST,Interleukin-6 receptor subunit beta,16596,146,1.23 [0.53-2.89],0.6291104283290703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL7,Interleukin-7,16574,148,0.89 [0.71-1.13],0.3359430537874989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL7R,Interleukin-7 receptor subunit alpha,16623,145,0.99 [0.74-1.31],0.9206711768121963
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL9,Interleukin-9,14233,119,0.82 [0.57-1.19],0.3020780880006362
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,16206,143,1.15 [0.90-1.47],0.2599137115138494
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMMT,MICOS complex subunit MIC60,14445,123,1.18 [0.82-1.71],0.3753890851224146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMPA1,Inositol monophosphatase 1,16463,144,0.99 [0.77-1.26],0.907965289660478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMPACT,Protein IMPACT,14478,121,1.34 [0.98-1.83],0.070212091843061
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMPG1,Interphotoreceptor matrix proteoglycan 1,14051,117,0.80 [0.43-1.49],0.4777590385081769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ING1,Inhibitor of growth protein 1,16198,143,0.93 [0.67-1.29],0.679685270055177
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INHBB,Inhibin beta B chain,14204,118,1.30 [0.94-1.81],0.1165892902803083
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INHBC,Inhibin beta C chain,16623,145,1.04 [0.72-1.51],0.8304350985296243
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPP1,Inositol polyphosphate 1-phosphatase,16535,147,1.31 [1.00-1.70],0.0492864150541878
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",14129,115,1.40 [1.02-1.90],0.0353059980409522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",14472,123,0.94 [0.62-1.44],0.7847176549708206
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",16535,147,1.01 [0.87-1.18],0.8834270306475733
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSL3,Insulin-like 3,14478,121,0.92 [0.75-1.13],0.4445254339411156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSL4,Early placenta insulin-like peptide,14445,123,1.20 [0.89-1.62],0.2213290936739681
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSL5,Insulin-like peptide INSL5,14431,123,1.05 [0.88-1.25],0.6144322248603734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSR,Insulin receptor,14069,119,2.51 [0.89-7.05],0.0808547561727905
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IPCEF1,Interactor protein for cytohesin exchange factors 1,16432,141,0.97 [0.82-1.14],0.6990949336496667
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IQGAP2,Ras GTPase-activating-like protein IQGAP2,16535,147,1.12 [0.86-1.46],0.4085462636837037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",16307,141,1.08 [0.91-1.27],0.3803608794539427
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IRAK1,Interleukin-1 receptor-associated kinase 1,16319,145,1.01 [0.81-1.26],0.9035435319048416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IRAK4,Interleukin-1 receptor-associated kinase 4,16574,148,1.00 [0.87-1.15],0.9684400530690674
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,16010,142,0.76 [0.51-1.13],0.1745189001709144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISM1,Isthmin-1,16574,148,1.20 [0.81-1.77],0.3591508382078926
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISM2,Isthmin-2,14504,123,1.14 [0.78-1.67],0.5099574317120923
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IST1,IST1 homolog,14316,123,1.04 [0.87-1.24],0.7005577765110376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA11,Integrin alpha-11,16574,148,0.78 [0.51-1.21],0.2662969445512025
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA2,Integrin alpha-2,14204,118,0.98 [0.59-1.65],0.9536667781120588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA5,Integrin alpha-5,16623,145,1.60 [0.88-2.90],0.1239009153330104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA6,Integrin alpha-6,16574,148,1.04 [0.78-1.37],0.7983626279935853
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAL,Integrin alpha-L,14069,119,1.26 [0.82-1.92],0.2940324500788567
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAM,Integrin alpha-M,16623,145,1.29 [0.82-2.05],0.2722870483201245
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAV,Integrin alpha-V,16761,145,0.73 [0.30-1.81],0.5002987170225667
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAX,Integrin alpha-X,14233,119,1.39 [1.09-1.78],0.0079434215273084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB1,Integrin beta-1,16629,145,1.62 [0.81-3.22],0.1698276937515019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB1BP1,Integrin beta-1-binding protein 1,16261,143,0.92 [0.63-1.32],0.6378896078923167
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB1BP2,Integrin beta-1-binding protein 2,16307,141,1.00 [0.88-1.15],0.9670093561212044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB2,Integrin beta-2,16522,141,1.11 [0.64-1.91],0.7093611453719021
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB5,Integrin beta-5,16671,146,1.06 [0.71-1.57],0.7833712543417499
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB6,Integrin beta-6,16319,145,1.15 [0.70-1.87],0.5803506160009925
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB7,Integrin beta-7,16761,145,1.01 [0.73-1.39],0.9471240806141856
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGBL1,Integrin beta-like protein 1,14504,123,1.41 [0.90-2.22],0.135934596965489
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,14518,122,1.04 [0.41-2.65],0.9352682830558964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,16700,145,0.95 [0.64-1.40],0.7850019840989401
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,14518,122,0.98 [0.49-1.97],0.9555240176986952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,14445,123,1.50 [1.16-1.95],0.0020703671165635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITM2A,Integral membrane protein 2A,16574,148,1.09 [0.86-1.38],0.4889367540706242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITPA,Inosine triphosphate pyrophosphatase,14028,116,1.07 [0.82-1.41],0.6069888273245057
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",14129,115,1.06 [0.82-1.37],0.6715781865266707
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",14051,117,1.12 [0.77-1.64],0.5421461982750286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",16227,143,1.02 [0.77-1.37],0.8686429378872322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IZUMO1,Izumo sperm-egg fusion protein 1,13997,119,0.91 [0.61-1.37],0.6676627116019966
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JAM2,Junctional adhesion molecule B,16735,146,1.57 [0.91-2.69],0.1020083639014017
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JAM3,Junctional adhesion molecule C,14204,118,0.92 [0.63-1.33],0.6431840232889394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JCHAIN,Immunoglobulin J chain,16319,145,1.15 [0.91-1.46],0.2463219270493508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,13997,119,1.13 [0.85-1.50],0.3974516487417165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JPT2,Jupiter microtubule associated homolog 2,14431,123,1.03 [0.84-1.26],0.7565632262460555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JUN,Transcription factor AP-1,16319,145,1.03 [0.77-1.38],0.8264935979365232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,16535,147,1.22 [0.87-1.71],0.2577098743541895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KAZN,Kazrin,14431,123,1.09 [0.92-1.29],0.3156059698636188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCNC4,Potassium voltage-gated channel subfamily C member 4,14051,117,1.21 [0.93-1.58],0.1596837320670698
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCNH2,Potassium voltage-gated channel subfamily H member 2,14119,118,0.95 [0.74-1.21],0.6609739132202787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCNIP4,Kv channel-interacting protein 4,16227,143,0.82 [0.58-1.15],0.2532526315685959
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCTD5,BTB/POZ domain-containing protein KCTD5,14217,121,1.21 [0.84-1.74],0.3056478003898623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KDM3A,Lysine-specific demethylase 3A,14069,119,0.96 [0.77-1.18],0.6845622912887743
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KDR,Vascular endothelial growth factor receptor 2,16671,146,1.37 [0.75-2.47],0.3040581903872313
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KEL,Kell blood group glycoprotein,16227,143,1.05 [0.69-1.58],0.8247536682320111
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KHDC3L,KH domain-containing protein 3,13997,119,0.91 [0.68-1.20],0.492818544209349
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KHK,Ketohexokinase,14129,115,0.98 [0.73-1.31],0.8777052370813828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA0319,Dyslexia-associated protein KIAA0319,14478,121,1.23 [0.73-2.06],0.4438947222988439
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA1549,UPF0606 protein KIAA1549,14233,119,0.95 [0.74-1.21],0.6605526884645985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA1549L,UPF0606 protein KIAA1549L,14233,119,1.80 [1.14-2.84],0.0114639140253961
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA2013,Uncharacterized protein KIAA2013,14445,123,1.13 [0.86-1.50],0.3811477421464312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIF1C,Kinesin-like protein KIF1C,14028,116,1.13 [0.68-1.86],0.6425226005291758
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIF20B,Kinesin-like protein KIF20B,14051,117,1.13 [0.92-1.39],0.2493113918891894
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIF22,Kinesin-like protein KIF22,14028,116,1.05 [0.91-1.22],0.5066227237353602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIFBP,KIF-binding protein,16535,147,0.97 [0.82-1.16],0.7677851429700294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,14445,123,0.96 [0.79-1.16],0.6865550934032828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,16261,143,0.95 [0.79-1.15],0.585727390351496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,14431,123,1.00 [0.91-1.11],0.9701868524038256
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,16261,143,0.90 [0.80-1.01],0.0770926726824563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,13997,119,1.14 [0.97-1.34],0.1144801887164945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIRREL1,Kin of IRRE-like protein 1,14051,117,1.06 [0.79-1.42],0.7193049818176098
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIRREL2,Kin of IRRE-like protein 2,16227,143,1.33 [0.96-1.87],0.0909155066813826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIT,Mast/stem cell growth factor receptor Kit,16670,145,1.30 [0.79-2.14],0.3087698759922687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KITLG,Kit ligand,16596,146,0.95 [0.63-1.42],0.79505168664836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLB,Beta-klotho,16227,143,0.87 [0.71-1.06],0.1604261033683275
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLF4,Krueppel-like factor 4,14051,117,0.99 [0.64-1.53],0.9615259077004992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLHL41,Kelch-like protein 41,14472,123,1.04 [0.72-1.49],0.8358333540467734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK1,Kallikrein-1,16449,145,1.04 [0.93-1.16],0.5302876107462196
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK10,Kallikrein-10,16618,145,1.18 [0.83-1.67],0.348015018299634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK11,Kallikrein-11,16511,144,1.16 [0.75-1.80],0.5120138411685993
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK12,Kallikrein-12,16261,143,1.04 [0.93-1.16],0.5239628201730884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK13,Kallikrein-13,16252,146,1.24 [0.90-1.72],0.1907461569164533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK14,Kallikrein-14,16761,145,1.05 [0.77-1.44],0.7534286230950265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK15,Kallikrein-15,14422,123,1.40 [1.01-1.94],0.0409557682030799
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK3,Prostate-specific antigen,14504,123,1.26 [1.07-1.49],0.0048845194744054
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK4,Kallikrein-4,16761,145,1.03 [0.81-1.31],0.7994904903288506
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK6,Kallikrein-6,16641,145,1.21 [0.75-1.96],0.4297423918950234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK7,Kallikrein-7,13849,118,1.13 [0.71-1.81],0.6028057560207338
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK8,Kallikrein-8,16064,132,1.52 [1.01-2.28],0.0457510791565547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLKB1,Plasma kallikrein,14203,118,0.98 [0.47-2.04],0.9607945964163414
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRB1,Killer cell lectin-like receptor subfamily B member 1,16776,146,1.31 [0.90-1.92],0.1575842330590768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,14051,117,0.92 [0.66-1.27],0.6036407186511069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRD1,Natural killer cells antigen CD94,16776,146,1.14 [0.83-1.55],0.4241581386905421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRF1,Killer cell lectin-like receptor subfamily F member 1,14069,119,1.25 [0.90-1.73],0.1805085118789152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRK1,NKG2-D type II integral membrane protein,14478,121,1.22 [0.86-1.75],0.268678015603647
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT14,"Keratin, type I cytoskeletal 14",15704,140,1.08 [0.65-1.78],0.7658317312189378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT17,"Keratin, type I cytoskeletal 17",14028,116,0.79 [0.48-1.30],0.3520577022041211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT18,"Keratin, type I cytoskeletal 18",16535,147,1.16 [0.97-1.39],0.0955177135864909
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT19,"Keratin, type I cytoskeletal 19",16539,148,1.00 [0.80-1.24],0.976618236005162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT5,"Keratin, type II cytoskeletal 5",16227,143,1.44 [1.11-1.87],0.0067968265070093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT6C,"Keratin, type II cytoskeletal 6C",14028,116,1.50 [1.03-2.17],0.0324574104653085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT8,"Keratin, type II cytoskeletal 8",14051,117,1.07 [0.86-1.32],0.5462512483849724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KYAT1,Kynurenine--oxoglutarate transaminase 1,16576,146,1.07 [0.83-1.39],0.5884146643310864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KYNU,Kynureninase,16776,146,1.03 [0.74-1.45],0.8431019509846027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,L1CAM,Neural cell adhesion molecule L1,16671,146,1.55 [0.94-2.56],0.0887794064295411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,14489,121,0.89 [0.73-1.08],0.2488664316627077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LACRT,Extracellular glycoprotein lacritin,14411,123,1.13 [0.82-1.55],0.4652913909475555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LACTB2,Endoribonuclease LACTB2,16596,146,0.99 [0.79-1.24],0.8998587204878681
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAG3,Lymphocyte activation gene 3 protein,16535,147,1.48 [1.05-2.10],0.0264490075069918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,16598,147,1.05 [0.70-1.57],0.8283072658827364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,16463,144,1.13 [0.97-1.31],0.1044367705257678
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMA1,Laminin subunit alpha-1,14028,116,1.20 [0.91-1.59],0.2015022304524363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMA4,Laminin subunit alpha-4,16677,147,0.94 [0.61-1.46],0.7919803955491691
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMB1,Laminin subunit beta-1,14129,115,0.99 [0.54-1.80],0.9743682692000918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMP1,Lysosome-associated membrane glycoprotein 1,14095,120,0.81 [0.39-1.72],0.5894930032237997
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMP2,Lysosome-associated membrane glycoprotein 2,16093,135,1.29 [0.59-2.82],0.5166274948219263
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMP3,Lysosome-associated membrane glycoprotein 3,16750,145,0.96 [0.72-1.27],0.7658758776593294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMTOR5,Ragulator complex protein LAMTOR5,14445,123,1.29 [0.88-1.89],0.1861261015863518
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAP3,Cytosol aminopeptidase,16319,145,1.13 [0.83-1.52],0.4383562499730969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LARP1,La-related protein 1,14445,123,1.20 [0.94-1.53],0.1540915478470566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAT,Linker for activation of T-cells family member 1,16776,146,0.94 [0.77-1.13],0.4953370459999705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAT2,Linker for activation of T-cells family member 2,16535,147,1.02 [0.91-1.15],0.711321575611672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LATS1,Serine/threonine-protein kinase LATS1,14069,119,1.11 [0.90-1.37],0.3217264062497936
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAYN,Layilin,16434,144,1.59 [1.06-2.38],0.0254058902096489
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LBP,Lipopolysaccharide-binding protein,16700,145,1.05 [0.82-1.35],0.7038468412788614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LBR,Delta(14)-sterol reductase LBR,16735,146,1.10 [0.90-1.34],0.3479764282115942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCAT,Phosphatidylcholine-sterol acyltransferase,14510,123,1.48 [0.66-3.32],0.340523950069113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCN15,Lipocalin-15,14472,123,0.95 [0.71-1.27],0.7216015858942655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCN2,Neutrophil gelatinase-associated lipocalin,16157,142,1.03 [0.70-1.51],0.8835449499855622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCP1,Plastin-2,14504,123,0.84 [0.57-1.23],0.36113164308101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LDLR,Low-density lipoprotein receptor,16655,143,1.03 [0.77-1.39],0.8204195015744254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LDLRAP1,Low density lipoprotein receptor adapter protein 1,14472,123,0.96 [0.80-1.14],0.6304441787712496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LECT2,Leukocyte cell-derived chemotaxin-2,14489,121,1.33 [1.03-1.73],0.0308272528272587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEFTY2,Left-right determination factor 2,16731,145,0.95 [0.71-1.27],0.7180993159684332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEG1,Protein LEG1 homolog,13744,116,0.96 [0.73-1.25],0.7479239273031555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LELP1,Late cornified envelope-like proline-rich protein 1,14051,117,0.74 [0.55-0.99],0.0446480273924971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEO1,RNA polymerase-associated protein LEO1,14472,123,1.40 [1.01-1.95],0.0444540441983594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEP,Leptin,16596,146,0.95 [0.76-1.18],0.6566969869363952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEPR,Leptin receptor,16596,146,0.67 [0.41-1.10],0.113771115137397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LETM1,Mitochondrial proton/calcium exchanger protein,14472,123,1.02 [0.74-1.42],0.8839506565024502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS1,Galectin-1,16596,146,1.35 [0.89-2.05],0.1552260491988583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS3,Galectin-3,16658,143,1.09 [0.66-1.80],0.7267388646927057
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS3BP,Galectin-3-binding protein,14518,122,1.13 [0.64-1.97],0.6791114893484376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS4,Galectin-4,16598,147,1.13 [0.88-1.47],0.3437725629876792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS7_LGALS7B,Galectin-7,16573,143,1.24 [0.89-1.73],0.2122143667199832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS8,Galectin-8,16735,146,1.05 [0.82-1.34],0.6941155354290721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS9,Galectin-9,16614,147,1.36 [0.85-2.17],0.2051586387894105
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGMN,Legumain,16677,147,1.01 [0.67-1.52],0.9716551053239838
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LHB,Lutropin subunit beta,16261,143,0.94 [0.79-1.13],0.5241997976987121
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,16627,147,1.21 [0.96-1.53],0.1119229198955265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LIF,Leukemia inhibitory factor,16227,143,0.90 [0.66-1.23],0.5154584844704959
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LIFR,Leukemia inhibitory factor receptor,16574,148,0.89 [0.47-1.66],0.706174426908569
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,16623,145,1.40 [0.91-2.16],0.1247968824613107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,14504,123,1.13 [0.97-1.33],0.1262252179008667
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,14028,116,1.03 [0.73-1.46],0.847435814812465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,16570,146,1.20 [0.76-1.90],0.4432406849307682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,14489,121,0.96 [0.76-1.21],0.7350673157755455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,16810,143,1.35 [0.78-2.33],0.2802941639367893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,16750,143,1.23 [0.80-1.91],0.3489431070321603
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,16319,145,1.42 [1.03-1.97],0.0321832259411824
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,16810,143,1.06 [0.86-1.31],0.5993299840856166
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LIPF,Gastric triacylglycerol lipase,14129,115,0.92 [0.69-1.23],0.5825903450361942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMNB1,Lamin-B1,14406,123,1.12 [0.87-1.46],0.3829148953215314
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMNB2,Lamin-B2,14478,121,1.62 [0.91-2.90],0.1042884140256555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMOD1,Leiomodin-1,14472,123,0.80 [0.46-1.37],0.4113450569949508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMOD2,Leiomodin-2,14051,117,0.87 [0.63-1.20],0.3933084228309785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LONP1,"Lon protease homolog, mitochondrial",14129,115,0.95 [0.77-1.18],0.6712162039416161
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPA,Apolipoprotein(a),14181,116,1.01 [0.91-1.11],0.8830017483233373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPCAT2,Lysophosphatidylcholine acyltransferase 2,16535,147,1.29 [1.03-1.63],0.0295194195325929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPL,Lipoprotein lipase,16596,146,0.82 [0.61-1.10],0.1893942677893358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPO,Lactoperoxidase,16032,139,1.04 [0.81-1.35],0.7533378871014944
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPP,Lipoma-preferred partner,14028,116,1.09 [0.83-1.44],0.5253866263767207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,14028,116,1.22 [0.95-1.56],0.1246940020034005
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,14119,118,1.03 [0.70-1.53],0.8776459497657545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRG1,Leucine-rich alpha-2-glycoprotein,14518,122,1.01 [0.52-1.94],0.9833876366964558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,16703,145,0.83 [0.54-1.27],0.3881673877226365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,14017,119,0.79 [0.40-1.57],0.5065586057558491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP1,Prolow-density lipoprotein receptor-related protein 1,16535,147,0.70 [0.40-1.24],0.223494064301225
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP11,Low-density lipoprotein receptor-related protein 11,16596,146,1.29 [0.86-1.93],0.211455463014709
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP2,Low-density lipoprotein receptor-related protein 2,14119,118,0.83 [0.49-1.39],0.4696341441860855
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP2BP,LRP2-binding protein,14119,118,0.88 [0.69-1.12],0.3028394859654872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,16735,146,0.79 [0.58-1.06],0.1205063663163475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC25,Leucine-rich repeat-containing protein 25,16535,147,1.39 [0.96-2.01],0.0767754411279287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC37A2,Leucine-rich repeat-containing protein 37A2,14431,123,1.55 [1.04-2.30],0.0297714694975696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC38,Leucine-rich repeat-containing protein 38,14119,118,0.92 [0.63-1.33],0.6448193160815701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC59,Leucine-rich repeat-containing protein 59,14489,121,1.16 [0.82-1.65],0.398109661709236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,14445,123,1.44 [1.04-2.01],0.0292082448905058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRN1,Leucine-rich repeat neuronal protein 1,16319,145,1.07 [0.73-1.56],0.739262797675402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,14119,118,0.85 [0.54-1.36],0.5032612409719465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,14472,123,0.96 [0.49-1.88],0.903007607471666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LSM1,U6 snRNA-associated Sm-like protein LSm1,16261,143,1.19 [0.93-1.52],0.1584341300405796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LSM8,U6 snRNA-associated Sm-like protein LSm8,14233,119,1.04 [0.85-1.27],0.6871508303312273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LSP1,Lymphocyte-specific protein 1,16574,148,1.08 [0.75-1.55],0.671819011275101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTA,Lymphotoxin-alpha,16574,148,1.10 [0.76-1.60],0.5992040324526922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTA4H,Leukotriene A-4 hydrolase,16761,145,1.19 [0.93-1.51],0.1653482912001325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTB,Lymphotoxin-beta,14445,123,1.14 [0.73-1.78],0.5544261576442001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTBP2,Latent-transforming growth factor beta-binding protein 2,16810,143,1.41 [0.87-2.28],0.1624042534213013
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTBP3,Latent-transforming growth factor beta-binding protein 3,16261,143,1.31 [1.03-1.67],0.0293904888479342
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTBR,Tumor necrosis factor receptor superfamily member 3,16543,147,1.52 [0.93-2.48],0.0916645736918093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTO1,Protein LTO1 homolog,16319,145,1.15 [0.82-1.61],0.423079757471175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LUZP2,Leucine zipper protein 2,14445,123,1.30 [0.93-1.83],0.1260740954607778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LXN,Latexin,16394,144,1.20 [0.99-1.47],0.0696294567262379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY6D,Lymphocyte antigen 6D,16550,146,1.39 [0.96-2.00],0.0799403643766958
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY75,Lymphocyte antigen 75,16574,148,1.21 [0.82-1.78],0.3311118570418752
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY9,T-lymphocyte surface antigen Ly-9,16394,143,1.76 [1.06-2.94],0.0295452688521918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY96,Lymphocyte antigen 96,16463,144,1.27 [0.85-1.89],0.2372643075169058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYAR,Cell growth-regulating nucleolar protein,16261,143,1.24 [1.02-1.52],0.0347489233246608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYN,Tyrosine-protein kinase Lyn,16535,147,0.98 [0.83-1.16],0.8173370448536057
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPD1,Ly6/PLAUR domain-containing protein 1,16227,143,0.92 [0.72-1.19],0.5332344778009623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPD3,Ly6/PLAUR domain-containing protein 3,16526,143,1.11 [0.71-1.73],0.6552060566082272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPD8,Ly6/PLAUR domain-containing protein 8,16261,143,0.99 [0.72-1.35],0.9506278624150588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPLA2,Acyl-protein thioesterase 2,14051,117,0.97 [0.81-1.15],0.6888671539222571
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,14119,118,1.11 [0.96-1.29],0.170504413724341
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,14518,122,1.13 [0.47-2.72],0.7930078944819364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYZL2,Lysozyme-like protein 2,13997,119,1.25 [0.79-1.97],0.3357598978223761
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LZTFL1,Leucine zipper transcription factor-like protein 1,14204,118,1.02 [0.79-1.31],0.8702480512682741
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,M6PR,Cation-dependent mannose-6-phosphate receptor,14129,115,0.88 [0.53-1.44],0.60511136726061
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,16398,142,1.21 [0.94-1.55],0.1372331276486522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAEA,E3 ubiquitin-protein transferase MAEA,16261,143,1.27 [0.90-1.79],0.1784519771461183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAG,Myelin-associated glycoprotein,14119,118,1.20 [0.84-1.71],0.3139114325727294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAGEA3,Melanoma-associated antigen 3,14233,119,0.94 [0.78-1.13],0.5109591178157987
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAGED1,Melanoma-associated antigen D1,16261,143,0.84 [0.60-1.16],0.2908248237363048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAMDC2,MAM domain-containing protein 2,14489,121,2.10 [1.32-3.33],0.0016074598462982
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAMDC4,Apical endosomal glycoprotein,14445,123,0.93 [0.67-1.28],0.6530043220435298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",14129,115,1.49 [0.72-3.08],0.2802102103290032
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAN2B2,Epididymis-specific alpha-mannosidase,14489,121,1.28 [0.96-1.72],0.0976827257168407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",13997,119,1.22 [0.87-1.70],0.2486660311360359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANF,Mesencephalic astrocyte-derived neurotrophic factor,16677,147,0.98 [0.87-1.11],0.7722826823180245
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANSC1,MANSC domain-containing protein 1,16671,146,1.29 [0.76-2.20],0.3440677834832664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANSC4,MANSC domain-containing protein 4,14028,116,1.01 [0.78-1.29],0.95632028504533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,14051,117,0.65 [0.37-1.14],0.1319114236649981
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,14028,116,1.09 [0.86-1.37],0.4831564969659665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP2,Microtubule-associated protein 2,14478,121,1.43 [1.03-1.98],0.0326413924385684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,14431,123,1.21 [0.93-1.59],0.1581358454546747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,16574,148,0.98 [0.84-1.13],0.751253335340189
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,16261,143,1.03 [0.88-1.20],0.7001514926613939
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,16434,144,0.99 [0.87-1.13],0.9244491597072464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPK13,Mitogen-activated protein kinase 13,13997,119,1.22 [0.86-1.75],0.2676423723060608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPK9,Mitogen-activated protein kinase 9,16574,148,1.09 [0.77-1.54],0.6281652110464255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPKAPK2,MAP kinase-activated protein kinase 2,14233,119,1.12 [0.88-1.43],0.347434823558495
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPRE3,Microtubule-associated protein RP/EB family member 3,13997,119,1.03 [0.92-1.16],0.5720462752055968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPT,Microtubule-associated protein tau,16227,143,1.15 [0.86-1.53],0.353007729072787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MARCO,Macrophage receptor MARCO,16596,146,0.93 [0.52-1.65],0.7956747217700455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MARS1,"Methionine--tRNA ligase, cytoplasmic",14180,118,1.09 [0.88-1.35],0.4199970414162574
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MASP1,Mannan-binding lectin serine protease 1,16434,144,3.13 [1.63-6.02],0.0006178812077019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MATN2,Matrilin-2,16626,147,1.71 [1.03-2.82],0.0370261667085833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MATN3,Matrilin-3,16432,141,1.13 [0.72-1.77],0.5883948351429518
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAVS,Mitochondrial antiviral-signaling protein,16261,143,1.02 [0.87-1.21],0.7885460772944737
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAX,Protein max,16227,143,0.97 [0.84-1.12],0.677074394427386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MB,Myoglobin,16810,143,1.35 [1.04-1.74],0.0227050873007622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MBL2,Mannose-binding protein C,14313,119,1.05 [0.89-1.23],0.5976098749809602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCAM,Cell surface glycoprotein MUC18,16700,145,1.27 [0.81-1.98],0.2942932159095734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",14472,123,1.27 [0.89-1.82],0.1842136550860564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCEMP1,Mast cell-expressed membrane protein 1,14069,119,1.04 [0.85-1.26],0.7186641210594129
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCFD2,Multiple coagulation factor deficiency protein 2,16509,145,0.99 [0.70-1.39],0.9490431471027094
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCTS1,Malignant T-cell-amplified sequence 1,14431,123,0.71 [0.34-1.47],0.3531325516294258
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,16463,144,0.86 [0.70-1.07],0.1744958179647567
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDH1,"Malate dehydrogenase, cytoplasmic",14430,123,1.48 [1.00-2.21],0.0512040120970721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDK,Midkine,16627,144,1.01 [0.76-1.35],0.9224768660784948
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDM1,Nuclear protein MDM1,14119,118,0.73 [0.41-1.33],0.3081230288339114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",14129,115,0.91 [0.75-1.12],0.3871638553322234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MED18,Mediator of RNA polymerase II transcription subunit 18,16261,143,0.95 [0.78-1.15],0.5878242786093923
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MED21,Mediator of RNA polymerase II transcription subunit 21,14028,116,0.94 [0.64-1.38],0.7475428902333043
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEGF10,Multiple epidermal growth factor-like domains protein 10,16598,147,1.07 [0.73-1.56],0.738116389962187
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEGF11,Multiple epidermal growth factor-like domains protein 11,14028,116,0.63 [0.33-1.21],0.1641275564758837
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEGF9,Multiple epidermal growth factor-like domains protein 9,16772,143,1.99 [0.91-4.35],0.0851813164627718
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MELTF,Melanotransferrin,14489,121,1.29 [0.73-2.29],0.3798670656593503
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MENT,Protein MENT,14204,118,0.79 [0.37-1.70],0.5406585550763107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEP1A,Meprin A subunit alpha,14431,123,1.05 [0.82-1.33],0.7131346516202093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEP1B,Meprin A subunit beta,16596,146,0.96 [0.85-1.08],0.4841134023673488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEPE,Matrix extracellular phosphoglycoprotein,16598,147,0.73 [0.41-1.30],0.2820420375822171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MERTK,Tyrosine-protein kinase Mer,16776,146,1.22 [0.67-2.19],0.5176546377710274
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MESD,LRP chaperone MESD,16623,145,0.97 [0.86-1.10],0.6578724659487103
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MET,Hepatocyte growth factor receptor,16656,142,0.75 [0.36-1.60],0.464407926784022
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,METAP1,Methionine aminopeptidase 1,16227,143,1.00 [0.60-1.67],0.9950903651129048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",16574,148,0.97 [0.81-1.15],0.7043486544306309
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,METAP2,Methionine aminopeptidase 2,16731,145,1.04 [0.80-1.35],0.7764837905198766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP3,Microfibril-associated glycoprotein 3,16307,141,1.00 [0.73-1.36],0.9871147452402989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP3L,Microfibrillar-associated protein 3-like,14119,118,0.91 [0.68-1.22],0.5360768856696321
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP4,Microfibril-associated glycoprotein 4,14204,118,1.71 [0.98-2.96],0.057036992470702
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP5,Microfibrillar-associated protein 5,16810,143,1.33 [0.91-1.93],0.1382416405712109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFGE8,Lactadherin,16623,145,1.14 [0.81-1.61],0.4402769999793087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MGLL,Monoglyceride lipase,16652,147,0.94 [0.79-1.10],0.4366594690310813
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MGMT,Methylated-DNA--protein-cysteine methyltransferase,16574,148,0.99 [0.88-1.12],0.9198523811598568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MIA,Melanoma-derived growth regulatory protein,16671,146,1.10 [0.74-1.63],0.6496700767150702
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MICALL2,MICAL-like protein 2,14119,118,1.14 [0.90-1.45],0.2872547037889152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,16574,148,1.04 [0.94-1.16],0.433908197365612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MIF,Macrophage migration inhibitory factor,16600,144,1.05 [0.84-1.31],0.6476409609500726
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MILR1,Allergin-1,16319,145,1.03 [0.77-1.38],0.840583128246613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,14445,123,1.03 [0.87-1.21],0.7611674793132088
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MINK1,Misshapen-like kinase 1,14478,121,1.02 [0.84-1.23],0.8658175567139321
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MITD1,MIT domain-containing protein 1,16463,144,0.96 [0.82-1.11],0.5656983153747243
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MKI67,Proliferation marker protein Ki-67,14069,119,1.26 [0.86-1.83],0.2317966868010903
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MLLT1,Protein ENL,13997,119,0.92 [0.69-1.23],0.5670817464591613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MLN,Promotilin,16574,148,1.08 [0.92-1.28],0.357127827060282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MME,Neprilysin,16535,147,0.96 [0.79-1.16],0.644484798592929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP1,Interstitial collagenase,15991,139,1.07 [0.91-1.27],0.4173784840062712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP10,Stromelysin-2,16566,146,0.82 [0.63-1.06],0.1353155524049087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP12,Macrophage metalloelastase,16626,144,1.02 [0.78-1.34],0.8852460156737832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP13,Collagenase 3,16227,143,1.05 [0.66-1.67],0.8229244597852406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP15,Matrix metalloproteinase-15,14489,121,1.20 [0.90-1.61],0.2088018413158903
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP3,Stromelysin-1,16623,145,1.20 [0.89-1.60],0.2258250885827533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP7,Matrilysin,16281,141,1.26 [0.91-1.73],0.1602358865427107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP8,Neutrophil collagenase,16703,146,1.18 [0.97-1.43],0.1054866285250141
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP9,Matrix metalloproteinase-9,16595,145,1.18 [0.92-1.51],0.1849429196454514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",14028,116,0.96 [0.67-1.40],0.8465804922408362
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MN1,Transcriptional activator MN1,14119,118,0.92 [0.66-1.27],0.5923841351658634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MNAT1,CDK-activating kinase assembly factor MAT1,14233,119,1.10 [0.76-1.61],0.6087583600118155
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MNDA,Myeloid cell nuclear differentiation antigen,16567,146,1.07 [0.93-1.22],0.3534413980929259
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MOCS2,Molybdopterin synthase catalytic subunit,14204,118,1.03 [0.78-1.36],0.8306657905901944
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MOG,Myelin-oligodendrocyte glycoprotein,16761,145,1.07 [0.69-1.67],0.7518959512111149
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORC3,MORC family CW-type zinc finger protein 3,14478,121,1.24 [0.70-2.20],0.4706788002726131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORF4L1,Mortality factor 4-like protein 1,14233,119,1.01 [0.65-1.58],0.9486246473322232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORF4L2,Mortality factor 4-like protein 2,13997,119,1.20 [0.79-1.83],0.3891706532083898
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORN4,MORN repeat-containing protein 4,13997,119,0.97 [0.77-1.23],0.8162961983297812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPHOSPH8,M-phase phosphoprotein 8,16307,141,1.02 [0.83-1.24],0.8584971293200748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPI,Mannose-6-phosphate isomerase,16535,147,1.00 [0.84-1.19],0.9930471460731446
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,16652,147,0.92 [0.76-1.11],0.3833277830185333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPO,Myeloperoxidase,16623,145,1.21 [0.91-1.62],0.1947809571952536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPRIP,Myosin phosphatase Rho-interacting protein,14410,123,0.84 [0.56-1.27],0.4098428725420318
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRC1,Macrophage mannose receptor 1,14510,123,1.27 [0.69-2.34],0.4349005412667157
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRI1,Methylthioribose-1-phosphate isomerase,14119,118,1.13 [0.86-1.48],0.3928658404211932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL24,"39S ribosomal protein L24, mitochondrial",14028,116,0.94 [0.57-1.53],0.7953292358644487
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL28,"39S ribosomal protein L28, mitochondrial",14472,123,1.05 [0.68-1.61],0.8349222144370264
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL46,"39S ribosomal protein L46, mitochondrial",16227,143,0.88 [0.50-1.54],0.6507013696961714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL52,"39S ribosomal protein L52, mitochondrial",13967,119,0.84 [0.42-1.69],0.6236457167989964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",14472,123,0.93 [0.72-1.21],0.5980795567473899
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPS16,"28S ribosomal protein S16, mitochondrial",14069,119,0.83 [0.42-1.64],0.5917177314153629
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSLN,Mesothelin,16505,147,1.06 [0.83-1.35],0.6573469031039805
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSLNL,Mesothelin-like protein,14119,118,0.64 [0.38-1.08],0.0953880288128636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSMB,Beta-microseminoprotein,16575,143,1.27 [1.03-1.57],0.0252172198381069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSR1,Macrophage scavenger receptor types I and II,16735,146,1.05 [0.76-1.45],0.7809488345102997
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSRA,Mitochondrial peptide methionine sulfoxide reductase,16671,146,0.99 [0.81-1.22],0.9558328753843552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MST1,Hepatocyte growth factor-like protein,14274,120,0.97 [0.76-1.24],0.7833352733193366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSTN,Growth/differentiation factor 8,16307,141,1.26 [0.95-1.68],0.1083544457207149
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTDH,Protein LYRIC,14069,119,0.95 [0.79-1.15],0.6191646884986126
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",14478,121,0.96 [0.47-1.95],0.9147250034054256
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,14233,119,1.06 [0.90-1.24],0.4739709587130817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTIF3,"Translation initiation factor IF-3, mitochondrial",14431,123,0.89 [0.73-1.09],0.2648884660276343
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTPN,Myotrophin,16307,141,0.93 [0.58-1.50],0.7726407906939592
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTR,Methionine synthase,14028,116,1.08 [0.84-1.38],0.553520898833415
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTSS1,Protein MTSS 1,14431,123,1.09 [0.93-1.27],0.2800443409175478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTSS2,Protein MTSS 2,14445,123,1.00 [0.84-1.19],0.9925232286327884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTUS1,Microtubule-associated tumor suppressor 1,14233,119,1.35 [1.03-1.77],0.0287800865277148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUC13,Mucin-13,16227,143,0.97 [0.72-1.31],0.8562127060886671
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUC16,Mucin-16,16535,147,1.01 [0.93-1.09],0.8554067610647905
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUC2,Mucin-2,14504,123,0.98 [0.82-1.18],0.8699828659167115
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUCL3,Mucin-like protein 3,13997,119,1.09 [0.74-1.60],0.6625162345010982
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MVK,Mevalonate kinase,16319,145,1.02 [0.84-1.23],0.8612938026664865
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MXRA8,Matrix remodeling-associated protein 8,14204,118,1.06 [0.60-1.90],0.8325060497512222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYBPC1,"Myosin-binding protein C, slow-type",14489,121,1.13 [0.90-1.43],0.298523858833657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYBPC2,"Myosin-binding protein C, fast-type",14129,115,0.98 [0.79-1.22],0.8590636356382143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,14472,123,1.11 [0.86-1.42],0.4188218211647199
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYDGF,Myeloid-derived growth factor,14489,121,1.00 [0.84-1.20],0.996532474499135
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYH4,Myosin-4,14028,116,1.21 [0.85-1.73],0.2800674752000682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYH7B,Myosin-7B,13997,119,1.25 [0.89-1.76],0.2016877165538387
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYH9,Myosin-9,14504,123,1.04 [0.90-1.21],0.579507873876975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",14028,116,1.60 [1.17-2.20],0.003160689427472
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL3,Myosin light chain 3,14129,115,1.14 [0.89-1.45],0.3040841247996413
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL4,Myosin light chain 4,14129,115,1.32 [0.99-1.77],0.0596822332638699
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL6B,Myosin light chain 6B,14119,118,1.02 [0.84-1.23],0.8668580542666073
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",14119,118,1.11 [0.79-1.55],0.5499422266272062
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYO6,Unconventional myosin-VI,14472,123,1.51 [1.07-2.11],0.0177265903249202
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYO9B,Unconventional myosin-IXb,16319,145,1.09 [0.88-1.35],0.4373687101924797
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOC,Myocilin,16623,145,1.23 [0.88-1.72],0.2276547109751138
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOM1,Myomesin-1,14051,117,1.25 [0.92-1.69],0.1490015127369183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOM2,Myomesin-2,14028,116,0.97 [0.68-1.40],0.8828688844045499
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOM3,Myomesin-3,14204,118,1.09 [0.89-1.32],0.4074899933547578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MZB1,Marginal zone B- and B1-cell-specific protein,16651,147,1.31 [1.00-1.73],0.0528742688770214
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MZT1,Mitotic-spindle organizing protein 1,16261,143,1.25 [0.95-1.63],0.1119890483440883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAA10,N-alpha-acetyltransferase 10,14028,116,1.17 [0.82-1.66],0.3941902923163646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAA80,N-alpha-acetyltransferase 80,14119,118,1.04 [0.89-1.20],0.6387786408296036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAAA,N-acylethanolamine-hydrolyzing acid amidase,16386,142,1.23 [0.97-1.56],0.0931689940886618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NACC1,Nucleus accumbens-associated protein 1,14445,123,1.14 [0.85-1.53],0.3790415164330326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NADK,NAD kinase,16596,146,1.12 [0.88-1.43],0.3664498274580067
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAGA,Alpha-N-acetylgalactosaminidase,14037,119,1.13 [0.85-1.50],0.3923494880639987
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAGK,N-acetyl-D-glucosamine kinase,14102,115,1.36 [1.00-1.86],0.0527059583792014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,14204,118,1.51 [0.65-3.49],0.3362807581410014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAMPT,Nicotinamide phosphoribosyltransferase,16261,143,1.12 [0.87-1.43],0.3769683110078694
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAP1L4,Nucleosome assembly protein 1-like 4,14401,123,1.33 [0.86-2.06],0.1929621655276919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAPRT,Nicotinate phosphoribosyltransferase,14478,121,1.20 [0.73-1.96],0.4785586802739809
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NARS1,"Asparagine--tRNA ligase, cytoplasmic",14472,123,1.00 [0.69-1.45],0.9910464711889546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NBL1,Neuroblastoma suppressor of tumorigenicity 1,16671,146,1.57 [0.91-2.70],0.1043001263462436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NBN,Nibrin,16319,145,1.08 [0.83-1.40],0.5601280228715056
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCAM1,Neural cell adhesion molecule 1,16700,145,1.26 [0.79-2.01],0.3379145153155284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCAM2,Neural cell adhesion molecule 2,16623,145,1.01 [0.59-1.74],0.9625701966731502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCAN,Neurocan core protein,16735,146,1.03 [0.70-1.53],0.8635543488581154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCF2,Neutrophil cytosol factor 2,16548,148,1.07 [0.91-1.26],0.4064356959588363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCK2,Cytoplasmic protein NCK2,16677,147,0.98 [0.86-1.13],0.8019036894182213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCLN,Nicalin,16319,145,0.90 [0.65-1.24],0.5168823910293097
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCR1,Natural cytotoxicity triggering receptor 1,16547,146,0.89 [0.60-1.33],0.5654165119450227
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,14431,123,1.32 [0.80-2.19],0.2803677626327006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCS1,Neuronal calcium sensor 1,16761,145,1.02 [0.60-1.72],0.9501532950512264
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDRG1,Protein NDRG1,16227,143,0.95 [0.74-1.21],0.6779494147327949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,14445,123,1.09 [0.85-1.40],0.4971193727744685
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,14051,119,1.37 [0.84-2.24],0.2021089007393083
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,14431,123,0.95 [0.78-1.16],0.6099355495445113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",16261,143,0.84 [0.67-1.05],0.1334450608668278
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEB,Nebulin,14028,116,1.23 [0.81-1.87],0.3260457462143818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECAP2,Adaptin ear-binding coat-associated protein 2,14028,116,1.13 [0.88-1.45],0.3302199980418446
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECTIN1,Nectin-1,14069,119,1.02 [0.60-1.73],0.94251864900074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECTIN2,Nectin-2,16570,146,1.43 [0.89-2.31],0.1412675893676588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECTIN4,Nectin-4,16671,146,1.57 [1.02-2.42],0.0425819843517266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,14069,119,1.08 [0.75-1.57],0.6833500269286159
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEDD9,Enhancer of filamentation 1,14069,119,1.07 [0.65-1.76],0.7817887304933582
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEFL,Neurofilament light polypeptide,16173,143,1.07 [0.76-1.49],0.7083427226658517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEK7,Serine/threonine-protein kinase Nek7,14233,119,1.06 [0.85-1.32],0.6160892299404302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NELL1,Protein kinase C-binding protein NELL1,16671,146,1.13 [0.79-1.60],0.5032085548083638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NELL2,Protein kinase C-binding protein NELL2,16677,147,1.13 [0.68-1.87],0.6301485971962681
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NENF,Neudesin,14445,123,1.04 [0.90-1.20],0.6063950551916439
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEO1,Neogenin,14472,123,1.24 [0.60-2.55],0.5632489149844839
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEXN,Nexilin,14510,123,1.19 [0.93-1.52],0.1608831143362935
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFASC,Neurofascin,16776,146,0.92 [0.54-1.56],0.755995696981337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFAT5,Nuclear factor of activated T-cells 5,14069,119,1.20 [0.99-1.46],0.0592436862598528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",16574,148,1.00 [0.86-1.17],0.9644935113391616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",16319,145,0.91 [0.71-1.18],0.4921707504515168
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFE2,Transcription factor NF-E2 45 kDa subunit,14129,115,1.23 [0.96-1.56],0.0966079119183568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFIC,Nuclear factor 1 C-type,14472,123,1.03 [0.72-1.47],0.867741686177217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFKB1,Nuclear factor NF-kappa-B p105 subunit,14028,116,1.10 [0.86-1.41],0.4406425711762801
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFKB2,Nuclear factor NF-kappa-B p100 subunit,14233,119,1.03 [0.75-1.40],0.8588455480438355
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFKBIE,NF-kappa-B inhibitor epsilon,16261,143,1.13 [0.83-1.53],0.4416780375699051
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",14431,123,0.96 [0.81-1.14],0.6290152871160182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFX1,Transcriptional repressor NF-X1,14028,116,1.03 [0.79-1.35],0.8030756395503185
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFYA,Nuclear transcription factor Y subunit alpha,14028,116,1.09 [0.72-1.66],0.6758330495060965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NGF,Beta-nerve growth factor,16463,144,0.91 [0.27-3.13],0.8872043776186543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NGFR,Tumor necrosis factor receptor superfamily member 16,14489,121,1.57 [1.00-2.48],0.0513745708995203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NGRN,Neugrin,14478,121,0.96 [0.44-2.12],0.9239077360876948
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NHLRC3,NHL repeat-containing protein 3,13843,118,1.41 [0.79-2.54],0.2485713817934886
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NID1,Nidogen-1,16640,145,0.85 [0.57-1.27],0.4303453003376042
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NID2,Nidogen-2,16623,145,0.86 [0.70-1.05],0.1397953721913542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NINJ1,Ninjurin-1,16261,143,1.06 [0.82-1.38],0.6566500947421573
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NIT1,Deaminated glutathione amidase,14129,115,1.10 [0.74-1.64],0.6296231181683345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NIT2,Omega-amidase NIT2,14437,121,1.06 [0.83-1.34],0.6643972954658295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NLGN1,Neuroligin-1,14119,118,0.73 [0.52-1.04],0.0809012355029717
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NLGN2,Neuroligin-2,14051,117,1.18 [0.85-1.62],0.3177519654468844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NME1,Nucleoside diphosphate kinase A,14069,119,1.97 [0.96-4.03],0.0640922843569635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NME3,Nucleoside diphosphate kinase 3,16626,147,1.07 [0.57-1.99],0.8336183993660427
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMI,N-myc-interactor,14395,123,1.08 [0.85-1.37],0.5212384036493506
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,16463,144,1.14 [0.96-1.35],0.1433730541450411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMRK2,Nicotinamide riboside kinase 2,13997,119,0.78 [0.47-1.31],0.3561379581132385
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,14472,123,1.00 [0.77-1.30],0.9844380737262656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOMO1,Nodal modulator 1,16623,145,1.60 [0.84-3.05],0.1491310138441888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOP56,Nucleolar protein 56,14028,116,1.11 [0.96-1.27],0.1552380576637673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOS1,"Nitric oxide synthase, brain",16227,143,1.26 [0.97-1.65],0.0842448322531219
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOS2,"Nitric oxide synthase, inducible",14028,116,1.12 [0.72-1.74],0.6024568561223838
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOS3,"Nitric oxide synthase, endothelial",16227,143,1.26 [0.98-1.62],0.0751782759250759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOTCH1,Neurogenic locus notch homolog protein 1,16810,143,1.20 [0.46-3.11],0.7080970687589326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOTCH2,Neurogenic locus notch homolog protein 2,14504,123,1.13 [0.48-2.62],0.7809528295845749
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOTCH3,Neurogenic locus notch homolog protein 3,16810,143,1.48 [0.94-2.31],0.088728864127961
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPC2,NPC intracellular cholesterol transporter 2,14257,121,1.23 [0.71-2.13],0.4607209968742709
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPDC1,Neural proliferation differentiation and control protein 1,16596,146,1.38 [0.88-2.16],0.160945191603732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPHS1,Nephrin,14069,119,1.22 [0.72-2.07],0.4577363125965249
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPHS2,Podocin,14069,119,1.14 [0.99-1.33],0.0754628971238421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPL,N-acetylneuraminate lyase,14489,121,1.35 [0.92-1.97],0.1233939265204916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPPB,Natriuretic peptides B,16307,141,1.10 [0.99-1.23],0.0819883708747934
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPPC,C-type natriuretic peptide,16574,148,1.00 [0.74-1.35],0.98355935354908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPR1,Atrial natriuretic peptide receptor 1,14028,116,1.02 [0.65-1.60],0.927893688413164
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTN,Neuroplastin,16261,143,1.09 [0.91-1.29],0.3488040105589796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTX1,Neuronal pentraxin-1,16623,145,0.95 [0.66-1.38],0.7944983835239618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTX2,Neuronal pentraxin-2,14504,123,0.82 [0.48-1.40],0.4751403575958914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTXR,Neuronal pentraxin receptor,16596,146,1.28 [0.84-1.96],0.244026540847444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPY,Pro-neuropeptide Y,16761,145,0.96 [0.77-1.21],0.7574872059675479
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRCAM,Neuronal cell adhesion molecule,16596,146,1.17 [0.70-1.98],0.5471472067132808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRGN,Neurogranin,14510,123,0.97 [0.80-1.18],0.7958281874783608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRN1,Neuritin,14472,123,0.95 [0.57-1.57],0.8330977715277981
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRP1,Neuropilin-1,16723,145,0.97 [0.56-1.67],0.9116768302999744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRP2,Neuropilin-2,16623,145,1.50 [0.91-2.49],0.1146072964748696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRTN,Neurturin,16319,145,0.99 [0.73-1.33],0.9271969367718984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRXN3,Neurexin-3,14119,118,0.77 [0.44-1.36],0.3652679815060404
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NSFL1C,NSFL1 cofactor p47,16735,146,1.09 [0.87-1.37],0.4352971961473669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",14489,121,1.09 [0.85-1.38],0.5075450057178517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5C1A,Cytosolic 5'-nucleotidase 1A,14478,121,1.73 [1.17-2.55],0.0063417394479495
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5C3A,Cytosolic 5'-nucleotidase 3A,16549,147,1.06 [0.90-1.26],0.4792283324316919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5E,5'-nucleotidase,16671,146,1.00 [0.76-1.31],0.9728971662623758
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTF3,Neurotrophin-3,16574,148,1.31 [0.87-1.95],0.192024300199807
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTF4,Neurotrophin-4,16261,143,1.16 [0.82-1.65],0.4011574436379989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTRK2,BDNF/NT-3 growth factors receptor,16596,146,0.84 [0.47-1.51],0.566013648102738
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTRK3,NT-3 growth factor receptor,16735,146,1.30 [0.65-2.60],0.4521999525473336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTproBNP,N-terminal prohormone of brain natriuretic peptide,16596,146,1.19 [1.06-1.35],0.0038840103522404
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUB1,NEDD8 ultimate buster 1,16574,148,1.04 [0.87-1.23],0.6936779582541339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,14445,123,1.07 [0.91-1.26],0.4160442118632621
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUCB2,Nucleobindin-2,16726,144,0.84 [0.56-1.27],0.4148925900545228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDC,Nuclear migration protein nudC,16776,146,1.07 [0.84-1.35],0.5851444733430589
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,14129,115,1.46 [0.83-2.56],0.1922523098424285
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,14028,116,0.85 [0.57-1.25],0.407344522208104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT16,U8 snoRNA-decapping enzyme,14401,122,1.03 [0.84-1.26],0.7885598710618988
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],16535,147,1.11 [0.87-1.42],0.4142252911088951
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT5,ADP-sugar pyrophosphatase,16623,145,1.19 [0.89-1.59],0.2522071218581174
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUMB,Protein numb homolog,14069,119,1.02 [0.83-1.27],0.8268687395812397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUP50,Nuclear pore complex protein Nup50,14028,116,1.03 [0.62-1.74],0.8978822792985648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NXPE4,NXPE family member 4,14028,116,1.18 [0.71-1.95],0.5219850161906538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NXPH1,Neurexophilin-1,16227,143,0.99 [0.67-1.45],0.9439845605125468
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NXPH3,Neurexophilin-3,14069,119,1.27 [0.70-2.31],0.4310114630269023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OBP2B,Odorant-binding protein 2b,16412,141,0.92 [0.72-1.18],0.5136103431179956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OCLN,Occludin,14472,123,1.31 [0.90-1.91],0.1532820323683217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ODAM,Odontogenic ameloblast-associated protein,16204,143,0.96 [0.73-1.26],0.7625318396825358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OFD1,Oral-facial-digital syndrome 1 protein,14233,119,0.99 [0.75-1.30],0.943672834453822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGA,Protein O-GlcNAcase,14431,123,1.14 [0.89-1.46],0.3092165616231888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGFR,Opioid growth factor receptor,16535,147,1.50 [0.96-2.34],0.0765214423120142
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGN,Mimecan,16623,145,1.28 [0.91-1.81],0.1582596343467029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,14233,119,0.92 [0.68-1.23],0.5593923753285508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OLFM4,Olfactomedin-4,13651,114,1.13 [0.97-1.32],0.1095297847907211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OLR1,Oxidized low-density lipoprotein receptor 1,16443,145,1.11 [0.87-1.41],0.388778373452126
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OMD,Osteomodulin,16677,147,1.33 [0.92-1.92],0.1273743893182446
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OMG,Oligodendrocyte-myelin glycoprotein,16535,147,1.15 [0.92-1.42],0.2158942077272109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OMP,Olfactory marker protein,14051,117,1.17 [0.86-1.61],0.317447642825288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OPHN1,Oligophrenin-1,14478,121,1.01 [0.85-1.19],0.9368410192135416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OPLAH,5-oxoprolinase,14129,115,1.19 [0.92-1.54],0.1953817672312505
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OPTC,Opticin,16535,147,0.93 [0.66-1.30],0.6592472812247118
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ORM1,Alpha-1-acid glycoprotein 1,14463,122,1.17 [0.49-2.80],0.7289372624679922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSBPL2,Oxysterol-binding protein-related protein 2,14478,121,1.28 [0.90-1.81],0.1695664135120297
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSCAR,Osteoclast-associated immunoglobulin-like receptor,16626,147,1.30 [0.85-2.00],0.2291941371351578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSM,Oncostatin-M,16508,147,1.11 [0.90-1.37],0.3193401376441899
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSMR,Oncostatin-M-specific receptor subunit beta,16723,145,0.86 [0.40-1.83],0.6922807754729018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSTN,Osteocrin,14119,118,1.18 [0.80-1.73],0.3999779951803439
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OTOA,Otoancorin,14051,117,1.27 [0.98-1.66],0.0741332185601812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OTUD6B,Deubiquitinase OTUD6B,14431,123,1.11 [0.83-1.50],0.4874026137588573
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OTUD7B,OTU domain-containing protein 7B,14472,123,0.99 [0.75-1.31],0.952509415300465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",14129,115,1.08 [0.83-1.41],0.5587435889307251
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OXT,Oxytocin-neurophysin 1,16735,146,1.13 [1.02-1.25],0.0185229169864956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,P4HB,Protein disulfide-isomerase,16536,145,1.08 [0.73-1.59],0.7024609101703352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PACS2,Phosphofurin acidic cluster sorting protein 2,14028,116,1.36 [1.03-1.80],0.0278939153213131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PADI2,Protein-arginine deiminase type-2,16319,145,1.20 [0.98-1.45],0.0711228428122382
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PADI4,Protein-arginine deiminase type-4,16204,143,1.13 [0.95-1.34],0.1631741063849315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAEP,Glycodelin,16463,144,1.01 [0.87-1.18],0.9145656244405732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,14472,123,1.05 [0.92-1.20],0.4839383993846315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",14233,119,1.16 [0.83-1.62],0.376194415552646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,16307,141,0.99 [0.76-1.30],0.954312646986585
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAGR1,PAXIP1-associated glutamate-rich protein 1,14129,115,1.27 [0.87-1.87],0.219254703234269
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,13975,119,1.01 [0.72-1.42],0.9589079999437248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAK4,Serine/threonine-protein kinase PAK 4,16227,143,1.08 [0.85-1.37],0.5419738182378231
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALLD,Palladin,14069,119,0.90 [0.56-1.46],0.6740322549993398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALM,Paralemmin-1,14346,123,1.21 [0.69-2.13],0.5023412666745081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALM2,Paralemmin-2,14478,121,1.49 [0.95-2.33],0.0853404970536814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALM3,Paralemmin-3,14028,116,1.05 [0.84-1.31],0.6811708451106067
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAM,Peptidyl-glycine alpha-amidating monooxygenase,16727,143,1.45 [0.84-2.52],0.1828206642372248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAMR1,Inactive serine protease PAMR1,16623,145,0.87 [0.50-1.52],0.6243210842495119
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAPPA,Pappalysin-1,16319,145,0.96 [0.70-1.32],0.7860216421496253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PARD3,Partitioning defective 3 homolog,14233,119,0.96 [0.75-1.22],0.7412289599721813
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PARK7,Parkinson disease protein 7,16623,145,1.21 [0.91-1.61],0.1808516706419294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PARP1,Poly [ADP-ribose] polymerase 1,16574,148,1.13 [0.90-1.41],0.2984276298701017
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAXX,Protein PAXX,14204,118,1.25 [0.85-1.83],0.2512143186786844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PBK,Lymphokine-activated killer T-cell-originated protein kinase,13997,119,1.97 [1.15-3.38],0.0139427316225195
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PBLD,Phenazine biosynthesis-like domain-containing protein,16227,143,1.26 [0.94-1.69],0.1168833665396884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,14431,123,1.57 [0.95-2.60],0.0778893146536216
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCARE,Photoreceptor cilium actin regulator,14051,117,1.16 [0.98-1.38],0.0812242545423424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,14180,118,1.44 [1.00-2.06],0.04731802240711
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCBP2,Poly(rC)-binding protein 2,14472,123,1.03 [0.81-1.31],0.8228461393529722
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH1,Protocadherin-1,16723,145,2.05 [1.19-3.53],0.00985879254273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH12,Protocadherin-12,14472,123,1.64 [0.84-3.19],0.1487712401261418
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH17,Protocadherin-17,16596,146,1.74 [1.18-2.55],0.0051060196808222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH7,Protocadherin-7,14431,123,1.43 [0.96-2.12],0.0756623855230125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH9,Protocadherin-9,14431,123,0.96 [0.58-1.59],0.8712614311163344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDHB15,Protocadherin beta-15,14445,123,1.24 [0.82-1.88],0.3057077768381294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCNA,Proliferating cell nuclear antigen,13997,119,0.92 [0.68-1.25],0.6077429013182107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCSK7,Proprotein convertase subtilisin/kexin type 7,14445,123,0.90 [0.61-1.34],0.6150945912360859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCSK9,Proprotein convertase subtilisin/kexin type 9,16810,143,0.78 [0.54-1.14],0.1953948573590577
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCYT2,Ethanolamine-phosphate cytidylyltransferase,14431,123,1.02 [0.81-1.29],0.8417672802863297
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDAP1,28 kDa heat- and acid-stable phosphoprotein,14489,121,1.01 [0.85-1.22],0.8843324046383665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD1,Programmed cell death protein 1,16732,145,1.00 [0.70-1.43],0.9996418032897528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD1LG2,Programmed cell death 1 ligand 2,16535,147,1.07 [0.67-1.71],0.7786439909714533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD5,Programmed cell death protein 5,16735,146,1.08 [0.84-1.38],0.5695823813805974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD6,Programmed cell death protein 6,16596,146,0.93 [0.77-1.13],0.4862756969100873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCL2,Phosducin-like protein 2,13997,119,0.98 [0.69-1.38],0.8896307541124406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",13997,119,0.92 [0.65-1.32],0.6595716354635617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",14028,116,0.95 [0.69-1.31],0.7502673927244394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",14204,118,1.01 [0.85-1.20],0.9154732932797808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFA,Platelet-derived growth factor subunit A,16810,143,0.82 [0.67-1.00],0.0537845996365505
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFB,Platelet-derived growth factor subunit B,16677,147,0.87 [0.73-1.03],0.0992507307649821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFC,Platelet-derived growth factor C,16261,143,0.97 [0.56-1.68],0.9274551787811725
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFRA,Platelet-derived growth factor receptor alpha,16596,146,1.26 [0.75-2.11],0.3896028968895179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFRB,Platelet-derived growth factor receptor beta,16810,143,1.43 [0.92-2.21],0.110948930218348
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA2,Protein disulfide-isomerase A2,13997,119,0.87 [0.55-1.37],0.555364847679538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA3,Protein disulfide-isomerase A3,14204,118,0.72 [0.34-1.53],0.39209893650284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA4,Protein disulfide-isomerase A4,14504,123,0.97 [0.72-1.30],0.8311688850644884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA5,Protein disulfide-isomerase A5,13997,119,0.91 [0.66-1.25],0.5585336145895392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDLIM5,PDZ and LIM domain protein 5,14472,123,1.02 [0.88-1.18],0.8267328567702521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDLIM7,PDZ and LIM domain protein 7,16677,147,1.02 [0.91-1.15],0.6953036599984741
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",16261,143,1.03 [0.77-1.39],0.8215490801715464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDRG1,p53 and DNA damage-regulated protein 1,14119,118,1.06 [0.78-1.45],0.6976459822359784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,13997,119,1.14 [0.88-1.48],0.3204379496438458
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDZD2,PDZ domain-containing protein 2,14028,116,1.22 [0.93-1.60],0.1598136314048147
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,14069,119,1.25 [0.85-1.84],0.2637450611609077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PEAR1,Platelet endothelial aggregation receptor 1,16810,143,1.28 [0.67-2.44],0.4636949911399461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PEBP1,Phosphatidylethanolamine-binding protein 1,16623,145,1.21 [0.94-1.56],0.1327774910607081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PECAM1,Platelet endothelial cell adhesion molecule,16623,145,1.14 [0.70-1.86],0.5878892696693387
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PECR,Peroxisomal trans-2-enoyl-CoA reductase,14129,115,1.01 [0.52-1.94],0.983034883024608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PENK,Proenkephalin-A,14204,118,1.12 [0.64-1.96],0.6874004752570282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PEPD,Xaa-Pro dipeptidase,14510,123,0.99 [0.51-1.93],0.9774119928642356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PER3,Period circadian protein homolog 3,14069,119,0.93 [0.80-1.08],0.3235967363050871
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PF4,Platelet factor 4,14415,122,0.87 [0.73-1.05],0.1425813590839915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFDN2,Prefoldin subunit 2,16227,143,1.14 [0.87-1.48],0.336507906042703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFDN4,Prefoldin subunit 4,13997,119,1.24 [0.92-1.67],0.1624890435521684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFDN6,Prefoldin subunit 6,14119,118,0.96 [0.72-1.28],0.7965400041521459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",16503,147,1.02 [0.84-1.23],0.8437395746391614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGA4,Pepsin A-4,14510,123,1.01 [0.81-1.25],0.9567709281392512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",14489,121,1.15 [0.83-1.59],0.398853894027358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGF,Placenta growth factor,16776,146,2.02 [1.22-3.36],0.006695392971887
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGLYRP1,Peptidoglycan recognition protein 1,16750,143,1.25 [0.90-1.75],0.1794291496407299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,14338,120,1.24 [0.68-2.26],0.4846135832509908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGLYRP4,Peptidoglycan recognition protein 4,14028,116,1.20 [0.93-1.56],0.1577254023050666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGM2,Phosphoglucomutase-2,14119,118,0.95 [0.68-1.31],0.7336131850586385
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGR,Progesterone receptor,14069,119,1.01 [0.85-1.20],0.9180021838813786
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHACTR2,Phosphatase and actin regulator 2,14472,123,0.97 [0.83-1.13],0.713019885927759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHLDB1,Pleckstrin homology-like domain family B member 1,14431,123,1.53 [1.11-2.11],0.0100931229158405
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHLDB2,Pleckstrin homology-like domain family B member 2,13997,119,1.08 [0.92-1.28],0.3486004150238765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,16463,144,1.87 [1.13-3.09],0.0153824081099706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,14204,118,1.30 [0.84-2.01],0.2480237267787867
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PI16,Peptidase inhibitor 16,14510,123,1.01 [0.50-2.03],0.988697710286124
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PI3,Elafin,16412,140,1.25 [0.97-1.62],0.0903217033713059
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",14472,123,1.12 [0.90-1.40],0.2997488621446075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIGR,Polymeric immunoglobulin receptor,16409,143,1.05 [0.69-1.61],0.8105025738080914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,16574,148,1.10 [0.87-1.39],0.4475041298834922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,16623,145,1.92 [1.18-3.11],0.0086255914013115
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,14069,119,1.16 [0.87-1.56],0.3091663822694461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PILRA,Paired immunoglobulin-like type 2 receptor alpha,16623,145,1.59 [1.11-2.28],0.0109531552788792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PILRB,Paired immunoglobulin-like type 2 receptor beta,16596,146,1.42 [1.08-1.87],0.0125184605627036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,14204,118,1.05 [0.81-1.35],0.7234102281347152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PITHD1,PITH domain-containing protein 1,13975,119,1.03 [0.83-1.29],0.7720719446434597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKD1,Polycystin-1,14489,121,1.62 [0.83-3.16],0.1611914453015344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKD2,Polycystin-2,14028,116,1.23 [0.93-1.64],0.1498825992938998
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKLR,Pyruvate kinase PKLR,16635,147,1.20 [0.97-1.49],0.0854637974432397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKN3,Serine/threonine-protein kinase N3,14233,119,1.16 [0.94-1.45],0.1701722996978647
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G10,Group 10 secretory phospholipase A2,16463,144,0.64 [0.51-0.81],0.0002426611382201
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G15,Phospholipase A2 group XV,16671,146,1.95 [1.14-3.32],0.0140788749250202
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G1B,Phospholipase A2,16789,142,0.98 [0.70-1.38],0.9231761332617022
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G2A,"Phospholipase A2, membrane associated",16577,141,1.12 [0.85-1.46],0.4218013462050137
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G4A,Cytosolic phospholipase A2,16677,147,0.95 [0.80-1.12],0.5273615518434747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G7,Platelet-activating factor acetylhydrolase,16623,145,1.33 [0.84-2.10],0.2227183528374535
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLAT,Tissue-type plasminogen activator,16772,143,1.00 [0.74-1.35],0.999273094073226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLAU,Urokinase-type plasminogen activator,16623,145,1.21 [0.77-1.91],0.4141191632612282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLAUR,Urokinase plasminogen activator surface receptor,16507,147,1.22 [0.71-2.10],0.4682279491834334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLB1,"Phospholipase B1, membrane-associated",14478,121,0.87 [0.65-1.16],0.3332966450123208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",14069,119,0.99 [0.64-1.51],0.9494602961039972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",14478,121,1.00 [0.84-1.20],0.9693760570916312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLEKHO1,Pleckstrin homology domain-containing family O member 1,14478,121,1.11 [0.86-1.43],0.4154501646161213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLG,Plasminogen,14159,118,1.50 [0.69-3.28],0.3049670510859089
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLIN1,Perilipin-1,16227,143,1.29 [0.87-1.92],0.2061676602908795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLIN3,Perilipin-3,16596,146,1.06 [0.75-1.49],0.760732203554044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLPBP,Pyridoxal phosphate homeostasis protein,16596,146,1.08 [0.87-1.34],0.4866308074101433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLSCR3,Phospholipid scramblase 3,14451,121,1.22 [0.91-1.66],0.1879909731466484
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLTP,Phospholipid transfer protein,16759,143,0.89 [0.59-1.34],0.5676873190585037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXDC1,Plexin domain-containing protein 1,16261,143,1.12 [0.72-1.73],0.6260905515709025
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXDC2,Plexin domain-containing protein 2,14478,121,0.67 [0.34-1.33],0.2545510600065769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXNA4,Plexin-A4,16574,148,0.96 [0.81-1.15],0.6761530161853657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXNB2,Plexin-B2,16743,143,1.86 [1.01-3.40],0.0447500368228717
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXNB3,Plexin-B3,16549,146,0.90 [0.66-1.23],0.5111707061505663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,16509,146,1.03 [0.95-1.12],0.4151630019557474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMCH,Pro-MCH,14028,116,0.89 [0.69-1.15],0.3723124958093384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMM2,Phosphomannomutase 2,14028,116,1.00 [0.74-1.36],0.9800979544383592
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMS1,PMS1 protein homolog 1,14119,118,0.95 [0.67-1.36],0.7813712336544212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMVK,Phosphomevalonate kinase,16198,143,1.00 [0.87-1.14],0.9442442873663086
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNLIP,Pancreatic triacylglycerol lipase,14510,123,1.02 [0.77-1.33],0.906615849783636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNLIPRP1,Inactive pancreatic lipase-related protein 1,14478,121,1.07 [0.86-1.33],0.5262648190247765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNLIPRP2,Pancreatic lipase-related protein 2,16598,147,1.05 [0.99-1.11],0.0869208095417911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNMA1,Paraneoplastic antigen Ma1,14129,115,0.98 [0.71-1.36],0.9026955250338572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNMA2,Paraneoplastic antigen Ma2,14051,117,1.15 [0.80-1.66],0.4392796823250713
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",16319,145,0.97 [0.85-1.11],0.655735823933763
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PODXL,Podocalyxin,16535,147,0.86 [0.33-2.26],0.7643786008695531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PODXL2,Podocalyxin-like protein 2,16671,146,1.57 [0.93-2.64],0.0908662284245548
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POF1B,Protein POF1B,14069,119,1.47 [1.08-2.00],0.0153408536142938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POLR2A,DNA-directed RNA polymerase II subunit RPB1,14069,119,0.77 [0.41-1.45],0.4186039899804236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",16535,147,1.16 [0.79-1.71],0.4490752252557304
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POMC,Pro-opiomelanocortin,14129,115,1.02 [0.78-1.32],0.900942785889276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PON1,Serum paraoxonase/arylesterase 1,14510,123,1.06 [0.56-2.01],0.860946004155483
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PON2,Serum paraoxonase/arylesterase 2,16307,141,0.82 [0.53-1.25],0.3485656646061368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PON3,Serum paraoxonase/lactonase 3,16677,147,1.01 [0.59-1.71],0.9801305876987058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POSTN,Periostin,14504,123,1.20 [0.76-1.89],0.4401626829714806
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPBP,Platelet basic protein,14417,121,0.86 [0.70-1.05],0.1395383389544312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPCDC,Phosphopantothenoylcysteine decarboxylase,16735,146,1.29 [0.95-1.77],0.1032864013865076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPIB,Peptidyl-prolyl cis-trans isomerase B,16643,143,0.95 [0.81-1.11],0.5265056108669484
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPIE,Peptidyl-prolyl cis-trans isomerase E,14233,119,1.14 [0.90-1.45],0.2856367382608026
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",14504,123,0.89 [0.67-1.19],0.4464689045872272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPL,Periplakin,14069,119,1.46 [0.94-2.26],0.0880842625446089
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPM1A,Protein phosphatase 1A,16261,143,0.86 [0.52-1.41],0.5394872366284058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPM1B,Protein phosphatase 1B,14069,119,1.21 [0.96-1.52],0.1038385849358295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPM1F,Protein phosphatase 1F,14489,121,0.99 [0.71-1.39],0.9490757750475948
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPME1,Protein phosphatase methylesterase 1,16535,147,1.26 [0.99-1.61],0.0616354083472238
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,14445,123,1.03 [0.84-1.27],0.7807197062313782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,16671,146,1.03 [0.89-1.20],0.6792997437765769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,14233,119,0.84 [0.63-1.11],0.2220082714316513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,14472,123,1.17 [0.96-1.42],0.1169561224828491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,14472,123,0.91 [0.58-1.44],0.695117574608648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R2,Protein phosphatase inhibitor 2,16596,146,0.96 [0.80-1.16],0.689868058953613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R9B,Neurabin-2,16776,146,1.07 [0.91-1.25],0.4187407422551191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,14431,123,1.01 [0.87-1.17],0.871360480195929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP3R1,Calcineurin subunit B type 1,16463,144,0.89 [0.61-1.29],0.5395681020189287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPT1,Palmitoyl-protein thioesterase 1,14119,118,0.95 [0.74-1.22],0.671567803214194
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPY,Pancreatic prohormone,16606,146,1.04 [0.90-1.19],0.6178668422489435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PQBP1,Polyglutamine-binding protein 1,16261,143,1.05 [0.82-1.35],0.7007833822231911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRAME,Melanoma antigen preferentially expressed in tumors,13997,119,1.15 [0.57-2.34],0.7008726192768244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRAP1,Proline-rich acidic protein 1,14504,123,1.07 [0.69-1.66],0.7606527379162851
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRC1,Protein regulator of cytokinesis 1,14445,123,0.88 [0.57-1.38],0.5863747188267672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRCP,Lysosomal Pro-X carboxypeptidase,16724,142,1.18 [0.74-1.89],0.4925686218809569
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX1,Peroxiredoxin-1,16126,141,1.17 [1.00-1.38],0.0527440734234305
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX2,Peroxiredoxin-2,14248,118,1.24 [0.95-1.62],0.1158101786879956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",16319,145,0.89 [0.72-1.10],0.2692975052779838
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX5,"Peroxiredoxin-5, mitochondrial",16776,146,1.00 [0.80-1.24],0.9869915896142224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX6,Peroxiredoxin-6,16761,145,1.20 [0.95-1.51],0.1208344427744014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PREB,Prolactin regulatory element-binding protein,16319,145,1.49 [0.96-2.32],0.0778220372334386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRELP,Prolargin,16598,147,2.02 [1.10-3.70],0.0227430763328429
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRG2,Bone marrow proteoglycan,14504,123,0.79 [0.56-1.12],0.1810112678738797
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRG3,Proteoglycan 3,14504,123,0.66 [0.47-0.94],0.0203408033285238
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,16319,145,0.95 [0.72-1.27],0.7391494859206764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,14119,118,1.06 [0.62-1.81],0.8424873458781182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,16596,146,0.94 [0.79-1.12],0.4996151250289553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,14448,121,1.12 [0.90-1.40],0.2967056633724086
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKCQ,Protein kinase C theta type,16319,145,1.08 [0.78-1.49],0.6521686271646756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKD2,Serine/threonine-protein kinase D2,14028,116,1.04 [0.70-1.55],0.8281013272935797
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKG1,cGMP-dependent protein kinase 1,14204,118,1.05 [0.91-1.22],0.4708653454137431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,16261,143,1.06 [0.85-1.32],0.6128014024961979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRL,Prolactin,16735,146,0.86 [0.70-1.05],0.1385423726822159
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRND,Prion-like protein doppel,14478,121,1.26 [0.89-1.77],0.1892846947674432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROC,Vitamin K-dependent protein C,16670,145,1.01 [0.56-1.84],0.9724020634980088
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROCR,Endothelial protein C receptor,14028,116,1.19 [0.76-1.88],0.4420879203364569
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROK1,Prokineticin-1,16574,148,1.16 [0.89-1.52],0.2791336628935417
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROS1,Vitamin K-dependent protein S,14518,122,0.79 [0.40-1.56],0.490999330002457
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRR4,Proline-rich protein 4,14094,118,1.21 [0.95-1.54],0.1254846619353074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRR5,Proline-rich protein 5,14069,119,1.21 [0.85-1.71],0.2899057971091069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRRT3,Proline-rich transmembrane protein 3,14129,115,0.99 [0.61-1.61],0.9769319277684194
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS2,Trypsin-2,16700,145,1.10 [0.84-1.44],0.490264278727714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS22,Brain-specific serine protease 4,14069,119,1.61 [1.15-2.24],0.0053328351518868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS27,Serine protease 27,16559,146,0.90 [0.62-1.31],0.578025360937138
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS53,Serine protease 53,14478,121,1.21 [0.76-1.94],0.4166361466132116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS8,Prostasin,16561,147,1.15 [0.80-1.65],0.4441820837648894
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,16227,143,1.03 [0.90-1.17],0.7107527890972336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRTG,Protogenin,16761,145,1.11 [0.61-2.03],0.7403856288867171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRTN3,Myeloblastin,16189,140,0.81 [0.58-1.13],0.2190499875478841
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRUNE2,Protein prune homolog 2,14233,119,1.04 [0.58-1.87],0.8949453055286036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSAP,Prosaposin,14366,122,1.07 [0.57-2.02],0.8272800407140299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSAPL1,Proactivator polypeptide-like 1,14431,123,1.18 [0.83-1.67],0.3581910898668459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSCA,Prostate stem cell antigen,14431,123,1.06 [0.99-1.14],0.0756409452603157
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSG1,Pregnancy-specific beta-1-glycoprotein 1,16463,144,1.00 [0.88-1.13],0.9605894213878364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSIP1,PC4 and SFRS1-interacting protein,16574,148,1.08 [0.87-1.34],0.4743544339265974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMA1,Proteasome subunit alpha type-1,16261,143,0.70 [0.49-1.01],0.0599565822269781
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMC3,26S proteasome regulatory subunit 6A,13997,119,0.77 [0.43-1.39],0.3831133317691412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMD1,26S proteasome non-ATPase regulatory subunit 1,14472,123,1.30 [0.95-1.77],0.1026773101810935
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMD5,26S proteasome non-ATPase regulatory subunit 5,14119,118,1.07 [0.79-1.45],0.661528323664309
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMD9,26S proteasome non-ATPase regulatory subunit 9,16535,147,1.28 [1.00-1.63],0.0481195623251675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSME1,Proteasome activator complex subunit 1,16430,144,1.25 [0.84-1.84],0.2708103453165265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSME2,Proteasome activator complex subunit 2,16388,144,1.38 [0.93-2.06],0.1100627609986784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMG3,Proteasome assembly chaperone 3,16574,148,1.11 [0.84-1.47],0.4540100305019692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMG4,Proteasome assembly chaperone 4,14069,119,1.23 [0.92-1.64],0.1587275421048454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSPN,Persephin,16574,148,1.20 [1.03-1.41],0.0224497373888989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSRC1,Proline/serine-rich coiled-coil protein 1,16261,143,1.08 [0.84-1.38],0.5451774419809383
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,13726,111,1.00 [0.84-1.19],0.9838996688507208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",16227,143,1.04 [0.63-1.70],0.8760293778581152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTGDS,Prostaglandin-H2 D-isomerase,16511,143,1.53 [0.97-2.42],0.0653816160843341
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTGES2,Prostaglandin E synthase 2,13960,118,0.97 [0.70-1.36],0.8812406839318462
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTGR1,Prostaglandin reductase 1,14489,121,0.98 [0.79-1.21],0.819421326073768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTH,Parathyroid hormone,14119,118,1.12 [0.90-1.39],0.3283505302224407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,16574,148,1.37 [1.04-1.79],0.0235004829599265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTK7,Inactive tyrosine-protein kinase 7,16227,143,0.95 [0.64-1.42],0.8161584834079636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTN,Pleiotrophin,16307,141,1.43 [1.07-1.92],0.0158825047706866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTP4A3,Protein tyrosine phosphatase type IVA 3,14069,119,1.06 [0.77-1.46],0.720846621306378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,16463,144,1.07 [0.89-1.29],0.4667853155625083
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,16652,147,0.95 [0.81-1.12],0.5637720349108353
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,14048,119,1.04 [0.65-1.65],0.8751967340670213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRB,Receptor-type tyrosine-protein phosphatase beta,14489,121,0.65 [0.36-1.20],0.1696587895138926
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRC,Receptor-type tyrosine-protein phosphatase C,14504,123,1.22 [0.56-2.65],0.6110613888916128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRF,Receptor-type tyrosine-protein phosphatase F,16810,143,1.05 [0.63-1.75],0.8570423432625286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRH,Receptor-type tyrosine-protein phosphatase H,14431,123,1.10 [0.77-1.57],0.6125317008391906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,14431,123,1.13 [0.51-2.49],0.7604227936324924
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRM,Receptor-type tyrosine-protein phosphatase mu,16551,148,1.11 [0.61-2.04],0.7303726298195521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,16411,142,0.78 [0.49-1.23],0.2850662944838972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRR,Receptor-type tyrosine-protein phosphatase R,14478,121,0.92 [0.57-1.48],0.736719193391881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRS,Receptor-type tyrosine-protein phosphatase S,16810,143,1.37 [0.75-2.48],0.302729472909118
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,14489,121,1.16 [0.67-2.01],0.5865038154022659
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,14204,118,1.18 [0.87-1.59],0.2823221740282006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTS,6-pyruvoyl tetrahydrobiopterin synthase,16152,143,1.43 [1.11-1.83],0.0050209306168004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTTG1,Securin,14233,119,0.93 [0.60-1.44],0.749844819679311
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTX3,Pentraxin-related protein PTX3,16574,148,0.86 [0.65-1.13],0.2746860545155161
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PVALB,Parvalbumin alpha,16667,144,0.97 [0.85-1.10],0.6025534387590993
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PVR,Poliovirus receptor,16735,146,0.95 [0.63-1.44],0.8039951142785474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PXDNL,Peroxidasin-like protein,14445,123,0.99 [0.73-1.36],0.9683603460080832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PXN,Paxillin,16227,143,1.00 [0.75-1.33],0.9962724541440772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PYDC1,Pyrin domain-containing protein 1,14129,115,1.16 [0.76-1.76],0.4891776152062208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PYY,Peptide YY,14028,116,0.92 [0.77-1.10],0.3521832476618139
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PZP,Pregnancy zone protein,14518,122,0.90 [0.61-1.32],0.5742048564313751
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,QDPR,Dihydropteridine reductase,16522,145,1.04 [0.74-1.48],0.8084335428461396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,QPCT,Glutaminyl-peptide cyclotransferase,16664,142,1.90 [1.10-3.27],0.0205204305589356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,QSOX1,Sulfhydryl oxidase 1,14232,118,1.09 [0.73-1.63],0.6646082843142136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB10,Ras-related protein Rab-10,14489,121,0.97 [0.70-1.36],0.8781516776578292
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB11FIP3,Rab11 family-interacting protein 3,14489,121,1.04 [0.88-1.23],0.6318240769643015
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB27B,Ras-related protein Rab-27B,14489,121,1.02 [0.82-1.26],0.8702583109996652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB2B,Ras-related protein Rab-2B,14445,123,1.03 [0.77-1.37],0.835834171445402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB33A,Ras-related protein Rab-33A,14028,116,1.03 [0.78-1.36],0.816689676386543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB37,Ras-related protein Rab-37,16319,145,1.00 [0.83-1.20],0.9776923538272668
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB39B,Ras-related protein Rab-39B,14028,116,1.16 [1.00-1.35],0.0541552423536653
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,14051,117,1.01 [0.74-1.37],0.951816339392074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB44,Ras-related protein Rab-44,14445,123,1.12 [0.80-1.58],0.5006910425166509
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB6A,Ras-related protein Rab-6A,16574,148,0.93 [0.67-1.29],0.6536465504202269
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB6B,Ras-related protein Rab-6B,16227,143,1.20 [0.91-1.57],0.1874748540238629
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RABEP1,Rab GTPase-binding effector protein 1,14204,118,1.11 [0.88-1.40],0.3769753932321072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RABEPK,Rab9 effector protein with kelch motifs,16261,143,1.03 [0.80-1.33],0.8072420943947345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RABGAP1L,Rab GTPase-activating protein 1-like,16319,145,1.11 [0.87-1.41],0.4132619789201647
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAC3,Ras-related C3 botulinum toxin substrate 3,14119,118,1.16 [0.93-1.44],0.18265181911842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAD23B,UV excision repair protein RAD23 homolog B,16261,143,0.88 [0.63-1.22],0.4355147629184471
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAD51,DNA repair protein RAD51 homolog 1,14233,119,1.14 [0.87-1.49],0.3562370192749674
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RALB,Ras-related protein Ral-B,14069,119,1.29 [0.73-2.26],0.3807403622984991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RALY,RNA-binding protein Raly,14445,123,1.32 [1.00-1.75],0.0509988182295734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RANBP1,Ran-specific GTPase-activating protein,14129,115,1.10 [0.78-1.55],0.5775440807213436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RANBP2,E3 SUMO-protein ligase RanBP2,14051,117,1.04 [0.60-1.79],0.8836413970248954
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RANGAP1,Ran GTPase-activating protein 1,16261,143,0.82 [0.58-1.16],0.2691506297647921
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAP1A,Ras-related protein Rap-1A,14069,119,0.96 [0.74-1.26],0.7951768948982925
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAPGEF2,Rap guanine nucleotide exchange factor 2,14233,119,1.12 [0.81-1.56],0.4985098874533352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RARRES1,Retinoic acid receptor responder protein 1,16261,143,0.99 [0.63-1.57],0.9706892739738244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RARRES2,Retinoic acid receptor responder protein 2,16723,145,1.24 [0.92-1.66],0.153620840778078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RASA1,Ras GTPase-activating protein 1,16227,143,0.96 [0.61-1.51],0.8510261954524917
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,13997,119,1.21 [0.82-1.78],0.3297838533259373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RASSF2,Ras association domain-containing protein 2,16261,143,1.11 [0.88-1.41],0.3774470972737478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBFOX3,RNA binding protein fox-1 homolog 3,14472,123,1.44 [0.97-2.15],0.0719152357328505
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBKS,Ribokinase,16195,137,1.46 [1.09-1.97],0.012405485453347
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBM17,Splicing factor 45,14472,123,0.98 [0.78-1.23],0.8696518953313679
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBM19,Probable RNA-binding protein 19,14028,116,1.11 [0.78-1.58],0.5653487831390737
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBM25,RNA-binding protein 25,13997,119,1.25 [0.88-1.77],0.2059409520273505
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP1,Retinol-binding protein 1,14119,118,1.15 [0.93-1.43],0.1951427053630876
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP2,Retinol-binding protein 2,16535,147,1.08 [0.90-1.31],0.4051605611007434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP5,Retinol-binding protein 5,16535,147,1.21 [0.93-1.58],0.1458371162736591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP7,Retinoid-binding protein 7,14431,123,1.37 [1.08-1.74],0.0090088062697411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBPMS,RNA-binding protein with multiple splicing,14069,119,1.08 [0.84-1.39],0.5405382839674242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBPMS2,RNA-binding protein with multiple splicing 2,14129,115,1.18 [0.99-1.41],0.0650227533207072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RCC1,Regulator of chromosome condensation,14445,123,1.29 [0.98-1.70],0.0668352726521348
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RCOR1,REST corepressor 1,16307,141,0.78 [0.50-1.20],0.2511834552570883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,14129,115,1.45 [0.61-3.43],0.3998947701964566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REEP4,Receptor expression-enhancing protein 4,14472,123,1.20 [0.92-1.57],0.1718649094577381
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG1A,Lithostathine-1-alpha,16521,144,1.18 [0.88-1.57],0.2685492007314044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG1B,Lithostathine-1-beta,16810,143,1.06 [0.82-1.37],0.6650145513020547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG3A,Regenerating islet-derived protein 3-alpha,16810,143,1.00 [0.79-1.26],0.9682275846161692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG3G,Regenerating islet-derived protein 3-gamma,14445,123,1.37 [0.92-2.03],0.1252031811621912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG4,Regenerating islet-derived protein 4,16626,147,0.75 [0.55-1.01],0.058548450583246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RELB,Transcription factor RelB,14069,119,1.22 [0.89-1.67],0.2151398630449411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RELT,Tumor necrosis factor receptor superfamily member 19L,16623,145,1.56 [0.96-2.54],0.0750899799131421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REN,Renin,16596,146,0.95 [0.79-1.14],0.5956491867808447
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REPS1,RalBP1-associated Eps domain-containing protein 1,14069,119,1.14 [0.74-1.75],0.5506300633985716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REST,RE1-silencing transcription factor,13997,119,0.85 [0.50-1.46],0.5586629162185657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,16535,147,0.83 [0.57-1.22],0.355049401141246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RETN,Resistin,16583,142,1.11 [0.78-1.57],0.5635015990908175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REXO2,"Oligoribonuclease, mitochondrial",14028,116,0.84 [0.56-1.27],0.40591455508617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RFC4,Replication factor C subunit 4,14445,123,1.17 [0.52-2.64],0.7120847430609306
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGCC,Regulator of cell cycle RGCC,14472,123,0.99 [0.79-1.25],0.9485335446069904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,14233,119,1.06 [0.82-1.37],0.6450273673187533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGMA,Repulsive guidance molecule A,16735,146,1.07 [0.67-1.70],0.7752418927255833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGMB,RGM domain family member B,16735,146,1.61 [0.95-2.71],0.076602184314953
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGS10,Regulator of G-protein signaling 10,14472,123,1.01 [0.76-1.36],0.9218285793017856
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGS8,Regulator of G-protein signaling 8,16319,145,0.86 [0.67-1.12],0.2702310360732677
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RHOC,Rho-related GTP-binding protein RhoC,16362,143,1.00 [0.88-1.14],0.964269669873543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RICTOR,Rapamycin-insensitive companion of mTOR,14069,119,1.23 [0.92-1.64],0.1713070426080818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,14204,118,1.58 [1.15-2.18],0.005016288310359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RILP,Rab-interacting lysosomal protein,16703,145,1.13 [0.88-1.44],0.3467399749382169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RILPL2,RILP-like protein 2,14489,121,1.02 [0.86-1.23],0.7924620027349308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,14028,116,1.14 [0.91-1.42],0.2539068303985416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RLN1,Prorelaxin H1,14472,123,1.24 [0.95-1.62],0.1075124587082634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RLN2,Prorelaxin H2,14176,118,1.39 [1.04-1.84],0.0246155054801842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE1,Ribonuclease pancreatic,14510,123,1.44 [0.78-2.64],0.2425778368539829
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE10,Inactive ribonuclease-like protein 10,14129,115,1.07 [0.74-1.55],0.7260513089609655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE3,Eosinophil cationic protein,16530,146,1.04 [0.92-1.18],0.5292144591257375
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE4,Ribonuclease 4,14022,119,1.35 [0.72-2.52],0.3498636903736813
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE6,Ribonuclease K6,14402,123,1.29 [0.82-2.03],0.272094780949121
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASEH2A,Ribonuclease H2 subunit A,14472,123,1.03 [0.73-1.45],0.8774640027529085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASET2,Ribonuclease T2,16744,142,1.33 [0.77-2.28],0.3061762745453387
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF149,E3 ubiquitin-protein ligase RNF149,14129,115,1.62 [0.94-2.81],0.0835415297638485
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF168,E3 ubiquitin-protein ligase RNF168,14069,119,0.89 [0.56-1.42],0.62140862990139
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF31,E3 ubiquitin-protein ligase RNF31,14069,119,1.01 [0.62-1.65],0.9651776116255296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF4,E3 ubiquitin-protein ligase RNF4,14233,119,1.02 [0.79-1.32],0.8547265519521281
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF41,E3 ubiquitin-protein ligase NRDP1,16261,143,1.10 [0.88-1.37],0.409903624157917
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF43,E3 ubiquitin-protein ligase RNF43,14233,119,1.20 [0.93-1.54],0.1533497630826634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF5,E3 ubiquitin-protein ligase RNF5,14129,115,0.94 [0.74-1.21],0.6387209076216667
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROBO1,Roundabout homolog 1,16626,147,1.46 [0.80-2.67],0.2167652702143746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROBO2,Roundabout homolog 2,16735,146,1.19 [0.62-2.26],0.6009360306154673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROBO4,Roundabout homolog 4,14129,115,1.03 [0.38-2.83],0.9509780660513472
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,16596,146,1.50 [0.95-2.39],0.0838756583088048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RP2,Protein XRP2,16535,147,1.02 [0.72-1.44],0.9049644933417308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPA2,Replication protein A 32 kDa subunit,14069,119,1.12 [0.65-1.94],0.6780771770614142
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPE,Ribulose-phosphate 3-epimerase,14233,119,1.06 [0.84-1.35],0.6274051182968561
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPGR,X-linked retinitis pigmentosa GTPase regulator,14119,118,1.07 [0.70-1.62],0.7582027198340509
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPL14,60S ribosomal protein L14,14129,115,1.15 [0.74-1.78],0.5312743943550953
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPS10,40S ribosomal protein S10,14028,116,1.13 [0.76-1.69],0.5435916456499876
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRAS,Ras-related protein R-Ras,14119,118,0.97 [0.84-1.11],0.6290461564342787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRM2,Ribonucleoside-diphosphate reductase subunit M2,16261,143,1.13 [0.85-1.49],0.4064564702572967
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,16261,143,0.93 [0.74-1.17],0.5427362156163518
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRP15,RRP15-like protein,14051,117,1.19 [1.00-1.42],0.0450559581789092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RSPO1,R-spondin-1,16463,144,1.17 [0.75-1.82],0.4997113959182336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RSPO3,R-spondin-3,16761,145,1.22 [0.72-2.08],0.460258775204449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTBDN,Retbindin,16535,147,1.10 [0.66-1.85],0.7044076551077989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTKN2,Rhotekin-2,14028,116,0.99 [0.69-1.42],0.9627411878261188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",14472,123,0.89 [0.74-1.08],0.2387610426824295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTN4R,Reticulon-4 receptor,16761,145,1.11 [0.71-1.71],0.6523475656310973
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RUVBL1,RuvB-like 1,16261,143,1.01 [0.87-1.16],0.9377794968736924
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RWDD1,RWD domain-containing protein 1,16735,146,1.04 [0.82-1.32],0.730025931871439
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RYR1,Ryanodine receptor 1,14028,116,0.67 [0.37-1.23],0.1948069689117377
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A11,Protein S100-A11,16481,146,1.03 [0.76-1.40],0.84473241482919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A12,Protein S100-A12,16384,144,1.00 [0.82-1.22],0.9898916144404734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A13,Protein S100-A13,14069,119,1.97 [1.35-2.88],0.0004466951275961
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A14,Protein S100-A14,14472,123,1.19 [0.87-1.62],0.282417576781516
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A16,Protein S100-A16,16204,143,1.08 [0.85-1.36],0.534680094735827
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A3,Protein S100-A3,14445,123,0.81 [0.50-1.30],0.3747548696666127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A4,Protein S100-A4,16671,146,1.03 [0.79-1.33],0.8430176379778174
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100G,Protein S100-G,14472,123,1.20 [0.86-1.68],0.2788003363617578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100P,Protein S100-P,16307,141,1.10 [0.85-1.42],0.4620410482700787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAA4,Serum amyloid A-4 protein,14518,122,0.83 [0.40-1.73],0.6214800754786154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAFB2,Scaffold attachment factor B2,14472,123,1.33 [0.81-2.19],0.2591334543506829
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAG,S-arrestin,14051,117,0.90 [0.63-1.29],0.5550060984054357
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAMD9L,Sterile alpha motif domain-containing protein 9-like,16574,148,1.02 [0.83-1.24],0.8831268904484042
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAP18,Histone deacetylase complex subunit SAP18,14233,119,1.15 [0.94-1.41],0.1642750424134617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SARG,Specifically androgen-regulated gene protein,14431,120,1.03 [0.88-1.22],0.6897692941387286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SART1,U4/U6.U5 tri-snRNP-associated protein 1,14028,116,1.39 [0.97-1.99],0.0728535564422219
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAT1,Diamine acetyltransferase 1,14028,116,1.10 [0.79-1.53],0.5700992170948049
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAT2,Thialysine N-epsilon-acetyltransferase,14233,119,1.16 [0.92-1.47],0.2060391100703046
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SATB1,DNA-binding protein SATB1,14472,123,0.91 [0.50-1.66],0.7586817233008081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SBSN,Suprabasin,14474,123,0.97 [0.59-1.60],0.910872009750636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCAMP3,Secretory carrier-associated membrane protein 3,16535,147,1.07 [0.90-1.27],0.4690976473103562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARA5,Scavenger receptor class A member 5,16735,146,0.95 [0.58-1.56],0.8388984671856539
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARB1,Scavenger receptor class B member 1,16227,143,0.80 [0.58-1.10],0.1651424620528737
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARB2,Lysosome membrane protein 2,16154,140,1.26 [0.78-2.04],0.3494524164869813
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARF1,Scavenger receptor class F member 1,16810,143,1.02 [0.71-1.46],0.9110904715621128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARF2,Scavenger receptor class F member 2,16735,146,1.43 [0.86-2.39],0.1691523308460671
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCG2,Secretogranin-2,16668,144,0.76 [0.48-1.21],0.2534661739777503
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCG3,Secretogranin-3,16626,147,0.92 [0.60-1.42],0.7040756188266326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB1A1,Uteroglobin,16617,146,1.17 [0.89-1.54],0.2682956752846873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB2A2,Mammaglobin-A,14028,116,1.46 [0.95-2.24],0.08769998705719
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB3A1,Secretoglobin family 3A member 1,14204,118,1.40 [0.71-2.75],0.3371209805492933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB3A2,Secretoglobin family 3A member 2,16652,147,0.91 [0.76-1.10],0.3445816738520078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGN,Secretagogin,16319,145,1.40 [1.02-1.93],0.0362068561258389
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCIN,Adseverin,14051,117,1.03 [0.82-1.31],0.7831528425815157
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCLY,Selenocysteine lyase,16703,145,1.05 [0.76-1.45],0.7887940343704689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN2A,Sodium channel protein type 2 subunit alpha,14051,117,1.06 [0.75-1.50],0.7455209307964394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN2B,Sodium channel subunit beta-2,14119,118,0.95 [0.50-1.81],0.8868835710348226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN3A,Sodium channel protein type 3 subunit alpha,14119,118,0.71 [0.40-1.25],0.2390439589253733
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN3B,Sodium channel subunit beta-3,14051,117,0.92 [0.62-1.35],0.6572288140665274
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN4B,Sodium channel subunit beta-4,14129,115,1.21 [0.79-1.86],0.3863068021980738
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCP2,Non-specific lipid-transfer protein,16261,143,1.01 [0.82-1.23],0.9554192477539344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCPEP1,Retinoid-inducible serine carboxypeptidase,14075,115,1.11 [0.77-1.60],0.5795207435519465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCRG1,Scrapie-responsive protein 1,14489,121,1.40 [0.77-2.54],0.2735890329674054
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCRIB,Protein scribble homolog,14129,115,1.15 [0.98-1.37],0.094780890507023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCRN1,Secernin-1,16574,148,1.05 [0.81-1.37],0.7221626368028276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCT,Secretin,14119,118,1.05 [0.73-1.51],0.7907755580583822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDC1,Syndecan-1,16596,146,0.90 [0.61-1.32],0.5853556404729459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDC4,Syndecan-4,16596,146,0.74 [0.54-1.01],0.0575276398529449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDCCAG8,Serologically defined colon cancer antigen 8,14445,123,1.13 [0.96-1.31],0.1350877470130505
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDHB,Succinate dehydrogenase,14431,123,0.89 [0.67-1.20],0.45213882272486
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDK2,Protein sidekick-2,14204,118,1.42 [0.94-2.14],0.0976086541967384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEC31A,Protein transport protein Sec31A,14129,115,1.04 [0.82-1.31],0.7532585016138943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEL1L,Protein sel-1 homolog 1,14129,115,1.17 [0.68-2.00],0.5795747145589417
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELE,E-selectin,16810,143,1.25 [0.93-1.69],0.1450076201437896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELENOP,Selenoprotein P,14518,122,1.23 [0.59-2.56],0.5814957804982637
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELL,L-selectin,14518,122,1.26 [0.58-2.73],0.5624134729375618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELP,P-selectin,16700,145,0.86 [0.66-1.12],0.2730785650003194
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELPLG,P-selectin glycoprotein ligand 1,16574,148,0.92 [0.53-1.60],0.7615932255225208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA3F,Semaphorin-3F,16596,146,1.28 [0.73-2.25],0.3911666321063267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA3G,Semaphorin-3G,14204,118,1.47 [1.01-2.13],0.0427111522578682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA4C,Semaphorin-4C,16535,147,1.03 [0.61-1.75],0.9001259531960002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA4D,Semaphorin-4D,16735,146,0.82 [0.50-1.32],0.4097170341195634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA6C,Semaphorin-6C,14069,119,1.33 [0.72-2.45],0.355827879419075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA7A,Semaphorin-7A,16772,143,1.69 [1.01-2.83],0.0449466563986297
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN3,Neuronal-specific septin-3,14472,123,1.01 [0.80-1.27],0.9648435033081272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN7,Septin-7,14233,119,1.19 [0.93-1.54],0.166047059755067
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN8,Septin-8,14453,121,1.75 [1.10-2.77],0.0175779548516979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN9,Septin-9,16535,147,1.02 [0.61-1.70],0.9398355306670994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA1,Alpha-1-antitrypsin,14221,120,1.74 [0.22-13.51],0.5966594538825774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA11,Serpin A11,16810,143,0.78 [0.54-1.12],0.1745444264657789
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA12,Serpin A12,16104,141,0.92 [0.78-1.09],0.3466828250978861
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA3,Alpha-1-antichymotrypsin,14460,122,0.81 [0.25-2.66],0.7334114878599507
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA4,Kallistatin,14235,118,1.69 [0.81-3.52],0.1616228549502787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA5,Plasma serine protease inhibitor,14287,119,1.44 [0.88-2.37],0.1445449183855356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA6,Corticosteroid-binding globulin,14518,122,0.75 [0.24-2.29],0.6118166510533598
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA7,Thyroxine-binding globulin,14518,122,0.67 [0.26-1.72],0.4007389034069467
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA9,Serpin A9,16447,146,0.96 [0.78-1.19],0.7109563486587104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB1,Leukocyte elastase inhibitor,16572,144,1.03 [0.88-1.22],0.7012344033059661
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB5,Serpin B5,16307,141,0.95 [0.70-1.29],0.7299069539717751
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB6,Serpin B6,16679,146,0.98 [0.76-1.27],0.8927570231524042
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB8,Serpin B8,16776,146,1.04 [0.82-1.32],0.7689184364654634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB9,Serpin B9,16463,144,1.09 [0.70-1.71],0.698619609605329
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINC1,Antithrombin-III,14490,121,1.43 [0.44-4.68],0.5514875548622223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPIND1,Heparin cofactor 2,14490,121,0.70 [0.37-1.30],0.2565789763000569
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINE1,Plasminogen activator inhibitor 1,16810,143,0.80 [0.65-1.00],0.0461393457009248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINE2,Glia-derived nexin,14489,121,0.88 [0.67-1.16],0.3789194516357059
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINF1,Pigment epithelium-derived factor,14284,119,1.28 [0.66-2.50],0.4629389138230828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINF2,Alpha-2-antiplasmin,14226,119,1.30 [0.35-4.88],0.6925780934041927
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPING1,Plasma protease C1 inhibitor,14490,121,0.84 [0.32-2.18],0.7140607166755704
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINH1,Serpin H1,14233,119,1.07 [0.94-1.23],0.3129187032577071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINI1,Neuroserpin,14180,118,1.37 [0.77-2.45],0.2889465512871836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINI2,Serpin I2,14431,123,1.07 [0.78-1.46],0.691727006008862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,16227,143,1.10 [0.88-1.38],0.4129655642225782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SETMAR,Histone-lysine N-methyltransferase SETMAR,16408,141,1.31 [0.81-2.13],0.2748673093530607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEZ6,Seizure protein 6 homolog,14119,118,0.79 [0.43-1.45],0.4454435579451662
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEZ6L,Seizure 6-like protein,16671,146,1.16 [0.68-1.98],0.5920233789014386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEZ6L2,Seizure 6-like protein 2,16535,147,1.13 [0.60-2.13],0.7003014598538462
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SF3B4,Splicing factor 3B subunit 4,16535,147,1.08 [0.89-1.31],0.451919789900652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFRP1,Secreted frizzled-related protein 1,16409,139,1.35 [0.96-1.88],0.0827070628218483
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFRP4,Secreted frizzled-related protein 4,14204,118,1.21 [0.77-1.91],0.41471799643731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFTPA1,Pulmonary surfactant-associated protein A1,16261,143,1.00 [0.77-1.31],0.9877496290932656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFTPA2,Pulmonary surfactant-associated protein A2,16261,143,1.17 [0.88-1.55],0.2723262602814205
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFTPD,Pulmonary surfactant-associated protein D,16596,146,1.03 [0.83-1.29],0.7712854758253689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SGSH,N-sulphoglucosamine sulphohydrolase,14225,120,1.20 [0.89-1.61],0.2354700600631482
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH2B3,SH2B adapter protein 3,16261,143,0.97 [0.83-1.13],0.7120491324593206
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH2D1A,SH2 domain-containing protein 1A,16574,148,0.93 [0.71-1.21],0.5869150548737271
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,14051,117,0.86 [0.62-1.21],0.3922253340028543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3BP1,SH3 domain-binding protein 1,14431,123,1.09 [0.79-1.51],0.59335276909827
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3GL3,Endophilin-A3,14160,118,1.05 [0.85-1.30],0.6276132916775211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3GLB2,Endophilin-B2,14478,121,1.27 [0.99-1.64],0.061584208295055
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHBG,Sex hormone-binding globulin,14510,123,1.01 [0.70-1.45],0.9627227753990312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHC1,SHC-transforming protein 1,13997,119,0.91 [0.77-1.07],0.2508197418193859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHD,SH2 domain-containing adapter protein D,13996,116,1.05 [0.87-1.27],0.6078552147885662
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHH,Sonic hedgehog protein,14069,119,0.69 [0.44-1.08],0.1018686287415576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHISA5,Protein shisa-5,14504,123,1.17 [0.60-2.32],0.6420673064555753
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHMT1,"Serine hydroxymethyltransferase, cytosolic",16652,147,1.00 [0.84-1.19],0.9698839011329912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHPK,Sedoheptulokinase,14233,119,1.46 [1.04-2.03],0.026516236634033
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIAE,Sialate O-acetylesterase,16649,146,1.05 [0.76-1.44],0.7893927543108807
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC1,Sialoadhesin,16677,147,1.07 [0.75-1.52],0.7198082140541919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC10,Sialic acid-binding Ig-like lectin 10,16574,148,1.11 [0.71-1.73],0.6605635778012535
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC15,Sialic acid-binding Ig-like lectin 15,16227,143,0.92 [0.74-1.14],0.4417918040444186
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC5,Sialic acid-binding Ig-like lectin 5,16623,145,1.14 [0.98-1.33],0.0780209288538058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC6,Sialic acid-binding Ig-like lectin 6,16761,145,1.46 [0.93-2.27],0.0974770267346085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC7,Sialic acid-binding Ig-like lectin 7,16596,146,0.94 [0.55-1.61],0.829645810391138
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC8,Sialic acid-binding Ig-like lectin 8,14129,115,1.12 [0.74-1.68],0.5940291078897435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC9,Sialic acid-binding Ig-like lectin 9,16733,145,1.17 [0.71-1.94],0.5336249069113821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIL1,Nucleotide exchange factor SIL1,14129,115,1.34 [0.88-2.06],0.1746670593276146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,16663,143,0.99 [0.76-1.28],0.9202308789715844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRPB1,Signal-regulatory protein beta-1,16581,147,1.12 [0.82-1.53],0.4748107783281365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRT1,NAD-dependent protein deacetylase sirtuin-1,14069,119,0.93 [0.74-1.17],0.5517529902775629
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRT2,NAD-dependent protein deacetylase sirtuin-2,16535,147,1.03 [0.87-1.22],0.7198637967765337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",16227,143,0.83 [0.61-1.12],0.2162912163367123
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIT1,Signaling threshold-regulating transmembrane adapter 1,16319,145,0.92 [0.70-1.21],0.5575324764096393
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SKAP1,Src kinase-associated phosphoprotein 1,16434,144,1.01 [0.82-1.23],0.9615836349786604
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SKAP2,Src kinase-associated phosphoprotein 2,16677,147,0.98 [0.85-1.13],0.8116363366085837
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SKIV2L,Helicase SKI2W,14028,116,1.44 [1.00-2.08],0.0482441519026787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLA2,Src-like-adapter 2,14472,123,0.95 [0.80-1.12],0.5404730617340842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF1,Signaling lymphocytic activation molecule,16319,145,0.93 [0.73-1.20],0.5853707184737222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF6,SLAM family member 6,16261,143,0.98 [0.65-1.48],0.93379474966776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF7,SLAM family member 7,16574,148,1.25 [0.97-1.60],0.0821789825466313
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF8,SLAM family member 8,16261,143,1.13 [0.85-1.50],0.4140833113322538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC12A2,Solute carrier family 12 member 2,14028,116,1.52 [0.93-2.47],0.0924432235392485
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC13A1,Solute carrier family 13 member 1,14445,123,0.91 [0.65-1.27],0.5730475655533322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC16A1,Monocarboxylate transporter 1,16227,143,1.19 [0.95-1.50],0.1383423382752844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC1A4,Neutral amino acid transporter A,14119,118,0.92 [0.63-1.33],0.6513881937608061
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC27A4,Long-chain fatty acid transport protein 4,16227,143,1.13 [0.92-1.40],0.2413573971483437
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC28A1,Sodium/nucleoside cotransporter 1,13997,119,0.88 [0.63-1.22],0.4274952611445014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC34A3,Sodium-dependent phosphate transport protein 2C,13997,119,0.99 [0.68-1.43],0.9378047291570956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC39A14,Zinc transporter ZIP14,16227,143,1.23 [0.81-1.85],0.3351757102944842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC39A5,Zinc transporter ZIP5,16574,148,0.97 [0.73-1.29],0.8420879117449588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC44A4,Choline transporter-like protein 4,14119,118,1.00 [0.77-1.29],0.9748350395437944
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC4A1,Band 3 anion transport protein,14504,123,1.04 [0.72-1.49],0.8421223137262431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC51B,Organic solute transporter subunit beta,14028,116,1.06 [0.84-1.34],0.6192557526134708
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,14204,118,1.00 [0.81-1.23],0.9660238411507964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,14431,123,0.88 [0.60-1.29],0.5029948557246691
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",13997,119,0.99 [0.72-1.35],0.9339090693494134
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLIT2,Slit homolog 2 protein,16227,143,1.05 [0.80-1.38],0.7403003860809538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLITRK1,SLIT and NTRK-like protein 1,14069,119,0.95 [0.55-1.66],0.8589467132108992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLITRK2,SLIT and NTRK-like protein 2,16761,145,0.93 [0.64-1.35],0.6896825126844663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLITRK6,SLIT and NTRK-like protein 6,16307,141,1.31 [0.87-2.00],0.2003640128505208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLK,STE20-like serine/threonine-protein kinase,14233,119,1.03 [0.84-1.27],0.7749996697234314
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLMAP,Sarcolemmal membrane-associated protein,14431,123,1.11 [0.90-1.36],0.3399040118149655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLURP1,Secreted Ly-6/uPAR-related protein 1,14386,122,1.19 [0.77-1.85],0.4367207052673341
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD1,Mothers against decapentaplegic homolog 1,16261,143,1.08 [0.90-1.29],0.4108659974780562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD2,Mothers against decapentaplegic homolog 2,14445,123,1.05 [0.82-1.35],0.7078918989541938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD3,Mothers against decapentaplegic homolog 3,14445,123,1.11 [0.80-1.54],0.5334854226354913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD5,Mothers against decapentaplegic homolog 5,16535,147,0.66 [0.32-1.35],0.2560653905611533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMARCA2,Probable global transcription activator SNF2L2,16227,143,0.94 [0.76-1.17],0.5992046186668497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMC3,Structural maintenance of chromosomes protein 3,13997,119,1.16 [0.86-1.56],0.3464072944168239
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMNDC1,Survival of motor neuron-related-splicing factor 30,14431,123,1.22 [0.97-1.54],0.091264394555946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMOC1,SPARC-related modular calcium-binding protein 1,16761,145,0.99 [0.62-1.56],0.951558093527689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMOC2,SPARC-related modular calcium-binding protein 2,16677,147,1.58 [1.09-2.30],0.0169766435474894
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPD1,Sphingomyelin phosphodiesterase,16648,146,1.23 [0.92-1.63],0.1658819465009988
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPD3,Sphingomyelin phosphodiesterase 3,14069,119,1.11 [0.83-1.47],0.4817273341696071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,16660,147,1.11 [0.89-1.39],0.3648463457326371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,14445,123,0.99 [0.79-1.24],0.9380027048846052
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMS,Spermine synthase,14051,117,1.04 [0.79-1.37],0.7765735690992035
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMTN,Smoothelin,14461,121,1.18 [0.98-1.41],0.0748971701831408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAP23,Synaptosomal-associated protein 23,16596,146,0.93 [0.79-1.10],0.4165566067740719
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAP25,Synaptosomal-associated protein 25,14051,117,1.05 [0.72-1.53],0.7996973429840167
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAP29,Synaptosomal-associated protein 29,16671,146,0.98 [0.83-1.15],0.8025803031414044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAPIN,SNARE-associated protein Snapin,14472,123,1.20 [0.90-1.61],0.2162902122340665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNCA,Alpha-synuclein,14204,118,1.17 [1.00-1.36],0.0497353480303233
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNCG,Gamma-synuclein,16463,144,1.10 [0.88-1.38],0.4112275882680062
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",14129,115,1.29 [0.78-2.14],0.3274441541658277
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNRPB2,U2 small nuclear ribonucleoprotein B'',14478,121,1.18 [0.88-1.58],0.2639049532295777
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNU13,NHP2-like protein 1,14028,116,1.15 [0.89-1.49],0.2778633415179591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX15,Sorting nexin-15,14204,118,1.11 [0.80-1.54],0.5239362576088784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX18,Sorting nexin-18,14431,123,1.18 [0.82-1.70],0.3718056098513028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX2,Sorting nexin-2,14445,123,1.14 [0.95-1.38],0.1642345779813039
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX5,Sorting nexin-5,14129,115,1.37 [0.79-2.39],0.2586303153523298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX9,Sorting nexin-9,16596,146,1.12 [0.90-1.39],0.3063987587309363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOD1,Superoxide dismutase [Cu-Zn],16321,143,1.10 [0.81-1.49],0.5579076295487906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOD2,"Superoxide dismutase [Mn], mitochondrial",16623,145,1.33 [0.91-1.93],0.1404284284372932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOD3,Extracellular superoxide dismutase,14510,123,1.13 [0.88-1.45],0.3547195448865419
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORBS1,Sorbin and SH3 domain-containing protein 1,14472,123,1.47 [1.12-1.94],0.0056695272118706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORCS2,VPS10 domain-containing receptor SorCS2,16261,143,1.10 [0.72-1.69],0.6639215606151625
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORD,Sorbitol dehydrogenase,16679,145,1.07 [0.86-1.35],0.5338782435648879
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORT1,Sortilin,16570,146,0.80 [0.53-1.20],0.275705081511289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOST,Sclerostin,16570,146,1.44 [0.99-2.09],0.0594046348297248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,14119,118,1.16 [0.86-1.55],0.325812289530764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOX2,Transcription factor SOX-2,14443,123,0.92 [0.44-1.92],0.823230346226483
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOX9,Transcription factor SOX-9,14119,118,0.70 [0.36-1.35],0.2857042965224021
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,14472,123,1.13 [0.65-1.99],0.6618931574750002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPAG1,Sperm-associated antigen 1,14472,123,1.09 [0.83-1.42],0.5514551786251611
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPARC,SPARC,16671,146,0.82 [0.67-0.99],0.0401213877226385
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPARCL1,SPARC-like protein 1,16644,145,1.29 [0.79-2.09],0.3093548830309534
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPART,Spartin,14204,118,1.17 [0.93-1.47],0.1856787026448956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPESP1,Sperm equatorial segment protein 1,14489,121,1.17 [0.70-1.97],0.5516284922989323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK1,Serine protease inhibitor Kazal-type 1,16623,145,1.28 [0.91-1.81],0.1632216367174554
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK2,Serine protease inhibitor Kazal-type 2,14204,118,1.31 [0.81-2.12],0.2768738412717388
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK4,Serine protease inhibitor Kazal-type 4,16574,148,0.81 [0.64-1.03],0.080089929850188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK5,Serine protease inhibitor Kazal-type 5,16623,145,1.42 [0.93-2.17],0.1049982700014849
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK6,Serine protease inhibitor Kazal-type 6,16761,145,1.07 [0.81-1.42],0.6181705172905816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK8,Serine protease inhibitor Kazal-type 8,14028,116,1.02 [0.63-1.66],0.9362193327040476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINT1,Kunitz-type protease inhibitor 1,16577,142,1.45 [0.79-2.65],0.2314693961741307
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINT2,Kunitz-type protease inhibitor 2,16677,147,0.81 [0.56-1.17],0.2672561285447149
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINT3,Kunitz-type protease inhibitor 3,14431,123,0.95 [0.85-1.06],0.3698328494623718
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPOCK1,Testican-1,16463,144,1.23 [0.69-2.17],0.4855076974335471
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPON1,Spondin-1,16626,147,1.27 [0.81-2.00],0.3040117194304406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPON2,Spondin-2,16529,146,1.22 [0.79-1.89],0.3665539524111224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPP1,Osteopontin,16788,143,0.87 [0.62-1.22],0.4138582247462644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",14069,119,1.26 [0.86-1.85],0.2423695034184974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRING1,SREBP regulating gene protein,13997,119,1.08 [0.83-1.41],0.5670659538973155
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRR1B,Cornifin-B,14233,119,0.95 [0.76-1.19],0.6365076508632965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRR3,Small proline-rich protein 3,14478,121,0.88 [0.68-1.15],0.3480530784086756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRY2,Protein sprouty homolog 2,16319,145,1.03 [0.88-1.21],0.7115217233688056
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",14051,117,1.06 [0.62-1.81],0.8222391063312612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPTLC1,Serine palmitoyltransferase 1,14478,121,0.99 [0.63-1.55],0.9563071091933962
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRC,Proto-oncogene tyrosine-protein kinase Src,16642,146,0.99 [0.88-1.12],0.8988371228671326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRP14,Signal recognition particle 14 kDa protein,16535,147,1.14 [0.90-1.44],0.2884587664893928
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRPK2,SRSF protein kinase 2,16574,148,1.02 [0.85-1.21],0.8591492984969411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRPX,Sushi repeat-containing protein SRPX,14489,121,1.19 [0.74-1.92],0.4830648780930896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSB,Lupus La protein,16227,143,1.05 [0.82-1.34],0.6952973509510247
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",14069,119,0.90 [0.53-1.55],0.7130309444650136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,16570,146,1.05 [0.93-1.19],0.4298445589752422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,16700,145,1.09 [0.77-1.54],0.6380688557263914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSH3,Protein phosphatase Slingshot homolog 3,13997,119,1.42 [0.82-2.45],0.2057172249090968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSNA1,Sjoegren syndrome nuclear autoantigen 1,14431,123,1.01 [0.72-1.42],0.9391138068973518
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST13,Hsc70-interacting protein,14204,118,1.23 [0.90-1.69],0.1983906195201307
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",16535,147,1.10 [0.78-1.54],0.592328185085813
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",16810,143,1.08 [0.66-1.76],0.7486017548578255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",14069,119,1.06 [0.76-1.47],0.7329631153056324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAB2,Stabilin-2,14504,123,1.33 [0.71-2.48],0.373721863574973
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAM,Signal transducing adapter molecule 1,14445,123,1.24 [0.81-1.89],0.3234187823336203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAMBP,STAM-binding protein,16434,144,1.10 [0.87-1.39],0.4438040728403191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAT2,Signal transducer and activator of transcription 2,14069,119,1.04 [0.82-1.31],0.7718089471410553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAT5B,Signal transducer and activator of transcription 5B,16535,147,0.99 [0.89-1.10],0.8036011276768653
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,13997,119,1.11 [0.87-1.42],0.4059442091405971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STC1,Stanniocalcin-1,16735,146,1.40 [1.02-1.92],0.0362487427067713
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STC2,Stanniocalcin-2,16606,145,1.55 [0.83-2.91],0.1733482074745424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STEAP4,Metalloreductase STEAP4,14051,117,0.98 [0.76-1.26],0.8467003820514527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STIP1,Stress-induced-phosphoprotein 1,16600,144,1.15 [0.92-1.44],0.2159506490272978
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STK11,Serine/threonine-protein kinase STK11,16307,141,1.10 [0.89-1.35],0.3882937647599583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STK24,Serine/threonine-protein kinase 24,16227,143,1.10 [0.86-1.40],0.451789291608262
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STK4,Serine/threonine-protein kinase 4,16596,146,0.98 [0.83-1.17],0.850002687038983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STOML2,"Stomatin-like protein 2, mitochondrial",13997,119,1.11 [0.93-1.32],0.2582805984371878
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX16,Syntaxin-16,16261,143,1.00 [0.77-1.30],0.9888184259853572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX1B,Syntaxin-1B,14119,118,1.31 [0.93-1.85],0.1252002365516027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX3,Syntaxin-3,14478,121,0.86 [0.53-1.41],0.5576412640332481
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX4,Syntaxin-4,16535,147,1.20 [0.97-1.49],0.0946235324039161
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX5,Syntaxin-5,14069,119,0.94 [0.59-1.50],0.7982177540943969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX6,Syntaxin-6,16261,143,1.05 [0.84-1.31],0.6564006070174768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX7,Syntaxin-7,14069,119,1.31 [0.92-1.88],0.1396965259265033
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX8,Syntaxin-8,16574,148,1.13 [0.84-1.52],0.4161957876562199
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STXBP1,Syntaxin-binding protein 1,14472,123,0.96 [0.77-1.20],0.7473468926362272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STXBP3,Syntaxin-binding protein 3,16261,143,0.95 [0.66-1.35],0.7664648412286242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUGP1,SURP and G-patch domain-containing protein 1,14431,123,1.42 [0.96-2.11],0.0818629561545175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUGT1,Protein SGT1 homolog,16261,143,1.06 [0.88-1.29],0.5123647940013635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SULT1A1,Sulfotransferase 1A1,16735,146,0.99 [0.89-1.11],0.9058173269335882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SULT2A1,Bile salt sulfotransferase,16574,148,1.12 [0.87-1.44],0.3811928802704659
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUMF1,Formylglycine-generating enzyme,14069,119,1.16 [0.94-1.44],0.1654728813032545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,16735,146,0.97 [0.73-1.28],0.8190156531509912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUOX,"Sulfite oxidase, mitochondrial",14472,123,1.06 [0.80-1.39],0.6947268328607081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD1,Sushi domain-containing protein 1,16307,141,1.08 [0.79-1.47],0.640616764492299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD2,Sushi domain-containing protein 2,16623,145,1.42 [0.87-2.33],0.1635885036062835
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD4,Sushi domain-containing protein 4,14445,123,0.98 [0.64-1.50],0.9155033740026144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD5,Sushi domain-containing protein 5,14127,118,1.07 [0.63-1.81],0.8072340184432456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SV2A,Synaptic vesicle glycoprotein 2A,14119,118,0.88 [0.65-1.20],0.4163338870012402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SWAP70,Switch-associated protein 70,14431,123,1.34 [0.88-2.04],0.1726846037463301
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYAP1,Synapse-associated protein 1,14204,118,1.10 [0.81-1.50],0.5390005012909378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,14051,117,0.85 [0.61-1.20],0.3653116452264136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYT1,Synaptotagmin-1,14478,121,1.20 [0.84-1.71],0.3129742916737141
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYTL4,Synaptotagmin-like protein 4,14489,121,1.11 [0.88-1.41],0.366955598418362
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,14233,119,1.06 [0.89-1.25],0.5140514738274407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TACC3,Transforming acidic coiled-coil-containing protein 3,16535,147,0.97 [0.85-1.10],0.6164763573286205
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TACSTD2,Tumor-associated calcium signal transducer 2,14732,122,1.13 [0.65-2.00],0.6605335355422547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TADA3,Transcriptional adapter 3,14445,123,1.21 [0.80-1.85],0.3687649435530893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAFA5,Chemokine-like protein TAFA-5,16535,147,1.33 [0.89-1.98],0.1642690117674739
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAGLN3,Transgelin-3,13997,119,0.82 [0.60-1.11],0.2013928319907721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TALDO1,Transaldolase,14443,123,1.24 [0.85-1.83],0.262934705853786
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TANK,TRAF family member-associated NF-kappa-B activator,16319,145,1.05 [0.85-1.30],0.6618162024086724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAP1,Antigen peptide transporter 1,14233,119,1.16 [0.91-1.48],0.2436958844504763
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TARBP2,RISC-loading complex subunit TARBP2,16227,143,1.10 [0.91-1.33],0.3392140654796694
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",14119,118,1.08 [0.87-1.34],0.5013030629908146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",14445,123,1.03 [0.66-1.60],0.9055857499741772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAX1BP1,Tax1-binding protein 1,14478,121,1.24 [0.95-1.62],0.111449010303765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBC1D17,TBC1 domain family member 17,16227,143,1.36 [1.02-1.81],0.0379773708764608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBC1D23,TBC1 domain family member 23,16535,147,1.00 [0.85-1.18],0.9909639125140908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBC1D5,TBC1 domain family member 5,16574,148,1.07 [0.90-1.28],0.4399144824347663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBCA,Tubulin-specific chaperone A,14204,118,1.15 [0.93-1.42],0.2009917160003269
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBCB,Tubulin-folding cofactor B,16463,144,1.00 [0.86-1.16],0.9765271262259252
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBCC,Tubulin-specific chaperone C,16463,144,1.03 [0.85-1.23],0.7755809020092106
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBL1X,F-box-like/WD repeat-containing protein TBL1X,16261,143,1.03 [0.86-1.23],0.747438897143505
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBR1,T-box brain protein 1,14119,118,1.11 [0.79-1.55],0.541854914146191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCL1A,T-cell leukemia/lymphoma protein 1A,16446,144,0.89 [0.77-1.03],0.1243097267406371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCL1B,T-cell leukemia/lymphoma protein 1B,16307,141,0.88 [0.71-1.09],0.2444733702756668
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCN1,Transcobalamin-1,14207,123,1.28 [0.79-2.06],0.3131069705023199
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCN2,Transcobalamin-2,16788,143,1.14 [0.71-1.83],0.5753982169970686
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCOF1,Treacle protein,14489,121,0.80 [0.44-1.46],0.4709171758467236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCP11,T-complex protein 11 homolog,14233,119,0.93 [0.66-1.30],0.6721934535380336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCTN3,Tectonic-3,14489,121,1.20 [0.67-2.16],0.5378024063912856
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDGF1,Teratocarcinoma-derived growth factor 1,16227,143,0.98 [0.89-1.08],0.6857690551732794
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDO2,"Tryptophan 2,3-dioxygenase",14119,118,0.86 [0.52-1.44],0.5717555623489603
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDP1,Tyrosyl-DNA phosphodiesterase 1,14445,123,1.14 [0.93-1.41],0.2080275741783371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDRKH,Tudor and KH domain-containing protein,16227,143,1.07 [0.90-1.28],0.4334878948929267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEF,Thyrotroph embryonic factor,14028,116,1.14 [0.78-1.68],0.4939579039060326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEK,Angiopoietin-1 receptor,16671,146,1.47 [0.75-2.86],0.2603649050946627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TERF1,Telomeric repeat-binding factor 1,14069,119,1.22 [0.68-2.18],0.5132528779534857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TET2,Methylcytosine dioxygenase TET2,14197,119,1.07 [0.91-1.25],0.4179197166293791
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEX101,Testis-expressed protein 101,14119,118,0.93 [0.68-1.29],0.6725882570137718
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEX33,Testis-expressed protein 33,14233,119,1.28 [0.92-1.79],0.1370227333746443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TF,Serotransferrin,14518,122,0.51 [0.23-1.13],0.0985296148523123
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFAP2A,Transcription factor AP-2-alpha,14051,117,1.06 [0.80-1.40],0.6796503596493159
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFF1,Trefoil factor 1,16547,144,0.99 [0.82-1.19],0.9138095345027006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFF2,Trefoil factor 2,16652,147,1.02 [0.79-1.32],0.8793959909206726
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFF3,Trefoil factor 3,16611,144,1.26 [0.89-1.77],0.1896256855094354
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFPI,Tissue factor pathway inhibitor,16602,145,1.06 [0.65-1.72],0.8291475751361587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFPI2,Tissue factor pathway inhibitor 2,16628,146,0.96 [0.64-1.45],0.8607449653779057
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFRC,Transferrin receptor protein 1,16694,145,1.10 [0.74-1.62],0.6479624562900916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TG,Thyroglobulin,14445,123,1.03 [0.88-1.20],0.7441113522979735
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFA,Protransforming growth factor alpha,16574,148,0.95 [0.69-1.32],0.7772825563671182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFB1,Transforming growth factor beta-1 proprotein,16750,145,0.91 [0.61-1.35],0.6320506229037426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFB2,Transforming growth factor beta-2 proprotein,14445,123,0.95 [0.68-1.32],0.7540222632502747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBI,Transforming growth factor-beta-induced protein ig-h3,16544,144,2.22 [1.30-3.81],0.0036384693852493
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBR1,TGF-beta receptor type-1,14069,119,1.40 [0.66-2.99],0.3789216491736782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBR2,TGF-beta receptor type-2,16671,146,1.54 [1.01-2.34],0.0423716190103037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBR3,Transforming growth factor beta receptor type 3,16810,143,1.00 [0.62-1.62],0.9979849088352952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGM2,Protein-glutamine gamma-glutamyltransferase 2,16577,146,1.09 [0.90-1.33],0.3611360147144534
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGOLN2,Trans-Golgi network integral membrane protein 2,14510,123,1.23 [0.64-2.35],0.5381064027952207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THAP12,52 kDa repressor of the inhibitor of the protein kinase,13975,119,0.93 [0.75-1.16],0.5377517865526615
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THBD,Thrombomodulin,16596,146,1.27 [0.78-2.08],0.336622577338231
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THBS2,Thrombospondin-2,16623,145,1.43 [0.98-2.10],0.0625105946039366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THBS4,Thrombospondin-4,16640,145,1.33 [0.96-1.84],0.0900221381287544
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THOP1,Thimet oligopeptidase,16508,145,1.21 [0.75-1.95],0.4276716005069169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THPO,Thrombopoietin,16307,141,0.89 [0.61-1.31],0.5516095026064125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THRAP3,Thyroid hormone receptor-associated protein 3,14028,116,1.01 [0.86-1.19],0.9087292705450152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THSD1,Thrombospondin type-1 domain-containing protein 1,13957,119,1.02 [0.60-1.72],0.9495355959977873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THTPA,Thiamine-triphosphatase,14420,123,1.07 [0.87-1.30],0.5355463772975233
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THY1,Thy-1 membrane glycoprotein,16735,146,1.73 [1.05-2.86],0.0326790824240043
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIA1,Nucleolysin TIA-1 isoform p40,16128,141,0.98 [0.86-1.11],0.7334452590382321
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIE1,Tyrosine-protein kinase receptor Tie-1,16810,143,0.75 [0.55-1.01],0.0576622812550895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",16198,143,1.15 [0.84-1.57],0.3739836408307242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,14233,119,1.20 [0.79-1.82],0.3898255180576772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,16700,145,1.19 [0.84-1.67],0.3300473961004815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,14489,121,0.87 [0.56-1.37],0.5530114932993319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,14478,121,1.10 [0.89-1.34],0.3757376413748424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP1,Metalloproteinase inhibitor 1,16467,143,1.10 [0.64-1.88],0.735245752754516
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP2,Metalloproteinase inhibitor 2,14489,121,1.38 [0.94-2.03],0.0977238491011091
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP3,Metalloproteinase inhibitor 3,16677,147,0.92 [0.82-1.03],0.1645791166717085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP4,Metalloproteinase inhibitor 4,16623,145,1.12 [0.78-1.61],0.5454591490997361
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TINAGL1,Tubulointerstitial nephritis antigen-like,16546,146,1.58 [0.81-3.11],0.1814887237982645
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TJAP1,Tight junction-associated protein 1,16671,146,1.04 [0.87-1.24],0.6712346051363502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TJP3,Tight junction protein ZO-3,14051,117,0.93 [0.60-1.45],0.7599690791751491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TK1,"Thymidine kinase, cytosolic",14233,119,1.05 [0.71-1.55],0.8234388962024979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR1,Toll-like receptor 1,14069,119,1.61 [0.88-2.96],0.1255821599011984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR2,Toll-like receptor 2,14233,119,1.34 [0.63-2.85],0.4511965537829498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR3,Toll-like receptor 3,16776,146,1.04 [0.81-1.32],0.766328728922607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR4,Toll-like receptor 4,14069,119,1.74 [0.97-3.09],0.061428624757403
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,14119,118,1.08 [0.79-1.47],0.6399491792415684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED1,Transmembrane emp24 domain-containing protein 1,14233,119,0.69 [0.48-1.00],0.0517135320813361
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED10,Transmembrane emp24 domain-containing protein 10,14028,116,0.77 [0.46-1.28],0.3089235341763701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED4,Transmembrane emp24 domain-containing protein 4,14028,116,1.03 [0.76-1.40],0.8485671347487076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED8,Protein TMED8,14431,123,1.04 [0.87-1.23],0.6838904590727031
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMEM106A,Transmembrane protein 106A,14445,123,0.97 [0.75-1.24],0.7866357284651285
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMEM132A,Transmembrane protein 132A,14129,115,1.04 [0.78-1.38],0.7924607498121484
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMEM25,Transmembrane protein 25,14472,123,1.12 [0.79-1.59],0.5216335354329078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMOD4,Tropomodulin-4,13997,119,1.03 [0.66-1.60],0.906469279380132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS11B,Transmembrane protease serine 11B,14051,117,0.75 [0.57-1.01],0.0561747508941127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS11D,Transmembrane protease serine 11D,14453,121,1.28 [0.84-1.94],0.2562215697080217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS15,Enteropeptidase,16535,147,1.00 [0.85-1.17],0.9567738380636698
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS5,Transmembrane protease serine 5,16388,141,1.07 [0.72-1.59],0.7292279056956406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMSB10,Thymosin beta-10,16623,145,1.00 [0.82-1.23],0.972024023683346
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNC,Tenascin,16700,145,1.17 [0.87-1.59],0.3031737811964972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNF,Tumor necrosis factor,16282,141,0.99 [0.65-1.50],0.9476848166221477
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,14431,123,1.21 [0.87-1.69],0.2626662116876334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,16319,145,0.99 [0.66-1.48],0.9449080127391992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,14204,118,0.96 [0.72-1.28],0.7859521752056202
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,16463,144,1.01 [0.64-1.61],0.959683146909041
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,16463,144,1.21 [0.95-1.56],0.1279397842153248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,16653,143,1.11 [0.81-1.50],0.5157818503147593
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,16776,146,1.24 [0.85-1.80],0.2594099922108011
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,16598,147,1.69 [1.03-2.79],0.0378170893228406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,16671,146,1.68 [1.12-2.50],0.0118618200545631
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,16626,147,1.97 [1.31-2.95],0.0010413116915746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,16319,145,1.28 [0.88-1.85],0.1928223930539904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,16626,147,1.14 [0.70-1.85],0.6058005792362229
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,14204,118,1.59 [1.03-2.45],0.0346579680852053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,16761,145,1.64 [1.06-2.52],0.0258337208347751
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,16623,145,1.46 [0.91-2.34],0.1197469287414308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,16623,145,1.22 [0.84-1.79],0.2927420276731049
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,16735,146,1.12 [0.65-1.92],0.6825298631126047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,16750,145,1.29 [0.87-1.90],0.2001890294920187
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,16463,144,1.23 [0.96-1.58],0.1012765055524301
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,16735,146,0.93 [0.66-1.30],0.6514014959112615
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,16463,144,1.36 [0.95-1.93],0.0904783399836709
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF10,Tumor necrosis factor ligand superfamily member 10,16776,146,0.81 [0.45-1.45],0.4763308611282749
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF11,Tumor necrosis factor ligand superfamily member 11,16574,148,0.93 [0.73-1.18],0.5363323122372357
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF12,Tumor necrosis factor ligand superfamily member 12,16776,146,0.93 [0.55-1.57],0.788398377674512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF13,Tumor necrosis factor ligand superfamily member 13,16677,147,0.53 [0.31-0.93],0.0281286628403416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,16790,143,0.89 [0.51-1.56],0.6868710398503797
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF14,Tumor necrosis factor ligand superfamily member 14,16463,144,0.99 [0.77-1.28],0.9434092209342372
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF8,Tumor necrosis factor ligand superfamily member 8,14504,123,0.91 [0.56-1.48],0.7021972098231803
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNIP1,TNFAIP3-interacting protein 1,14478,121,1.17 [0.97-1.42],0.102582537149382
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNN,Tenascin-N,14504,123,0.89 [0.60-1.32],0.5604471089672907
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNNI3,"Troponin I, cardiac muscle",16307,141,0.96 [0.80-1.14],0.6195261021011931
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNPO1,Transportin-1,14233,119,1.04 [0.63-1.72],0.8888782796043727
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNR,Tenascin-R,16463,144,1.21 [0.86-1.71],0.2731197886402502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNXB,Tenascin-X,16623,145,0.95 [0.53-1.70],0.8609071233401152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,14489,121,1.05 [0.84-1.31],0.6764905367347971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOP1,DNA topoisomerase 1,14431,123,1.07 [0.92-1.25],0.3675400979559341
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOP1MT,"DNA topoisomerase I, mitochondrial",13997,119,1.00 [0.70-1.42],0.9812147145603434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOP2B,DNA topoisomerase 2-beta,14069,119,1.11 [0.89-1.38],0.3511688389058511
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOR1AIP1,Torsin-1A-interacting protein 1,14129,115,0.96 [0.68-1.36],0.8350832948611171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53,Cellular tumor antigen p53,16261,143,0.91 [0.64-1.29],0.5892680115424657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53BP1,TP53-binding protein 1,14069,119,1.01 [0.82-1.24],0.935358924272322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53I3,Quinone oxidoreductase PIG3,13896,118,1.26 [0.90-1.76],0.1836337606589552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53INP1,Tumor protein p53-inducible nuclear protein 1,16307,141,0.73 [0.40-1.31],0.2848514870222359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP73,Tumor protein p73,14119,118,0.84 [0.50-1.41],0.5079490063634009
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPBGL,Trophoblast glycoprotein-like,14119,118,1.01 [0.66-1.52],0.9765720680153536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPD52L2,Tumor protein D54,14204,118,1.00 [0.85-1.18],0.9968642723367844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPK1,Thiamin pyrophosphokinase 1,14489,121,0.98 [0.52-1.87],0.9618207657579246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPM3,Tropomyosin alpha-3 chain,14028,116,1.05 [0.71-1.56],0.7903425122887117
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPMT,Thiopurine S-methyltransferase,16261,143,1.15 [0.95-1.40],0.1590712733726996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPP1,Tripeptidyl-peptidase 1,16489,146,1.16 [0.85-1.59],0.3495768021954343
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPPP2,Tubulin polymerization-promoting protein family member 2,14233,119,1.05 [0.85-1.29],0.6599439809010033
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPPP3,Tubulin polymerization-promoting protein family member 3,16227,143,0.92 [0.61-1.37],0.672656737115915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPR,Nucleoprotein TPR,14028,116,1.36 [1.07-1.72],0.0108313985755825
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPRKB,EKC/KEOPS complex subunit TPRKB,13997,119,1.21 [0.99-1.48],0.0648226570191078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPSAB1,Tryptase alpha/beta-1,16752,145,1.13 [0.85-1.50],0.3933059981912767
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPSD1,Tryptase delta,14472,123,0.73 [0.43-1.23],0.2317797463167008
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPSG1,Tryptase gamma,14069,119,1.10 [0.57-2.12],0.7840188417119895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPT1,Translationally-controlled tumor protein,16319,145,0.95 [0.75-1.21],0.679224863486294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRAF2,TNF receptor-associated factor 2,16574,148,1.28 [1.04-1.56],0.0185750647751581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRAF3,"TNF receptor-associated factor 3, Isoform 2",14069,119,1.20 [0.78-1.84],0.3978655452416465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,14028,116,0.99 [0.69-1.44],0.9716623518512916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,14233,119,1.11 [0.92-1.33],0.2612148846955731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREH,Trehalase,14504,123,0.96 [0.76-1.22],0.7613338312186901
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREM2,Triggering receptor expressed on myeloid cells 2,16598,147,1.05 [0.79-1.40],0.7231566710854982
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREML1,Trem-like transcript 1 protein,14510,123,0.86 [0.62-1.21],0.3917557616257697
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREML2,Trem-like transcript 2 protein,16623,145,1.06 [0.68-1.65],0.7927662337376628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIAP1,TP53-regulated inhibitor of apoptosis 1,16761,145,1.01 [0.79-1.28],0.966604302247727
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM21,E3 ubiquitin-protein ligase TRIM21,16574,148,1.02 [0.84-1.24],0.8635493519688309
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM24,Transcription intermediary factor 1-alpha,14209,119,1.08 [0.82-1.41],0.5907108845533959
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,14431,123,1.11 [0.95-1.31],0.2001384747770028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM26,Tripartite motif-containing protein 26,13997,119,1.14 [0.86-1.51],0.3575217043996175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM40,E3 ubiquitin ligase TRIM40,14119,118,0.72 [0.55-0.93],0.0123492569029008
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM5,Tripartite motif-containing protein 5,16574,148,0.95 [0.80-1.13],0.5629192329339172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM58,E3 ubiquitin-protein ligase TRIM58,14445,123,1.20 [0.98-1.46],0.0771397303072127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRPV3,Transient receptor potential cation channel subfamily V member 3,14028,116,1.32 [0.99-1.77],0.0597316225425587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSC1,Hamartin,14069,119,0.96 [0.75-1.24],0.7610182819790977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSC22D1,TSC22 domain family protein 1,14472,123,1.07 [0.83-1.39],0.5967699981251211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSHB,Thyrotropin subunit beta,16596,146,1.14 [0.95-1.38],0.1523852658663252
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSLP,Thymic stromal lymphopoietin,16307,141,0.96 [0.75-1.25],0.7845205190036546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSNAX,Translin-associated protein X,14028,116,1.21 [0.77-1.88],0.4075569129981281
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN1,Tetraspanin-1,16307,141,1.19 [1.01-1.40],0.0363756016930359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN15,Tetraspanin-15,14028,116,1.21 [0.90-1.63],0.19671180516387
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN7,Tetraspanin-7,14051,117,1.00 [0.83-1.21],0.9998924471280936
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN8,Tetraspanin-8,14431,123,1.03 [0.87-1.23],0.7123177668623364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPYL1,Testis-specific Y-encoded-like protein 1,14069,119,1.11 [0.72-1.72],0.6380904310773392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TST,Thiosulfate sulfurtransferase,16191,143,1.04 [0.85-1.26],0.7229972922574149
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TTF2,Transcription termination factor 2,14119,118,0.97 [0.67-1.40],0.8605863441813795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TTN,Titin,14028,116,1.09 [0.85-1.40],0.5077998011850062
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TTR,Transthyretin,14361,121,0.85 [0.42-1.73],0.6594746571904246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TUBB3,Tubulin beta-3 chain,14051,117,0.66 [0.35-1.26],0.2063292993021213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TWF2,Twinfilin-2,14504,123,0.99 [0.80-1.22],0.9171434788967257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXK,Tyrosine-protein kinase TXK,14233,119,1.13 [0.93-1.38],0.2126674827325064
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXLNA,Alpha-taxilin,16463,144,1.00 [0.84-1.19],0.9996024490495728
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXN,Thioredoxin,14264,118,1.42 [1.04-1.95],0.0294771957137085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNDC15,Thioredoxin domain-containing protein 15,16671,146,1.27 [0.75-2.15],0.3812546881946043
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNDC5,Thioredoxin domain-containing protein 5,16735,146,1.02 [0.82-1.27],0.8813626939774135
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNDC9,Thioredoxin domain-containing protein 9,14478,121,0.91 [0.64-1.29],0.5932877791322289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNL1,Thioredoxin-like protein 1,14025,117,1.09 [0.93-1.28],0.289007115598357
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",16623,145,1.07 [0.78-1.48],0.6745758484480917
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TYMP,Thymidine phosphorylase,16486,145,0.90 [0.72-1.13],0.3737243873598441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TYRO3,Tyrosine-protein kinase receptor TYRO3,16596,146,1.42 [0.85-2.39],0.1811195856861752
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",14069,119,1.09 [0.82-1.44],0.5535532307257325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBAC1,Ubiquitin-associated domain-containing protein 1,16535,147,1.40 [0.92-2.13],0.1175282424937687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBE2B,Ubiquitin-conjugating enzyme E2 B,14445,123,1.21 [0.70-2.11],0.4947432712515902
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,14489,121,1.12 [0.84-1.49],0.4304292745069028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,14069,119,0.94 [0.68-1.29],0.6897220218316289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBQLN3,Ubiquilin-3,14028,116,0.88 [0.61-1.28],0.5029064579740072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBXN1,UBX domain-containing protein 1,14204,118,1.17 [0.90-1.51],0.2400166697204971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,14431,123,1.01 [0.89-1.14],0.9296926137278432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UGDH,UDP-glucose 6-dehydrogenase,14028,116,1.08 [0.91-1.27],0.3792064274233128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UHRF2,E3 ubiquitin-protein ligase UHRF2,14028,116,0.73 [0.41-1.33],0.3084861366588854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ULBP2,UL16-binding protein 2,16463,144,1.44 [0.99-2.11],0.0585213635628473
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UMOD,Uromodulin,16768,143,0.98 [0.74-1.30],0.8869876487479543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UNC5D,Netrin receptor UNC5D,14069,119,1.26 [0.64-2.50],0.5045624614638641
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UNC79,Protein unc-79 homolog,13997,119,1.29 [0.97-1.72],0.0771061532207743
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UNG,Uracil-DNA glycosylase,14445,123,1.01 [0.62-1.65],0.9800075380764564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UPB1,Beta-ureidopropionase,14489,121,1.17 [0.97-1.42],0.0981528899069066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UPK3A,Uroplakin-3a,14051,117,1.20 [0.86-1.67],0.2814545862666467
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UPK3BL1,Uroplakin-3b-like protein 1,14203,119,1.10 [0.81-1.48],0.5433913184774839
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UROD,Uroporphyrinogen decarboxylase,14204,118,1.01 [0.77-1.31],0.9664597457989904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UROS,Uroporphyrinogen-III synthase,14119,118,1.09 [0.85-1.40],0.4771845813704101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USO1,General vesicular transport factor p115,16535,147,1.03 [0.88-1.22],0.6915689978339303
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP25,Ubiquitin carboxyl-terminal hydrolase 25,14445,123,1.15 [0.90-1.47],0.2574992773351928
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP28,Ubiquitin carboxyl-terminal hydrolase 28,14478,121,1.49 [1.04-2.13],0.028420757772529
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP47,Ubiquitin carboxyl-terminal hydrolase 47,14028,116,1.08 [0.89-1.32],0.4336881677266857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP8,Ubiquitin carboxyl-terminal hydrolase 8,16307,141,1.01 [0.86-1.19],0.8755523303451649
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UXS1,UDP-glucuronic acid decarboxylase 1,16261,143,0.78 [0.57-1.05],0.1019915710340093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAMP5,Vesicle-associated membrane protein 5,16307,141,1.05 [0.80-1.38],0.7484959454094509
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAMP8,Vesicle-associated membrane protein 8,14069,119,1.08 [0.88-1.32],0.4701941827340807
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VASH1,Tubulinyl-Tyr carboxypeptidase 1,16574,148,0.97 [0.81-1.16],0.7259578492808159
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VASN,Vasorin,16362,143,1.39 [0.80-2.42],0.2447743736645238
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VASP,Vasodilator-stimulated phosphoprotein,14510,123,1.01 [0.79-1.28],0.95705074592196
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,16535,147,1.43 [0.68-3.02],0.3444828519801344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAV3,Guanine nucleotide exchange factor VAV3,14051,117,1.09 [0.91-1.30],0.3716239580809356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VCAM1,Vascular cell adhesion protein 1,16670,145,1.29 [0.74-2.25],0.367710348379633
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VCAN,Versican core protein,16735,146,1.15 [0.71-1.89],0.5675541255993
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VCPKMT,Protein-lysine methyltransferase METTL21D,13997,119,1.18 [1.01-1.39],0.0416112466037878
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFA,Vascular endothelial growth factor A,16731,146,0.98 [0.76-1.27],0.8735277358727442
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFB,Vascular endothelial growth factor B,14069,119,1.24 [0.67-2.30],0.4919389747796652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFC,Vascular endothelial growth factor C,16671,146,0.86 [0.66-1.12],0.2694623339684721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFD,Vascular endothelial growth factor D,16749,146,1.61 [1.08-2.40],0.0204838080907288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VGF,Neurosecretory protein VGF,14472,123,0.60 [0.34-1.07],0.0845280419690084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VIM,Vimentin,16307,141,0.98 [0.87-1.12],0.8032315991581587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VIPR1,Vasoactive intestinal polypeptide receptor 1,14129,115,0.78 [0.35-1.74],0.5475337773857228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VIT,Vitrin,14489,121,1.64 [1.03-2.62],0.0385646347234554
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VMO1,Vitelline membrane outer layer protein 1 homolog,16535,147,1.28 [1.02-1.62],0.0354604688809298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VNN1,Pantetheinase,14510,123,1.10 [0.86-1.41],0.4323783252412351
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VNN2,Vascular non-inflammatory molecule 2,16535,147,0.82 [0.60-1.12],0.204619077289151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS28,Vacuolar protein sorting-associated protein 28 homolog,14233,119,1.17 [0.90-1.51],0.24256538608418
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS37A,Vacuolar protein sorting-associated protein 37A,16535,147,0.99 [0.82-1.19],0.9242715112700428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS4B,Vacuolar protein sorting-associated protein 4B,14445,123,1.00 [0.83-1.20],0.9646858730623286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS53,Vacuolar protein sorting-associated protein 53 homolog,16535,147,1.06 [0.87-1.27],0.574172402058444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG10,V-set and immunoglobulin domain-containing protein 10,14445,123,1.59 [1.09-2.33],0.0164225195642523
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,14028,116,1.35 [0.82-2.20],0.2344443262642059
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG2,V-set and immunoglobulin domain-containing protein 2,14445,123,1.05 [0.81-1.36],0.730149771874893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG4,V-set and immunoglobulin domain-containing protein 4,16606,145,1.13 [0.79-1.62],0.4946023483750847
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,16567,146,0.96 [0.75-1.22],0.7140821601553133
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSNL1,Visinin-like protein 1,14478,121,1.11 [0.70-1.75],0.6673341966052942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSTM1,V-set and transmembrane domain-containing protein 1,16227,143,1.16 [0.88-1.53],0.2881446038092642
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSTM2B,V-set and transmembrane domain-containing protein 2B,14233,119,1.21 [0.85-1.73],0.2871768524366604
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,16307,141,1.00 [0.78-1.29],0.9724367139209787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,16735,146,0.96 [0.78-1.18],0.7161680857945878
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VTCN1,V-set domain-containing T-cell activation inhibitor 1,16261,143,0.85 [0.51-1.40],0.5198980983991561
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,14204,118,1.12 [0.83-1.52],0.4588586602783553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWA1,von Willebrand factor A domain-containing protein 1,16731,145,1.34 [0.94-1.90],0.1032124213960811
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWA5A,von Willebrand factor A domain-containing protein 5A,13997,119,0.92 [0.72-1.18],0.5126431635406343
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWC2,Brorin,16403,141,1.03 [0.71-1.51],0.8670075401131269
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWC2L,von Willebrand factor C domain-containing protein 2-like,14472,123,1.07 [0.74-1.53],0.7229660899634134
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWF,von Willebrand factor,16810,143,1.02 [0.83-1.25],0.8481550077440394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WARS,"Tryptophan--tRNA ligase, cytoplasmic",16623,145,1.15 [0.78-1.70],0.4829237655070325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WAS,Wiskott-Aldrich syndrome protein,16319,145,1.12 [0.90-1.39],0.312896398453555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASF1,Wiskott-Aldrich syndrome protein family member 1,16307,141,1.09 [0.93-1.28],0.2969020387764725
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASF3,Wiskott-Aldrich syndrome protein family member 3,16227,143,1.03 [0.86-1.23],0.7518739855352906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASHC3,WASH complex subunit 3,14478,121,1.11 [0.89-1.39],0.3531309782483635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASL,Neural Wiskott-Aldrich syndrome protein,14069,119,1.00 [0.74-1.34],0.9851500890843818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WDR46,WD repeat-containing protein 46,14445,123,1.13 [0.71-1.80],0.6099536837383748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFDC1,WAP four-disulfide core domain protein 1,14138,121,0.94 [0.67-1.32],0.7084595813019747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFDC12,WAP four-disulfide core domain protein 12,16740,145,1.16 [0.92-1.46],0.2085295149812459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFDC2,WAP four-disulfide core domain protein 2,15795,139,1.17 [0.79-1.72],0.4317928050749802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",16408,141,0.80 [0.56-1.16],0.2463034799284353
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",16626,147,1.02 [0.66-1.57],0.9188367183695544
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WIF1,Wnt inhibitory factor 1,16761,145,1.02 [0.66-1.58],0.9129972844399238
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WNT9A,Protein Wnt-9a,16319,145,0.97 [0.58-1.63],0.9021052648405888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,16463,144,1.08 [0.82-1.43],0.5778731873453602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XCL1,Lymphotactin,16761,145,0.89 [0.67-1.18],0.4263000954885385
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XG,Glycoprotein Xg,16735,142,1.34 [0.85-2.12],0.2130833743467023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XIAP,E3 ubiquitin-protein ligase XIAP,14069,119,1.16 [0.85-1.57],0.3451904986936711
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XPNPEP2,Xaa-Pro aminopeptidase 2,16671,146,1.04 [0.89-1.20],0.6380521734393985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XRCC4,DNA repair protein XRCC4,16227,143,1.06 [0.71-1.57],0.7863777547195203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YAP1,Transcriptional coactivator YAP1,14478,121,1.72 [0.95-3.10],0.0743541572792619
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",14431,123,1.03 [0.92-1.16],0.5932399137705868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YES1,Tyrosine-protein kinase Yes,16535,147,0.98 [0.86-1.11],0.7410088026548611
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YJU2,Splicing factor YJU2,14445,123,1.12 [0.66-1.89],0.6834811050162128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YOD1,Ubiquitin thioesterase OTU1,14028,116,1.42 [1.08-1.87],0.012939850003449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YTHDF3,YTH domain-containing family protein 3,16319,145,1.04 [0.87-1.24],0.6485804816953067
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YWHAQ,14-3-3 protein theta,14204,118,1.14 [0.90-1.46],0.2719149834264975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YY1,Transcriptional repressor protein YY1,14069,119,0.93 [0.49-1.77],0.8358315803872535
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZBP1,Z-DNA-binding protein 1,14069,119,1.16 [0.76-1.76],0.4922660113302453
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZBTB16,Zinc finger and BTB domain-containing protein 16,16261,143,1.00 [0.81-1.24],0.9913323119825344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZBTB17,Zinc finger and BTB domain-containing protein 17,16307,141,1.21 [0.88-1.67],0.2370842800661931
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZCCHC8,Zinc finger CCHC domain-containing protein 8,14028,116,1.16 [0.90-1.49],0.2468261581076368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZFYVE19,Abscission/NoCut checkpoint regulator,14431,123,1.02 [0.84-1.24],0.8084506126442595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZHX2,Zinc fingers and homeoboxes protein 2,14478,121,1.36 [0.93-1.98],0.1163605920629249
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNF174,Zinc finger protein 174,14069,119,1.24 [0.85-1.80],0.263566959260482
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNF75D,Zinc finger protein 75D,14233,119,0.84 [0.61-1.16],0.2968386500154005
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNF830,Zinc finger protein 830,14445,123,1.00 [0.80-1.25],0.9995964545059558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNRD2,Protein ZNRD2,14431,123,1.21 [0.95-1.54],0.1229410141333694
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,14445,123,0.98 [0.71-1.34],0.8834151095547487
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZP3,Zona pellucida sperm-binding protein 3,14129,115,0.97 [0.91-1.04],0.4270702813620607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZP4,Zona pellucida sperm-binding protein 4,13997,119,0.69 [0.36-1.33],0.2699652851931131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZPR1,Zinc finger protein ZPR1,14051,117,0.94 [0.78-1.15],0.5678771892845167
